Autonomic dysfunction and perioperative outcome by Whittle, J
	 	 		
	  1 	
 
 
 
 
Autonomic dysfunction and  
perioperative outcome 
 
 
 
 
John Oliver Rafe Whittle 
 
University College London 
 
 
 
 
 
 
Thesis submitted for the degree of 
Doctor of Medicine (Research) 
 
 
 
 
 
 
 
 
 
 
	 	 		
	  2 	
 
 
 
	 	 		
	  3 	
 
 
 
 
 
 
 
 
 
 
 
I, John Oliver Rafe Whittle, confirm that the work presented in this thesis is my own.  
Where information has been derived from other sources, I confirm that this has been 
indicated in the thesis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Signed…………………………………….. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 	 		
	  4 	
 
 
 
		  5 	
Abstract 
	
	 	
Abstract	
 
Objective: To examine the relationship between established autonomic dysfunction, 
measures of cardiopulmonary physiology and perioperative outcome in high-risk 
patients presenting for major surgery. 
 
Summary background data: Experimental data demonstrate that autonomic activity 
is a key modulator of both cardiovascular and immune function following tissue injury 
and inflammation. Autonomic dysfunction is associated with adverse outcomes 
across several medical populations. Whether pre-existing autonomic dysfunction is 
detrimental following controlled tissue injury (surgery) in humans is unknown. 
 
Summary of studies:  Parasympathetic autonomic dysfunction (PAD), defined by 
impaired heart rate recovery after exercise, was associated with a distinct 
physiological profile in patients presenting for preoperative Cardiopulmonary 
Exercise Testing (CPET). This comprised impaired cardiac performance at peak 
exercise, reduced peak oxygen uptake and anaerobic threshold as well as 
chronotropic incompetence. Levels of GRK2, a regulator of beta adrenoreceptor and 
immune/inflammatory activity, in circulating lymphocytes were raised in cells derived 
from individuals with PAD. 
 
Retrospective analysis of outcomes from two prospectively collected colorectal 
surgical cohorts (n=1047) revealed PAD to be common (>30%) and associated with 
an increased length of hospital stay (12 days (95% CI: 9-16) vs. 8 days (95% CI: 6-
8.5), p=0.01), as well as increased risk of significant Clavien-Dindo defined 
morbidity, postoperative gastrointestinal function, sepsis and increased 90-day 
mortality (RR 1.1 (1.007-1.41), p=0.008). 
 
Intraoperative haemodynamic data indicated impaired cardiac contractility and 
increased risk of intraoperative hypotension, possibly contributing to detriments in 
postoperative outcome. 
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Sympathetic autonomic hyperactivity, defined by excessive anticipatory heart rate 
rise prior to starting loaded exercise was associated with a different CPET profile to 
that seen in PAD, defined by evidence of cardiac ischaemia during exercise, 
resulting in impaired cardiac contractile function at peak effort, but also associated 
with increased hospital length of stay. Patients with PAD did not necessarily 
demonstrate sympathetic hyperactivity, but when both were present, physiological 
performance and postoperative outcomes were further impaired. 
 
Conclusions: Both preoperative parasympathetic and sympathetic autonomic 
dysfunction are associated with impaired perioperative outcomes. These data 
demonstrate in high risk surgical patients that established autonomic dysregulation is 
associated with the development of sepsis, myocardial ischaemia, critical illness and 
mortality following major elective surgery.  The autonomic nervous system 
represents an underexplored target for therapies aimed at reducing the morbidity 
burden of major surgery. 
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1 Introduction	
 
1.1 Introduction 
 
Postoperative morbidity is a significant public health burden, which results in 
individual suffering and exhibits a strong relationship with reductions in longer term 
quality of life, morbidity and mortality (Moonesinghe et al. 2011).  To date, whilst 
common co-morbidities associated with impaired postoperative outcomes have been 
well described (Khuri et al. 2005; Story 2011), biological mechanisms as to how and 
why higher risk patients develop postoperative critical illness have remained 
underexplored.  This thesis examines the potential contribution of one candidate 
mechanism for the development of postoperative morbidity: established autonomic 
dysfunction.   
 
In this chapter, I will discuss the importance of postoperative morbidity and mortality 
as a public health problem and explore common mechanisms by which 
postoperative morbidity develops.  I will then describe how intact autonomic function 
is essential for biological stability and introduce the concept of autonomic 
dysfunction.  I will subsequently outline why autonomic dysfunction is likely to be 
highly prevalent in the high risk surgical population and explore potential 
mechanisms by which autonomic dysfunction might drive the development of 
postoperative morbidity, multi-organ dysfunction and critical illness.  Finally, I will 
explore commonly used methods to assess autonomic function and propose the use 
of heart rate recovery after exercise as the most appropriate measure of established 
parasympathetic autonomic in the surgical population. 
 
1.1.1 Post-operative morbidity and mortality are important and incompletely 
understood issues in healthcare  
 
Over 300 million surgical procedures are performed worldwide each year (Weiser et 
al. 2016).  In Europe in 2016, around 100 patients per 100,000 population underwent 
colectomy (Eurostat 2016).  Inpatient mortality after surgery varies widely, but across 
Europe around 4% of patients die before hospital discharge (Pearse et al. 2012).  Of 
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those undergoing major surgery, between and 10% & 17% suffer major 
postoperative complications (Khuri et al. 2005; Ghaferi et al. 2009; McNicol et al. 
2007, Ferraris et al. 2014) and up to half suffer short-term minor postoperative 
morbidity (Grocott et al. 2007; Bennett-Guerrero et al. 1999) resulting in increased 
usage of healthcare resources and delayed or failed recovery to preoperative 
function.  Of those patients who go on to develop serious postoperative 
complications, between 10% & 20% go on to die within 30 days (Ferraris et al. 
2014). 
 
Postoperative morbidity further carries implications for long-term health.  In a 
landmark study of 105,951 patients, those who survived to hospital discharge but 
had suffered a postoperative complication in the first 30 days after surgery, suffered 
up to a 20% increase in mortality up to 10 years postoperatively.  This may reflect 
both the premorbid state of patients presenting for surgery influencing the likelihood 
of development of post operative complications, as well as the impact of these 
complications themselves on long term health (Khuri et al. 2005).  Similar to other 
hospital-treated diseases such as community acquired pneumonia, many patients 
may leave hospital with ongoing subclinical inflammation, which may result in longer 
term morbidity and mortality despite apparent clinical recovery at discharge (Ackland 
& Edwards 2010).  These findings have been supported since by several other 
studies (Toner & Hamilton 2013). 
 
Within the cohort of patients who are deemed at highest risk, a significant minority 
appear to suffer the majority of post-operative complications (Pearse et al. 2006, 
Ferraris et al. 2014).  Identifying which individuals from this high risk group are at 
greatest risk, and indeed refining our definitions and scoring systems for 
perioperative risk has been a focus of much interest in recent years (Moonesinghe et 
al. 2009, Ferraris et al. 2014).   
 
The potential of accurately identifying those at the highest risk has only been partially 
recognised and incompletely realised to date.  Many of the risk factors used today to 
identify those at increased risk of postoperative morbidity have been derived from 
relatively underpowered cohort studies that are able to identify broad groups of 
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patients and individual risk factors for perioperative complications, but lack plausible 
biological mechanisms to explain the development of specific postoperative 
morbidity.   
 
Aside from better informing the consent process; directing potentially beneficial 
treatment strategies towards those most likely to benefit thereby promoting 
appropriate allocation of healthcare resources, a more complete mechanistic 
understanding of drivers of perioperative morbidity will help development of new 
therapeutic and management strategies in addition to better definitions of 
perioperative risk.   
 
1.1.2 Mechanisms of postoperative morbidity 
 
Morbidity after surgery often affects multiple systems, including those remote from 
the operative site (Bennett-Guerrero et al. 1999).  The incidence of gastrointestinal 
dysfunction after lower limb surgery, for example, may be as high as 17% (Grocott et 
al. 2007).  Evidence is accumulating for the existence of multisystem drivers for the 
development of pathology remote from the operative site, which are influenced by 
disruption in physiological control and regulation pathways (Edwards et al. 2015; 
Karmali et al. 2015; Sultan et al. 2014).  This implies that multisystem 
pathophysiological processes underlie much of postoperative morbidity.  The link 
between pre-existing systemic pathophysiology and the development of new 
pathologies in the postoperative period has not been well elucidated.   
 
Surgical trauma activates multiple metabolic, bioenergetic, immunological and neuro-
humoral processes that interact closely in ways still not well understood.  Additional 
complexity is contributed by pre-existing pathology and subsequent and diverse 
physiological stressors applied during the operative period and beyond. 
 
Surgery of moderate to major severity induces neurological, immune and 
inflammatory changes, both through direct tissue trauma and through secondary 
pathways (Kohl & Deutschman 2006).  Hypothalamo-pituitary activation, increases in 
sympathetic nervous activity, vagal withdrawal, hormonal and metabolic changes 
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associated with catabolism and increases in the metabolic demand and usage of 
oxygen have all be described; and dysregulation of all these systems has been 
associated with perioperative morbidity (Pearse et al. 2005; Shoemaker 1988; 
Desborough 2000; Ackland et al. 2015).   
 
Why in patients seemingly matched in terms of commonly recorded risk factors, the 
cardiometabolic, neurological and immune/inflammatory response to surgery in 
certain individuals can vary so widely from that in others is not fully understood.  
These variations, particularly in the higher risk cohort, result in the development of 
multi-organ dysfunction and increased susceptibility to complications such as sepsis 
in seemingly otherwise matched patients. 
 
Dysfunction of the autonomic nervous system (ANS), by virtue of the central role of 
the ANS in the regulation of multiple core biological processes is a strong candidate 
mechanism for the promotion of and development of postoperative morbidity. 
1.2 The Autonomic Nervous System in health and disease 
 
1.2.1 Intact autonomic function is central to maintaining biological stability 
 
The autonomic nervous system is that part of the nervous system responsible for the 
control of biological systems that are not normally consciously regulated or directed.  
Autonomic functions include the control of respiration, as well as cardiovascular and 
gastrointestinal regulation (Figure 1-1). 
Classically, the autonomic nervous system is described as a component of the 
peripheral nervous system consisting of two branches; parasympathetic 
(predominantly cholinergic) and sympathetic (predominantly adrenergic), which are 
both anatomically and functionally differentiated.  Commonly, the two systems are 
conceived as having opposite actions where activation of one limb will result in an 
inhibitory response from the other.  However, current understanding offers a more 
nuanced interpretation of function, where one limb may directly support or enable 
function in the other.  A third system of neurons which are non-adrenergic and non-
cholinergic have relatively recently been described that are integral to autonomic 
function and may act in part to help integrate activity of the two limbs.   
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Central regulation of autonomic function is integrated by the hypothalamus, which 
receives input from multiple specialised centres (such as the vasomotor, apneustic 
and pneumotactic centres and the dorsal vagal nucleus) as well as regulatory input 
from the limbic and somatosensory systems, including sensory input from both 
peripheral afferent sympathetic and parasympathetic neurons (Hall & Guyton 2006).   
 
 
Figure 1-1: The Autonomic Nervous System 
Red represents the sympathetic nervous outflow (thoraco-lumbar), whereas blue represents 
parasympathetic outflow (cranio-sacral), including cranial nerve X (the vagus nerve). Current 
understanding could include other interfaces, such as that between the autonomic and immune 
systems.  Reproduced from Henry Carter (1918), Public Domain.  
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In health, the autonomic nervous system is both responsible for biological stability 
through homeostasis (the maintenance of equilibrium between interdependent 
elements permitting optimal function of multiple physiological processes, e.g. the 
maintenance of organ perfusion pressure through the regulation of blood pressure) 
as well as the maintenance of stability through change by appropriate responses to 
intrinsic and environmental physiological stressors (allostasis; e.g. an increase in 
heart rate in response to a demand such as exercise, an important component of 
homeostasis; McEwen & Wingfield 2003).  Allostatic changes are in general adaptive 
in the short term (Schulkin 2004), though in the long term can contribute to the 
pathogenesis of common chronic diseases (e.g. the role of chronic sympathetic 
activation secondary to psychological stress in the pathogenesis of end-organ 
damage secondary to hypertension; McEwen 1998; McEwen 2004).   
 
Dysfunction in autonomic controlled allostatic mechanisms may lead to disease 
through several mechanisms.  These include the frequent activation of allostatic 
mechanisms, failure to terminate an allostatic response after a stressor has been 
removed and the inadequate response of an allostatic mechanism to another 
normally counter-regulated allostatic mechanism (e.g. failure of vagal activity to 
adequately counter elevated sympathetic outflow; McEwen 1998).  The maintenance 
of biological variability is therefore key to health and the maintenance of intact organ 
function, loss of which may result in multi system pathology (Godin & Buchman 
1996). 
 
By virtue of the multisystem connectivity resultant from autonomic innervation, the 
autonomic nervous system provides a conduit for inter-organ cross-talk which in 
health promotes adaptive function, but in disease may promote multi-organ 
dysfunction (Brumovsky & Gebhart 2010; Dobson et al. 2006; Davenport 2008; 
Kociol et al. 2009; Zoccali et al. 2014; Mastitskaya et al. 2012).  Diseases such as 
cardiac failure, hypertension and diabetes cause chronic physiological stress to the 
patient resulting in measurable damage to end-organ systems.  Autonomic 
dysfunction, possibly secondary to this load, is common in these conditions and 
plays a mechanistic role in their pathophysiology and impaired patient outcomes 
(Lauer 2009). 
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1.2.2 Autonomic dysfunction 
 
Human autonomic dysfunction has been variously described by alterations in heart 
rate variability parameters (Lauer 2009), detriments in baroreceptor function and 
altered cardiovascular reflexes (Latson et al. 1994), altered skin (sudomotor) 
responses to cardiovascular testing (Guinjoan et al. 1995) and altered heart rate 
dynamics in response to exercise (Jouven et al. 2009; Jouven et al. 2005; Cole et al. 
1999; Barbato1999).   
 
The sympathetic and parasympathetic nervous systems do not always work in 
opposition, but rather interact in a complex, dynamic manner.  These interactions are 
modulated in part by second messenger systems.  Both sympathetic and 
parasympathetic systems are able to inhibit reciprocal traffic presynaptically 
(Olshansky et al. 2008).   
 
At rest, vagal tone is dominant.  Indeed, under normal physiological conditions, a 
response known as accentuated antagonism, where intense vagus discharge 
overrides increases in sympathetic discharge (e.g. at times of stress or exercise), 
maintains appropriate balance between the two limbs of the ANS (Olshansky et al. 
2008).   
 
Parasympathetic Autonomic Dysfunction (PAD) is a condition where resting vagal 
tone and vagal reflexes, including accentuated antagonism, are reduced.  This may 
be accompanied by chronic elevations in sympathetic activity and/or sympathetic 
hyperactivity in response to stressors.  Baroreceptor dysfunction, commonly 
described in diabetes mellitus, heart failure, ischaemic heart disease and 
hypertension, is a prototypical example of PAD pathophysiology and is associated 
with chronic renin-angiotensin-aldosterone system (RAAS) activation (Yee & 
Struthers 1998). 
 
Both established and acquired impairments in vagal activity are likely to predispose 
to poorer outcomes after surgery through a variety of mechanisms including an 
exaggerated inflammatory response, impaired cellular immunity (Czura & Tracey 
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2005), reduced cardiac function (Kakinuma et al. 2009; De Ferrari 2014), and 
impaired post operative gastrointestinal function (Lubbers et al. 2010). 
 
1.3 Autonomic Dysfunction and the surgical patient 
 
1.3.1  Autonomic Dysfunction is likely to be common in higher risk surgical 
patients presenting for major surgery 
 
Of those patients who die following surgery, the vast majority (~96%) has significant 
medical co-morbidities at the time of surgery.  Many have a co-existing 
cardiovascular (76%) or respiratory pathology (56%) at time of presentation  
(National Confidential Enquiry into Perioperative Deaths, Outcomes & Efficiency, 
2010).   
 
In the UK, the EUSOS study (Pearse et al. 2012) revealed that, over the seven day 
study period, 2.5% of all patients presenting for surgery had a diagnosis of heart 
failure, 14.5% COPD, 13.4% Coronary artery disease and 10% either type-1 or 2 
diabetes; all conditions associated with autonomic dysfunction (Filipovic et al. 2003; 
Tang et al. 2009; Vinik et al. 2011; Ponikowski et al. 1997; Thayer et al. 2010). 
 
The burden of comorbidity in cancer patients, who frequently present for surgery, is 
particularly high. Up to 63% of those aged over 75 years old present with at least 
one co-morbid condition, the most common of which include cardiac or vascular 
disease (30%), diabetes (25%) and hypertension (25%; Coebergh et al. 1999). 
Again, in all of these pathologies, autonomic dysfunction is prevalent (Lauer 2009).   
 
Additionally, the demographic of patients presenting for major surgery is changing to 
reflect the aging population (Etzioni et al. 2003, Ngaage et al. 2008, Kordatou et al. 
2014, Linkhorn et al. 2016); the fastest growing segment being individuals aged over 
65, projected to increase in numbers by 53.2% by 2020 (Etzioni et al. 2003).  
Significant changes in autonomic function occur with age that are responsible for an 
impaired ability to adapt to environmental or intrinsic stressors (Hotta & Uchida 
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2010), with potentially important implications for the elderly patient presenting for 
surgery. 
In the postoperative period, severe morbidity may result in critical illness, intensive 
care unit admission and multi-organ dysfunction leading to death.  Again, the 
majority of patients in the intensive care unit already exhibit established features of 
chronic diseases commonly associated with autonomic dysfunction prior to requiring 
critical care (Angus et al. 2001; Angus et al. 2006).  Autonomic dysfunction itself, in 
the context of critical illness, is strongly associated with impaired outcome (Schmidt 
et al. 2008; Toner et al. 2013; Gang & Malik 2002). 
 
1.3.2 Major surgery presents a severe challenge to the autonomic nervous 
system 
 
Major surgery presents an enormous physiological challenge (Bennett 2005).  The 
autonomic nervous system is central to a regulated response in this context, since 
sympathetic activation and parasympathetic withdrawal are core features of the 
immediate inflammatory response to tissue injury (Desborough 2000). 
 
Alterations in blood volume, fluid shifts, adrenocortical and renin-angiotensin-
aldosterone axis activation result from, and cause, large shifts in autonomic outflow 
(Desborough 2000).  Similarly, many drugs (such as epinephrine, ephedrine, beta-
blockers) administered and interventions (such as neuraxial anaesthesia, regional 
blockade and intubation) carried out in the perioperative period, have a profound 
effect on autonomic activity (Licker et al. 2003; Hirayama et al. 2006; Desborough 
2000; Heller et al. 1984; Mazzeo et al. 2011).  
 
Individuals with established autonomic dysfunction may be at greater risk of 
perioperative morbidity as a result.  Intraoperative hypotension (Huang et al. 2006) 
and cardiovascular instability (Knuttgen et al. 1990), altered pain responses (Heller 
et al. 1984) and an increased risk for postoperative myocardial ischaemia and 
myocardial death, prolonged hospitalisation and surgical resource usage have all 
been described in patients presenting for surgery with impaired autonomic function 
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as defined by reduced heart rate variability (Knuttgen et al. 1990; Mazzeo et al. 
2011; Huang et al. 2006; Latson et al. 1994; Laitio et al. 2007). 
 
1.4 Autonomic Dysfunction as a key mechanism underlying acute and 
chronic disease 	
1.4.1 Autonomic Dysfunction drives the development of critical illness  
 
Critical illness after major surgery remains an important cause of postoperative 
morbidity and mortality.  The development of sepsis and multi-organ dysfunction are 
key features of postoperative critical illness, and are the chief causes of death in this 
period.   
 
The critical illness phenotype is characterised by features including sustained 
inflammation, cardiovascular dysfunction and immunosuppression.  It is becoming 
increasingly evident that deranged autonomic function provides the motor for its 
development (Toner 2014). 
 
Both clinical and experimental studies have demonstrated rapid and profound 
alterations in autonomic activity following a range of disparate pathologies, including 
surgery, resulting in critical illness.  In the first instance, alterations in autonomic 
activity in response to surgery and immune challenge may be adaptive, exaggerated, 
maladaptive or sustained changes subsequently resulting in pathology. 
 
1.4.2 Sympathetic nervous activation provides an adaptive response to 
physiological challenge 
 
Sympathetic nervous system activation is central and essential to a coordinated 
cardiorespiratory, metabolic and immune response to tissue injury and infection.  
Blood volume loss from surgery or trauma and signalling provoked by direct tissue 
damage result in sympathetic activation, maintaining blood pressure through 
increases in cardiac pre- and afterload, cardiac contractility and through renin-
angiotensin-aldosterone system (RAAS) activation (Desborough 2000).  However, as 
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will subsequently be described, excessive or prolonged sympathetic activity can be 
harmful. 
 
1.4.3 Autonomic activation is rapid and occurs in response to peripheral 
immune challenges 
 
The central nervous system (CNS) receives sensory input from the immune system 
through both humoral and neural routes (Czura & Tracey 2005).  Cytokines and 
other immunological mediators directly influence CNS centres devoid of blood-brain 
barrier (circumventricular regions) or via active transport systems resulting in 
classical hypothalamic-pituitary responses to illness and injury (Tracey 2010).  
Similarly, some mediators (e.g. IL-1B and endotoxin) are directly sensed by 
peripheral nerve endings resulting in the sickness syndrome (fever, anorexia, social 
isolation behaviour etc.).   
 
Whilst humoral immune to brain communication remains the predominant conduit 
when cytokine levels are high, the CNS can be informed of peripheral injury and 
inflammation via afferent nerve traffic, predominantly travelling in the vagus, when 
circulating cytokine levels are low.  Sensory information about the status of tissue 
injury is transmitted from immune modulating organs (liver, kidney, spleen, lungs, 
gut) via afferent vagal ascending fibers along with pain and other information. The 
precise mechanism by which the vagus senses inflammation is not yet known, but 
IL-1 receptor mRNA and discrete IL-1 binding sites have been found in neurons and 
glomus cells in the vagus nerve itself (Watkins & Maier 1999). 
 
The importance of peripheral neural sensors in the mediation of the immune 
response lies in the speed of response elicited.  Peripheral infusion of endotoxin to 
healthy volunteers rapidly results in an hyperadrenergic response characterised by 
rapid several fold increases in the levels of circulating catecholamines, and rapid, 
parallel reductions in heart rate variability.   
 
This sympathetic drive in response to immune challenge is both adaptive and 
essential, maintaining blood pressure and hence organ perfusion.  Early survival 
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from endotoxaemic shock is dependent on the maintenance of an elevated 
sympathetic drive.  Aside from the peripheral circulatory benefits in terms of 
increased cardiac output and salt/water retention of increased catecholamine release 
and RAAS activation, heat shock protein-70 prevents circulatory collapse through 
inhibition of inducible nitric oxide (iNOS) gene expression in the rostral ventrolateral 
medulla, the brain area responsible for elevations in sympathetic activity (Chan et al. 
2004). 
 
1.4.4 Loss of crucial signalling and receptor activity in autonomic dysfunction 
impairs the physiological response to critical illness 
 
The concept that impaired autonomic activity is central to the development of the 
critical illness phenotype, and for impaired survival from critical illness, has been 
demonstrated in laboratory models where the carotid sinus nerve is transected, 
preventing transduction of crucial biological information from carotid body 
chemoreceptors and carotid sinus baroreceptors to brain-stem control centres.  
Intact carotid body chemoreceptors are able to detect circulating inflammatory 
mediators, enhancing hypoxic sensitivity, thereby contributing to the ubiquitous 
features of tachycardia and tachypnoea, seen at the start of critical illness, often in 
the absence of hypoxia or acidosis (Ackland et al. 2007).   
 
Transection of the carotid sinus nerves results in reduced survival from 
endotoxaemic sepsis.  This is one demonstration of a central role for afferent 
autonomic signal transduction from chemo/immune sensors in the integrated 
immune response to sepsis (Tang et al. 1998).. 
 
Sepsis is associated with and perhaps causes an intrinsic failure in autonomic 
control, as demonstrated by post mortem data from septic patients, where CNS 
autonomic control areas in patients who had died from septic shock showed 
evidence of ischaemia and apoptosis as compared with those who had died from 
other causes (both non-septic shock and extra cranial injury; Sharshar et al. 2003).  
This failure of autonomic control is compounded by many of the conditions and 
therapies common in the critical care unit, which profoundly alter, if not ablate, 
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autonomic, baroreflex and chemoreceptor control.  These include sedation, 
neuromuscular blockade, immobilisation, bed rest and anxiety amongst others 
(Akada et al. 2008; Eriksson et al. 1993; Ebert 2005; Hughson et al. 1994; A. Toner 
et al., 2013). 
 
1.5 Autonomic neural regulation of inflammation 
 
The organisation of the ANS into a series of neural reflex circuits allows a rapid and 
profound influence on the immune response to various stressors, not just in terms of 
sensing and afferent signalling as described previously, but also in terms of a direct 
influence on the function of circulating immune cells. 
 
The inflammatory response is central to regulated antimicrobial defence and healing 
after tissue damage.  Excessive inflammation, or failure to resolve the initial 
inflammatory phase after tissue injury however, results in excessive tissue 
destruction, circulatory collapse and potentially death (Gentile 2012).  Additionally, 
immune changes due to autonomic dysfunction in chronic conditions such as cardiac 
failure, relevant to the high-risk surgical patient, demonstrate the implications of 
established disease on the response to immune or inflammatory challenge 
(Jankowska 2006, Florea 2014). 
 
The description of a series of neural inflammatory reflexes is key to understanding 
the role of autonomic activity in the real time sensing and regulation of inflammation 
and immunity.  A summary of autonomic-immune interactions is found in Table 1-1. 
 
1.5.1 Evidence for an autonomic–immune interaction: anatomical and cellular   
 
Evidence for cytokine-induced activation of the hypothalamic-adrenal axis provided 
the original evidence for bidirectional linkage of the autonomic and immune systems.  
Subsequent work has implicated corticosteroid-independent, circulating humoral and 
autonomic mechanisms in the mediation of stress related immune depression (Toner 
et al. 2013).  Evidence of extensive sympathetic and parasympathetic innervation of 
the thymus, spleen and other lymphoid tissue has been demonstrated in 
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neuroanatomical studies, additionally providing fixed loci for neuroimmune 
interaction (Rosas-Ballina & Tracey 2009; Nance & Sanders 2007; Stevens-Felten & 
Bellinger 1997; Anagnostou et al. 2007). 
 
In vitro work has indicated that both sympathetic and parasympathetic 
neurotransmitters can modulate all aspects of the immune response, including 
cytokine production, lymphocyte proliferation and antibody secretion (Tracey 2010).   
 
1.5.2 Sympathetic neural influence on immune function 
 
Alterations in circulating immune cell activity, specifically monocyte deactivation, 
have been identified as sharing pivotal mechanistic links in the pathogenesis of both 
critical illness and cardiac failure with the development of autonomic dysfunction.  
Immune dysregulation is a key feature of heart failure, a condition where chronic 
sympathetic hyperactivity is pathognomonic.  Absolute numbers, as well as function, 
of monocytes and T-cells are markedly altered in cardiac failure.  High levels of 
circulating endotoxin and lymphopaenia are also noted in heart failure resulting in 
down regulation of monocyte CD14+ expression and adversely altered Neutrophil to 
Lymphocyte Ratios (NLR) (Apostolakis et al. 2010). 
 
Sympathetic hyperactivity appears to further result in immune impairment through 
various additional pathways.  In parallel with reductions in cardiac performance 
(Silverman et al. 1993), lymphocytes exposed to tumour necrosis factor (TNF)-α 
(Singh et al. 1993) or serum obtained from septic patients (Bernardin et al. 2003) 
exhibit impaired production of cyclic adenosine monophosphate (c-AMP) following β-
adrenergic receptor stimulation, the levels of which help to determine the balance 
between cellular activation and suppression. 
 
Monocyte deactivation, common in cardiac failure, and characterised by reduced 
HLA-DR expression, diminished antigen presentation and bactericidal killing, is 
associated with increased risk of infection and higher mortality (Monneret et al. 
2008).  This deactivation may be reproduced by catecholamine inhibition of TNFα 
		  34 	
Introduction 
	
	 	
production associated with increased release of the anti-inflammatory cytokine IL-10 
(Meisel & Meisel 2011).   
 
Deleterious alterations in immune activity have been described in CD14+ monocytes 
isolated from patients with septic shock.  These monocytes demonstrate β-
adrenergic desensitisation after catecholamine stimulation in a parallel manner to the 
decrease in β-adrenergic sensitivity seen in non-survivors of critical illness (Link et 
al. 2008).  This monocyte response has been subsequently reproduced ex vivo by 
incubation of monocytes from healthy volunteers with Lipopolysaccharide (LPS) and 
isoproterenol (a β-adrenoreceptor agonist) (Ackland et al. 2015). 
 
Host-pathogen interactions are also altered in the presence of sympathoexcitation.  
Established sympathetic nervous system activation predisposes to the accumulation 
of bacteria in tissues and therefore increases the likelihood of sepsis (Straub et al. 
2000).  Both endogenous and exogenous catecholamines stimulate bacterial growth 
and increase the virulence of bacteria (Link et al. 2008). 
  
Sympathoexcitation acting both through humoral and direct neural pathways is, 
under normal circumstances, an adaptive response to acute tissue injury.  However, 
excessive or chronic activity is injurious through the promotion of an excessive 
inflammatory response, impairment of immune cell function, promotion of bacterial 
growth and alterations in host-pathogen interaction.  Dysregulated sympathetic 
activity as a component of autonomic dysfunction, in the perioperative period, is 
therefore likely to result in impaired immune/inflammatory outcomes, resulting in 
morbidity and likely mortality. 
 
1.5.3 Parasympathetic neural influence on immune function 
 
The vagus (CN X, or the ‘wandering’ nerve) is the longest cranial nerve and 
innervates the majority of the visceral organs with both sensory and motor fibres, the 
majority being sensory.  Importantly, these sensory fibres are able to rapidly monitor 
and subsequently control peripheral inflammatory responses. 
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Early evidence for this monitoring role was provided by the observation that sub-
diaphragmatic vagotomy abolished the expected stress and febrile responses to 
interleukin-1B (Watkins & Maier 1999).  This relationship was subsequently 
confirmed through observations of dose dependent increases in hepatic vagal nerve 
afferent activity following intraportal administration of both IL-1B and bacterial 
products.  It has been suggested that the vagus may be able to convey cytokine or 
bacterial product specific information to the brain stem, allowing differential 
responses to individual immune challenges (Watkins 2016).  
 
Similarly, the carotid body, acting through the carotid sinus and glossopharyngeal 
nerves as described previously, in addition to sensing oxygen, carbon dioxide and 
pH, acts as a sensor organ for peripheral inflammation, intact function of which is 
essential for survival from sepsis (Zapata et al. 2011).  For example, a significant 
increase in basal chemosensory discharge has been reported after IV 
Lipopolysaccharide infusion in cats.  This increase in discharge appears essential for 
survival from experimental sepsis (Fernández et al. 2008).  Importantly, section of 
the carotid and aortic nerves (sino-aortic denervation, SAD) prevents increases in 
respiratory rate normally seen in response to sepsis (Fernández et al. 2008). 
 
The precise mechanism of this sensing role has not been described, however, 
specific sensory neurons in the dorsal root and trigeminal ganglia of the peripheral 
nervous system are capable of directly sensing inflammatory mediators through the 
expression of toll-like sensors and immune receptors tailored to specific bacterial 
motifs (Ackland et al. 2007; Huston 2012).  Microarray analysis of both human and 
mouse carotid bodies have demonstrated expression of many key genes involved in 
the immune and inflammatory response (including many pro-inflammatory cytokines, 
NF-kB, IL-10R and HMGB-1, Mkrtcian et al. 2012). 
 
The vagal inflammatory reflex is central to the neural regulation of inflammation.  
Early studies demonstrated reduced levels of circulating TNFα after vagal stimulation 
in an inflammatory model (Borovikova et al).  This observation was extended by the 
demonstration of reduced inflammatory cytokine production in stimulated 
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macrophages in the presence of acetylcholine, the prototypical parasympathetic 
neurotransmitter. 
 
Evidence for an anatomical site for the interaction of the vagus nerve and immune 
cells comes from the description of splenic nerve terminals ending near an 
acetylcholine releasing population of T-cells.  This regional acetylcholine release 
appears to act on splenic immune cells (including macrophages) via the nicotinic 
acetylcholine receptor α7 (α7nAChR), resulting in reduced nuclear factor kB 
assembly as well as inhibiting inflammasome formation via mitochondrial α7nAChR 
activity.  α7nAChR knockout mice do not reduce TNFα production in response to 
vagal nerve stimulation.  Importantly, these same knockout animals demonstrate 
elevated systemic TNFα in response to endotoxaemia, and increased mortality, pin-
pointing the vagus as an essential regulator of the systemic inflammatory response 
(Parrish et al. 2008; Tracey 2002). 
 
Further evidence for vagal involvement in the systemic inflammatory response 
comes from the intestinal immunoendocrine axis.  Enteroendocrine cells, dispersed 
throughout the intestinal epithelium, collectively form the largest endocrine system in 
humans, and secrete more than 20 peptide hormones, classically studied for their 
roles in the postprandial uptake of nutrients (Worthington 2015).  Vagal activation is 
the prototypical response in response to gut hormone release after feeding (Dockray 
2014). 
 
Human and rodent studies have demonstrated alterations in both the number and 
activity of enteroendocrine cells in the gut during inflammation (Harrison et al. 2013).  
Enteroendocrine cells possess functional toll like receptors which can directly 
respond to both pathogens and commensal bacteria, thereby helping regulate the 
intestinal immune response through release of immunomodulators such as cytokines 
and direct orchestration of immune cell function (Bogunovic et al. 2007; Cani et al. 
2013; Worthington 2015). 
 
Immune cells also express a range of receptors for enteroendocrine hormone 
peptides (Genton & Kudsk 2003).  Interaction of gut hormones with these receptors 
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produces a wide range of effects varying from altered cellular recruitment, activation, 
phagocytosis, antigen presentation and cytokine secretion (Shajib & Khan 2015). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aside from direct interaction with immune cells, enteroendocrine peptides also 
modulate the vagal inflammatory response.  Cholecystokinin, produced in response 
to a fat rich diet, triggers increased vagal activity resulting in reduced inflammatory 
cytokine release from macrophages (Luyer et al. 2005).  These observations have 
been reproduced in a variety of inflammatory conditions (Matteoli & Boeckxstaens 
2013).  The vagal anti-inflammatory response and the direct influences of intestinal 
peptides on immune function, provide potential pathways for dietary modulation of 
the inflammatory response highly relevant to the surgical patient (Martindale et al. 
2013).   
Branch Effect Afferent/Efferent 
Sympathetic Hypothalamic-adrenal axis 
activation by cytokines 
Afferent 
Decreased monocyte numbers Efferent 
Reduced monocyte function Efferent 
Reduced monocyte HLA-DR 
expression 
Efferent 
Reduced Neutrophil to 
Lymphocyte ratio 
Efferent 
Altered immune cell 
activation/suppression 
Efferent 
Reduced antigen presentation Efferent 
Reduced bactericidal killing Efferent 
Altered host-pathogen interaction Efferent 
Accumulation of bacteria in the 
tissues 
Efferent 
Excessive inflammatory response Efferent 
Parasympathetic Carotid body sensing/modulation 
of inflammation 
Afferent 
Differential vagal sensing of 
cytokine/bacterial products 
Afferent 
Vagal inflammatory reflex Afferent/Efferent 
Intestinal immunoendocrine axis Afferent/Efferent 
Table 1-1 Key autonomic influencers	
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1.5.4 Clinical implications of the vagal inflammatory reflex in surgical patients 
 
The vagal inflammatory reflex has been identified as a potential therapeutic target 
across a wide variety of inflammatory conditions.  Nonselective α7nAChR blockade 
in experimental sepsis increases survival, and in aseptic surgery modulates 
neuroinflammation and preserves cognitive performance (Eriksson et al. 2016).  
 
Early changes in heart rate variability, associated with impaired cardiac contractility, 
in incipient sepsis point to early vagal nerve withdrawal.  Indeed, these early 
changes, even before the onset of severe sepsis or septic shock, are predictive of 
later mortality.  Prolonged or profound ongoing loss of heart rate variability is also 
associated with impaired survival from sepsis and critical illness (Toner et al. 2013). 
 
On the other hand, evidence for a protective role for intact vagal activity in sepsis is 
provided by increased survival and a reduced inflammatory burden in studies where 
the vagus nerve is directly stimulated or α7nAChR agonists are administered.  Some 
evidence exists in models of acute lung injury, with and without barotrauma, for a 
protective role of both vagal stimulation and α7nAChR agonism, potentially carrying 
implications both for, (1) intraoperative ventilator strategies (supported by clinical 
studies that show pulmonary benefits of intraoperative lung protective ventilation), 
and (2) post operative pulmonary complications in higher risk patients (Kessler et al. 
2012; Huston 2012). 
 
Taken together, intact or preserved, or even augmented, parasympathetic activity in 
the perioperative period could be predicted to have a protective effect in terms of the 
immune response to surgical trauma.  Regulation of an appropriate inflammatory 
response is the central mechanism underlying any proposed benefit.  Abrogation of 
excessive sympathetic activity, reduced septic, infectious and inflammatory 
complications (such as post operative pulmonary complications, myocardial 
ischaemia and gastrointestinal dysfunction) would be predicted in individuals with 
intact vagal function when compared with those with PAD.   
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Chronic vagal withdrawal has been associated with enhanced cytokine release and 
tissue damage in chronic inflammatory diseases (Tracey 2010; Straub et al. 1997; 
Tan et al. 1993; Toussirot et al. 1993).  The impact of established parasympathetic 
autonomic dysfunction on immune responses to sterile trauma can be hypothesised 
from vagotomy and pharmacological blockade studies, but has yet to be described in 
human surgical patients.   
 
1.6 Autonomic Dysfunction and the heart 
 
Both ischaemic heart disease and cardiac failure are common in the high risk 
surgical population and are associated with materially worsened outcomes (Fleisher 
et al. 2014). 
 
Whilst in particular, myocardial injury associated with troponin leak is associated with 
morbidity and mortality (Devereaux et al. 2012), the issue as to whether ischaemia 
rather than inflammation is the dominant pathophysiological mechanism remains 
unresolved (Moonesinghe et al. 2011).   
 
Autonomic dysfunction, both in terms of sympathetic over activity and 
parasympathetic withdrawal, is clearly associated with a dysregulated inflammatory 
response to tissue injury and may underlie some of the observations of increased 
cardiac risk in higher risk patients both through functional impairment of cardiac 
function (Olshansky et al. 2008) and through increased local inflammation resulting 
in myocardial cellular injury and death (Pavlov & Tracey 2005).  These observations, 
if translated to perioperative cardiac injury, would be associated with materially 
worse perioperative outcomes in patients with established autonomic dysfunction. 
 
1.6.1 Parasympathetic Autonomic Dysfunction and cardiac injury 
 
Aside from the clear benefits of preserved vagal activity in terms of slowing heart 
rate, allowing improved coronary perfusion, better diastolic filling time, and reduced 
cardiac work, key roles in the modulation of myocardial inflammation and cellular 
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responses to ischaemia have been described both in acute and chronic contexts 
(Paton et al. 2006; Rosas-Ballina & Tracey 2009). 
 
In patients with known ischaemic heart disease, reduced heart rate variability and 
other markers of parasympathetic autonomic dysfunction are strongly associated 
with increased risk for sudden death, arrhythmia and myocardial infarction (Huikuri & 
Mäkikallio 2001; Jouven et al. 2005).  Indeed, reduced heart rate variability and 
reduced heart rate recovery after exercise, a marker of impaired vagal activity, have 
both been correlated with both the extent and severity of coronary arterial disease 
(Rich et al. 1988; Ghaffari et al. 2011). 
 
Preserved vagal activity is protective in myocardial injury through several 
mechanisms, and its role in the moderation of reperfusion injury is of great 
importance, since reperfusion after infarct contributes up to 50% of final infarct size 
(Shinlapawittayatorn et al. 2014, Mastitskaya et al. 2012).   
 
Local inflammation, arrhythmia (in part through preservation of connexin-43; Ando et 
al. 2005), oxidative stress and cardiomyocyte calcium overload are key components 
of reperfusion injury, all of which may be ameliorated or even prevented through 
increased cardiac vagal activity before, during and after myocardial ischaemia 
(Kakinuma et al. 2013; Zhang et al. 2014; Xiong et al. 2009; Johnston & Webster 
2009; De Ferrari 2014; Shinlapawittayatorn et al. 2014). 
 
Intermittent vagus nerve stimulation for example, in one model, decreased 
myocardial infarct size in an atropine-dependent fashion (Uitterdijk et al. 2015). 
Increased activation of the PI3/AKT/hypoxia-inducible factor (HIF) 1a cell survival 
pathway, improved glucose usage and angioneogenesis with an associated reduced 
infarct size and preserved cellular function in an atropine dependent manner in 
animal models of cholinergic stimulation and dysfunction (Kakinuma et al. 2013; 
Kakinuma, Ando, Kuwabara, Rajesh G Katare, et al. 2005). 
 
Aside from a uniquely cardiac influence on myocardial responses to ischaemia, 
intact parasympathetic function plays a multi-system role.  Inter-organ cross-talk 
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mediated neurally by the parasympathetic nervous system further limits myocardial 
damage following coronary ischaemia-reperfusion injury (Mastitskaya et al. 2012). 
This is most clearly represented by the observation that remote ischaemic 
preconditioning, which dramatically attenuates myocardial damage following 
transient coronary artery ligation, is strongly dependent on intact vagal function 
(Mastitskaya et al. 2012).   
 
In the perioperative period, established or acquired autonomic dysfunction may 
therefore be deleterious through several mechanisms including: promotion of 
myocardial inflammation, worsening of established myocardial ischaemia through 
impaired cell survival, worsening of myocardial ischaemia-reperfusion injury, 
impaired angioneogenesis, increased mitochondrial ROS formation, 
arrhythmogenesis both through influence on sino-atrial and atrio-ventricular node 
activity and through altered expression of connexins. 
 
1.6.2 Sympathetic Autonomic Dysfunction and cardiac injury 
 
Sympathetic activation is provoked by both myocardial ischaemia and reperfusion 
and is mechanistically linked to the development of myocardial injury (Longhurst et 
al. 2001; Heusch et al. 1986; Minisi & Thames 1991; Schömig 1990; Kolettis et al. 
2016). 
 
Aside from the deleterious pro-inflammatory immune effects engendered by 
sympathetic activation, the accumulation of intracellular calcium, triggering 
myocardial necrosis, can be induced by excessive sympathetic activity (Dünser & 
Hasibeder 2009; Ellison et al. 2007).  This effect is potentiated both by metabolic 
dysregulation and a prothrombotic state, and may underlie, or at least exacerbate, 
the elevated troponin levels frequently seen in critically ill patients and in the 
perioperative period (Devereaux, Chan, et al. 2014; Sear et al. 2008).  
 
Acute psychological stress is associated with increased sympathetic activity and 
such stress alone can, in susceptible individuals, provoke excessive sympathetic 
outflow, representing sympathetic autonomic hyperactivity, and trigger endothelial 
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cell activation and coronary artery vasospasm, effects which importantly can be 
abolished by beta blockade (Nagele & Liggett 2011).  Excessive sympathetic 
activation, prominent in several illnesses characterised by increased levels of 
psychological stress, is strongly associated with increased risk of myocardial 
ischaemic events and sudden cardiac death (Dishman et al. 2000; Treiber et al. 
2001; McCraty et al. 2001; Ponikowski et al. 1997). 
 
Increased sympathetic activity and renin-angiotensin-aldosterone system activation 
in both chronic heart failure and at times of acute physiological stress promote 
reactive oxygen species production, myocardial cellular damage and mitochondrial 
dysfunction (Hubens et al. 2013; Sam et al. 2005). 
 
Aside from direct myocardial damage and promotion of inflammation, sympathetic 
activation promotes arrhythmogenesis both in the context of acute ischaemia and in 
chronic heart diseases and forms the basis for several therapeutic stratagies (Hou et 
al. 2016; Wengrowski et al. 2015). 
  
Abrogation of excessive sympathetic drive, most commonly through beta 
adrenoreceptor blockade, has therefore taken a central role in the management of 
acute myocardial ischaemia (Welch et al. 2012; Roffi et al. 2015).  A reduced heart 
rate allows coronary filling and reduces myocardial shear stress in a manner parallel 
to and complementary of preservation of vagal activity.  Further beneficial effects 
include reduction of myocardial cellular damage, decreases in ROS release, 
preservation of mitochondrial function and mitigation of tachyarrhythmias. 
 
A great deal of attention has been paid over the past decade to the issue of 
perioperative sympatholysis in an attempt to reduce cardiac risk through prevention 
and mitigation of cardiac ischaemia and through treatment of intraoperative 
tachycardia and hypertension which are associated with increased length of stay and 
complications after non-cardiac surgery (Reich et al. 2002).  
 
The most recent series of randomised trials (POISE 1 & 2) demonstrated that whilst 
beta blockade and alpha 2 blockade do appear to reduce the risk of perioperative 
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myocardial ischaemic events and arrhythmia, these benefits occur at the expense of 
greater risk of stroke and hypotension (Devereaux, Sessler, et al., 2014; Fleisher et 
al., 2014; POISE Group, 2008; Sear et al., 2008).  Haemodynamic instability due to 
sympatholysis may result in reduced cardiac contractility and rate with subsequent 
impaired organ perfusion and resultant triggering of pathophysiological cascades 
leading to multi-organ failure.   
 
The potential therapeutic benefits of sympatholysis, therefore, need to be balanced 
against the potential harms.  Preoperative identification of individuals who may come 
to harm due to exaggerated sympathetic outflow in the perioperative period could aid 
in the targeted application of sympatholysis.   
 
1.6.3 Autonomic Dysfunction and Cardiac Failure 
 
Autonomic dysfunction is strongly associated with and prognostically linked with 
cardiac failure.   Reduced heart rate variability has been associated with NYHA 
grade of heart failure (Adamson et al. 2004; Wijbenga et al. 1998), likelihood of 
death (Jiang et al. 1997) and even mode of death (Sandercock & Brodie 2006). 
 
Sympathetic activation is ubiquitous, likely compensatory for impaired ventricular 
function and linked with pathophysiological consequences (as outlined previously) 
(Floras 2009; Floras & Ponikowski 2015).  Ultimately, chronic sympathetic nervous 
system activation is associated with accelerated disease progression, dysregulation 
of adrenoreceptor signalling and transduction and ventricular remodelling 
(Triposkiadis et al. 2009; Sigurdsson & Swedberg 1994). 
 
As a result, beta adrenoreceptor blockade and modulators of the renin-angiotensin-
aldosterone axis have become the mainstays of cardiac failure management (Floras 
2009).  Autonomic influences on cardiac function are summarised in Table 1-2. 
 
1.6.4 The Parasympathetic Nervous System and Heart Failure 
 
Traditionally, sympathetic nervous outflow has been held solely responsible for 
modulating positive inotropy (Hall & Guyton 2006).  The influences of 
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parasympathetic activity on cardiac chronotropy are well described (G.G. et al. 
1992), but an increasing body of laboratory evidence is accumulating to indicate that 
parasympathetic muscarinic activity is essential for increasing cardiac contractility at 
times of increased demand (Hussain et al. 2009; Kitazawa et al. 2009; Kakinuma et 
al. 2009; Wang et al. 2007).  Indeed, reductions in vagal tone (Floras & Ponikowski 
2015; Ferrari 1993) and specifically, impaired cardiac muscarinic activity (Vatner et 
al. 1988; Kakinuma et al. 2009; Z. Wang et al. 2004) are core features of cardiac 
failure and are likely mechanistically linked to the reductions in cardiac performance 
(Olshansky et al. 2008).   
 
Table 1-2. Autonomic influences on and associations with cardiac function 
Branch Process Outcome 
Sympathetic/ 
Parasympathetic 
 
 
Local inflammation Myocardial cellular injury 
Troponin release 
Reduced heart rate variability Worsened Cardiac Failure 
Parasympathetic Reduced heart rate Improved coronary perfusion 
Reduced vagal outflow Increased severity coronary arterial 
disease 
Increased infarct size 
Increased oxidative stress/calcium 
overload 
Accelerated reperfusion injury 
Impaired ventricular remodelling 
Reduced connexin -43 expression Increased risk of arrhythmia 
PI3/AKT/HIF-1a activation Cell survival/reduced infarct size 
 Improved glucose usage 
Modulation of remote ischaemic 
conditioning 
Muscarinic activity Increased inotropy 
 
Sympathetic Accumulation of myocardial calcium Myocardial ischaemia/injury 
Metabolic dysregulation 
Activation of clotting cascade 
Endothelial activation 
Coronary artery vasospasm 
Renin-angiotensin-aldosterone axis 
activation 
Reactive oxygen species production 
Mitochondrial dysfunction 
Myocardial cellular damage 
Pathological ventricular remodelling 
Myocardial conducting system Arrhythmia 
Chronic activation Accelerated progression of cardiac 
failure 
Adrenoreceptor signalling Dysregulated receptor expression 
and signalling 
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Parasympathetic activation is reduced even in very early heart failure, and may 
provide prognostic information on patients at increased risk of developing 
progressive myocardial dysfunction (Kinugawa & Dibner-Dunlap 1995).  Lack of 
attenuation of sympathetic activity through increases in vagal tone is also common in 
cardiac failure and is associated with baroreceptor dysfunction, as well as central 
changes in sympathetic/parasympathetic interaction.   
 
Chronic vagal withdrawal, as described previously, is associated with inflammation 
which appears to play a pathogenic role in the progression of left ventricular 
dysfunction and remodelling in cardiac failure (Li & Olshansky 2011). 
 
Several therapies targeted at improving parasympathetic activity have shown 
beneficial effects in established cardiac failure.  These include Angiotensin 
Converting Enzyme (ACE) inhibitors, beta blockade, statins and vagal stimulation, 
(Zannad et al. 2015; Osterziel & Dietz 1996; Kubo et al. 2005; Pliquett et al. 2003).  
Impaired cardiac function in itself is a significant risk factor for the development of 
postoperative complications (Sabat et al., 2011).  Indeed, impaired intraoperative 
oxygen delivery due to impaired cardiac output is the focus of many perioperative 
goal directed therapy stratagies (Aya et al. 2013).  Despite this, there remains a 
cohort of patients who fail to respond to oxygen delivery driven (using fluids ± 
inotropes to achieve prescribed targets) goal directed therapy (Ackland et al. 2015).  
It could be hypothesised that vagal withdrawal may underlie these observations due 
to its negative influence on cardiac performance. 
 
Given the high incidence of morbidity associated with clinical and subclinical 
autonomic dysfunction in the high risk surgical population (e.g. hypertension & 
diabetes) it would appear likely that a proportion of these patients will suffer from 
consequent cardiac impairment, presenting the possibility of a previously unidentified 
cohort who may be at greater perioperative risk, but in whom targeted therapy 
directed at autonomic dysfunction may be of benefit. 
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1.7 G-protein receptor kinases and autonomic function 
 
1.7.1 G-protein receptor kinases play a key role in the pathophysiology of 
cardiac failure 
 
G protein-coupled receptors (GPCRs) are diverse, therapeutically important and play 
multiple central roles in the physiology of various organs, including the heart. The 
beta adrenoreceptor and angiotensin II type-1 receptor are key and relevant 
examples.  
 
Autonomic dysfunction, resulting in enhanced catecholamine release and RAAS 
activation, is strongly associated with increases in G-protein coupled receptor 
phosphorylation, mediated mainly through the G-protein receptor kinases GRK2 and 
GRK5, as well as increased Gi protein expression (Eschenhagen et al. 1992; 
Lymperopoulos et al. 2013; Lymperopoulos et al. 2007; Lymperopoulos 2011; 
Lymperopoulos et al. 2007).  These changes have functional implications including 
downregulation and functional uncoupling of the beta adrenoreceptor as well as 
other direct pathophysiological consequences in the heart and other organ systems. 
GRK2 elevation is canonical in human heart failure. 
 
Agonist binding of a GPCR promotes GRK phosphorylation.  This phosphorylation 
enhances the affinity of the receptor for binding with adaptor proteins (B-arrestins), 
which sterically prevent further GPCR agonist binding and signalling.  B-arrestin 
binding further promotes internalisation of the activated GPCR for either recycling 
(resensitisation) or degradation (downregulation); these processes are central in 
health to adaptive regulation of sympathetic stimulation, but in cardiac failure are key 
to disease progression.  The predominant consequence of chronic GRK2 activation 
is a reduction in numbers of expressed beta adrenoreceptors with resultant 
reductions in beta adrenoreceptor inotropic reserve (Woodall et al. 2014) 
(summarised in Figure 1-2). 
 
Impaired cardiac responses to beta adrenoreceptor stimulation are an important 
negative prognostic factor for survival in critical illness, where autonomic dysfunction 
is prototypical (Rhodes et al., 1999).  Similarly, reduced inotropy in response to 
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catecholamine stimulation is ubiquitous in established cardiac failure, and is 
associated with reductions in both the numbers of beta adrenoreceptors expressed 
on the failing myocardium and the maximal inotropic response possible 
(Lymperopoulos et al. 2013).  In sepsis-related myocardial dysfunction, as in cardiac 
failure, myocardial beta adrenoreceptor density and consequently signal transduction 
is reduced (de Montmollin et al. 2009).  Reductions in beta adrenoreceptor density in 
these conditions are modulated in large part by GRK2 (Evron et al. 2012; 
Lymperopoulos 2011; Iaccarino et al. 2005). 
 
In addition to roles in GPCR recycling and destruction, GRK2 and consequently 
beta-arrestins are strongly implicated in mitogenic signalling and RAAS activation in 
the failing heart, promoting cardiac hypertrophy, cardiomyocyte apoptosis and 
impaired contractility (independent of its GPCR desensitising activity)(Xiang & 
Kobilka 2003).  Further non-classical roles for GRK2 in heart failure include negative 
regulation of insulin signalling, altered cardiomyocyte metabolism, promotion of 
reactive oxygen species production through mitochondrial co-location and 
accelerated atherogenesis (Kim et al. 2008; Woodall et al. 2014). 
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Figure 1-2: The classical actions of G protein–coupled 
receptor kinase 2 (GRK2) on cardiac β-adrenergic 
receptors (βARs) during physiological conditions and 
disease states  
A. Under normal conditions, 
catecholamines (CA) activate 
the βAR, stimulating 
downstream signalling 
through Gαs that ultimately 
leads to increased 
contractility by activating 
adenylate cyclase (AC) and 
protein kinase A (PKA).  
 
 
B. As receptor activation 
occurs, signal desensitisation 
is triggered simultaneously by 
translocation of GRK2 to the 
membrane and binding to 
Gβγ where it is able to 
interact with the agonist-
occupied receptor and 
phosphorylate it, starting the 
G protein uncoupling process.  
G protein activation is blocked 
by recruitment of β-arrestin to 
the phosphorylated receptor. 
β-arrestins also start the 
receptor internalization and 
downregulation process. 
  
 
C. After cardiac injury, GRK2 
levels are increased due to 
stress-induced increases in 
catecholamines.  This 
increase in GRK2 helps to 
prevent overstimulation of the 
βAR initially, but over time a 
cycle of chronically increased 
βAR desensitization occurs 
contributing to the 
progression of heart failure. 
 
Reproduced with permission 
from (Woodall et al. 2014) 
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1.7.2 The extra-cardiac GRK2 interactome is central to multiple 
pathophysiological processes 
 
Outside of the heart, GRK2 and beta arrestins are implicated in multiple 
pathophysiological processes.  These include impaired immune cell chemotaxis and 
function (Liu et al. 2013; Lafarga et al. 2012), increased reactive oxygen species 
production (Ciccarelli et al. 2013) and altered innate immune responses (Loniewski 
et al. 2008).  As such, the GRK2 interactome is recognised as a key factor in the 
regulation of neuroendocrine-immune communication (Vroon et al. 2006; Heijnen 
2007). 
 
GRK2 has been implicated in the regulation of both severity and duration of acute 
inflammatory pain (N Eijkelkamp et al. 2010; Niels Eijkelkamp et al. 2010; Ferrari et 
al. 2012) as well as in the regulation of brain injury after ischaemia (Nijboer et al. 
2013).  Chronic GRK2 elevation in the adrenals secondary to prolonged BAR 
stimulation results in exaggerated catecholamine secretion, contributing to a positive 
feedback loop in the pathogenesis of heart failure (Lymperopoulos et al. 2007). 
Relevant physiological roles of GRK2 are summarised in Table 1-3. 
 
1.7.3 Lymphocyte GRK2 as a biomarker in parasympathetic autonomic 
dysfunction 
 
GRK2 is a useful biomarker in cardiac failure (Lymperopoulos 2011; Woodall et al. 
2014; Liggett 2005a).  Circulating lymphocyte GRK2 levels reflect those expressed in 
the cardiomyocyte (both cardiomyocytes and lymphocytes are subjected to a similar 
neurohormonal milieu), and are related to ejection fraction, NYHA class and 
prognosis (Liggett 2005a).   
 
Vagal withdrawal is strongly associated with and likely mechanistically linked to 
human cardiac failure.  Neurohormonal activation, secondary to cardiac impairment 
and associated with vagal withdrawal (including elevations in both catecholamine 
release and activation of the renin-angiotensin-aldosterone axis (RAAS) (Anker 
1998)), would be expected to be associated with alterations in the dynamics of beta 
adrenoreceptor recycling mediated through GRK2 and its downstream effects.   
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It is therefore highly likely that lymphocytes derived from individuals with established 
parasympathetic autonomic dysfunction will exhibit alterations in GRK2 expression.  
It is also possible that the total expression of GRK2 in these lymphocytes will reflect 
the degree of PAD in the individuals from whom they are taken.  Elevations in GRK2 
levels would further implicate PAD mechanistically in the development of cardiac 
impairment as well as neuro-immune dysfunction.  Lymphocyte GRK2 levels will 
therefore be explored as a potential biomarker for PAD in this thesis. 
 
 
 
 
Table 1-3: Physiological roles of GRK2 relevant to the high-risk surgical patient 
System: Process: 
Cardiovascular Reduced contractility 
Mitogenic signalling 
Cardiac hypertrophy 
Cardiomyocyte apoptosis 
Impaired apoptosis 
Negative regulation of cardiomyocyte metabolism 
Negative regulation of insulin signalling 
Promotion of Reactive Oxygen Species release 
Accelerated atherogenesis 
Biomarker in cardiac failure: related to degree of failure 
& prognosis 
Immune Increased ROS expression  
Impaired innate immunity  
Altered immune cell chemotaxis 
Altered expression of beta adreno and other receptors on 
lymphocyte cell surfaces 
Central Nervous Inflammatory pain modulation.  
 Increased ischaemic pain 
Regulation of ischaemic brain injury 
Neurohormonal RAAS activation 
Modulation of neuroendocrine-immune communication 
Second Messenger Beta adrenoreceptor downregulation 
Adrenal promotion of catecholamine secretion 
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1.8 Parasympathetic Autonomic Dysfunction and Postoperative 
Gastrointestinal Dysfunction 
 
The classical role for parasympathetic nervous activation resides in the regulation of 
gastrointestinal function as part of the ‘rest and digest’ paradigm (Hall & Guyton 
2006).  Parasympathetic withdrawal then, would be predicted to be associated with 
impairment of gastrointestinal function. 
 
Postoperative gastrointestinal dysfunction (PGID) is a common complication after all 
types of moderate to major surgery, not being limited to surgery on the gut or 
abdominal viscera.  PGID is associated not only with patient suffering and other 
morbidity, but also with increased hospital length of stay (Mythen 2009).  PGID is the 
most common postoperative morbid event in major non-cardiac surgery to be 
associated with a length of stay prolonged beyond seven days (Bennett-Guerrero et 
al. 1999).   
 
The pathogenesis of PGID is complex and multifactorial, though the disruption of 
neural reflexes that modulate coordinated bowel motility and/or inflammation of the 
intestinal muscularis is thought to be central (Tache et al. 1993; Mythen et al. 1993). 
 
Direct bowel manipulation influences local and systemic autonomic signalling, both 
through direct myenteric neural control (causing corticotrophin releasing factor 
release in the dorsal vagal complex with resultant non-cholinergic motor neuron 
activation through vagal and splanchnic routes) and through the influences of local 
and systemic inflammation (De Winter et al. 1997; Tache et al. 1993).   
 
Similarly, autonomic signalling is altered in non-gastrointestinal surgery, 
predominantly through the influences of inflammation on sympathetic activation and 
parasympathetic withdrawal.  Impaired gut mucosal perfusion, acting through 
hypoxia-induced local 5-HT3 activation of caudal vagal afferents and local 
inflammation, is also strongly implicated in the development of PGID, and is clearly 
related to impaired macrocirculatory parameters common in reduced cardiac output 
states, such as cardiac failure (Mythen 2009; Mythen et al. 1993). 
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Aside from interventions such as adequate filling, reduced bowel manipulation and 
balanced analgesia regimens, that in themselves are likely to have some beneficial 
autonomic influence, direct augmentation of vagal outflow has been successfully 
investigated both as prophylaxis for and as a potential therapy in PGID (The et al. 
2011; Lubbers et al. 2010; Karmali et al. 2015).  These interventions include sham 
feeding, early enteral feeding and direct vagus nerve stimulation.  Improved or 
preserved heart rate variability, as a marker of parasympathetic tone, is associated 
with reduced time to becoming morbidity free (Karmali et al. 2015).  
 
The role of established parasympathetic autonomic dysfunction in the promotion of 
PGID is not known, though it could be predicted to represent a greater risk for its 
subsequent development in the postoperative period. 
 
1.9 The influence of Autonomic Dysfunction on the physiological 
response to anaesthesia 
 
To date, many studies examining the influence of autonomic dysfunction in the 
perioperative period have predominantly focused on the cardiovascular 
consequences of the class of gross dysfunction noted in cardiovascular autonomic 
neuropathy (CAN) secondary to diabetes mellitus (Vohra et al. 1993; Knuttgen et al. 
1990; Knüttgen et al. 1990; Lankhorst et al. 2014).  CAN may however be caused by 
multiple disorders, including paraneoplastic syndromes and chemotherapy or 
radiotherapy (Lankhorst et al. 2014).  These latter conditions are of clear relevance 
to the surgical oncology population and such patients form the majority of the 
population to be explored in this thesis. 
 
Studies exploring the impact of CAN on patients undergoing surgery have 
demonstrated increased risks of perioperative cardiac complications, but have not 
examined both the potential consequences of subclinical autonomic dysfunction or 
predominantly parasympathetic autonomic dysfunction and its likely impact on multi-
system pathology (including immune/inflammatory dysfunction and PGID).  It is 
however highly likely that individuals exhibiting cardiovascular autonomic dysfunction 
will also display central and systemic signs of multi-system dysfunction (De Angelis 
et al. 2009).   
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Similarly, systematic exploration of the impact of autonomic dysfunction on cardiac 
function and cardiopulmonary physiology in the perioperative period has not 
previously been performed.  Studies to date looking at perioperative AD have been 
further hampered by the use of heterogeneous techniques used to assess 
cardiovascular autonomic function in the perioperative period which has lead to great 
variability in consequent reported morbidity and mortality (Lankhorst et al. 2014). 
 
The presence of cardiovascular autonomic neuropathy (caused by damage to the 
autonomic nerve fibres that innervate the heart and blood vessels, causing 
abnormalities in heart rate control and vascular dynamics; Lankhorst et al. 2014) is 
associated with both perioperative haemodynamic instability and postoperative 
complications. 
 
Anaesthesia, both general and regional, has major influences on perioperative 
autonomic function.  These changes may be particularly pronounced in diabetic 
patients, who are more prone to the development of intraoperative bradycardia and 
hypotension during anaesthesia; in particular during induction (Knuttgen et al. 1990; 
Vinik & Ziegler 2007; Burgos et al. 1989).  Intraoperative haemodynamic instability in 
CAN appears related to the severity of autonomic dysfunction (Knüttgen et al. 1990), 
and the degree of derangement on preoperative HRV analysis is related to the 
greatest drop in blood pressure during surgery.  Pharmacological intraoperative 
blood pressure support is more likely to be employed more frequently in patients with 
autonomic dysfunction (Burgos et al. 1989). 
 
Reduced preoperative heart rate variability predicts intraoperative hypotension, even 
when age, history of diabetes and ASA class are controlled for (Huang et al. 2006). 
 
Similarly, perioperative risks are increased: the risk of intraoperative hypothermia, 
itself associated with significant morbidity, is raised in CAN, suggesting autonomic 
involvement beyond the cardiovascular system (Kitamura et al. 2000).  
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Increased risk for perioperative myocardial infarction, myocardial ischaemia and 
heart failure and arrhythmia have all been reported associated with autonomic 
dysfunction (Laitio et al. 2004; Vinik & Ziegler 2007).  Importantly, the incidence of 
cardiac arrest at induction and in the perioperative period is much increased in 
patients with CAN (Vinik & Ziegler 2007; Burgos et al. 1989; Lankhorst et al. 2014). 
Aggregate perioperative cardiovascular morbidity and mortality may be increased up 
to three times in these individuals (Kitamura et al. 2000; Vinik & Ziegler 2007; 
Lankhorst et al. 2014).  Parasympathetic withdrawal in particular, as assessed by 
preoperative frequency domain analysis, appears highly predictive of one year 
mortality after major non-cardiac surgery (Filipovic et al. 2003). 
 
In the postoperative period, reduced heart rate variability, increased age and 
diabetes mellitus are all independent predictors of prolonged hospital length of stay 
(Gang & Malik 2002). 
 
1.9.1 Commonly used drugs in anaesthesia may exacerbate existing 
autonomic dysfunction 
 
Anaesthetic agents and drugs used commonly in the perioperative period have 
differing and profound effects on autonomic activity, which could potentially influence 
outcome in patients with established autonomic dysfunction.  The choice of 
anaesthetic technique therefore may have some bearing on perioperative outcome. 
 
During anaesthesia, both vagal and sympathetic activity may be suppressed, and the 
pattern is dependent on the agents used and the depth of anaesthesia (Mazzeo et 
al. 2011).  It would appear that patients with pre-existing autonomic dysfunction may 
be at greatest risk (Mazzeo et al. 2011; Lankhorst et al. 2014).  For illustration, the 
autonomic effects of several (but not all) commonly used drugs in the perioperative 
period are outlined subsequently. 
1.9.1.1 Inhalational anaesthetic agents 
 
In general, heart rate increases, and is associated with a decrease in heart rate 
variability, during inhalational anaesthesia.  Corresponding decreases in time domain 
measures such as SDNN, High Frequency and Low Frequency power at have also 
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been demonstrated.  With increasing doses of inhalational anaesthetic agent 
(different agents affecting activity to different extents), cardiac vagal activity, 
reflected in reduced high frequency power, decreases (Picker et al. 2001). 
1.9.1.2 Intravenous anaesthesia 
 
Propofol (a commonly used intravenous anaesthetic agent) administration is 
associated with hypotension, suppresses both baroreceptor sensitivity and 
peripheral sympathetic nervous activity (Ebert & Muzi 1994).  These changes are 
accompanied by reductions in high frequency power on heart rate variability 
measurement, reflecting reductions in cardiac parasympathetic activity (Deutschman 
et al. 1994).   
 
Propofol administration is associated with blocks in cardiac conduction (Liu et al. 
2011).  Whether this is due to autonomic nervous system influence is controversial. 
One study indicated that propofol administration does not affect cardiac conduction 
when autonomic nervous activity is completely blocked (Ikeno et al. 1999). 
1.9.1.3 Anticholinergic agents 
 
Administration of the commonly used muscarinic antagonists glycopyrrolate and 
Atropine result in reductions in both baroreceptor sensitivity and heart rate variability 
(with specific decreases in the high frequency or vagal component on frequency 
domain analysis) for several hours after administration (J. L. Parlow et al. 1997; J. 
Parlow et al. 1997).  These reductions persist beyond any measurable influence on 
heart rate or blood pressure (van Vlymen & Parlow 1997). 
 
At low dose, however, atropine administration results in an increase in central vagal 
tone and abrogation of peripheral, efferent, sympathetic nerve activity (Montano et 
al. 1998; Yuasa et al. 2000).  It is at higher doses, that the muscarinic effect at the 
sinoatrial node predominates. 
1.9.1.4 Opiates 
In general, opiate medications reduce low frequency power (reflecting reduced 
sympathetic cardiac activity).  Remifentanil in particular is associated with increases 
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in both heart rate variability and high frequency power, not blocked by atropine 
administration (Tirel et al. 2005). 
1.9.1.5 Neuraxial blockade 
 
Limited studies have been carried out directly examining the influence of regional 
anaesthesia on autonomic function, though neuraxial blockade inhibits efferent 
sympathetic outflow.  Thoracic blockade has greater effect on cardiovascular 
function than lumbar possibly due to involvement of cardiac acceleratory fibres, as 
well increased vasodilatation of splanchnic vessels resulting in venous pooling.  In 
labouring parturients, epidural block to T6 increased parasympathetic outflow, and 
decreased sympathetic power on HRV analysis.  Epidural analgesia is also 
associated with improved postoperative recovery of heart rate parameters (Licker et 
al. 2003).  Under spinal anaesthesia, preoperative increases in LF/HF ratio, thought 
to represent established sympathetic dominance, are predictive of hypotension 
(Hanss et al. 2006). 
 
1.9.2 Autonomic dysfunction is likely to result in impaired outcomes both 
during and after anaesthesia 
 
A clear signal appears to exist then relating cardiac autonomic neuropathy and 
impaired perioperative haemodynamic and cardiac outcome.  Perioperative cardiac 
risk is increased, as is the risk of haemodynamic instability, morbidity and mortality in 
the postoperative period.  
 
However, no attention has yet been paid to perioperative infectious/immune 
outcomes, integrated cardiovascular physiology or morbidity specific to either 
sympathetic or parasympathetic autonomic dysfunction.  Furthermore, a large cohort 
of patients who do not necessarily exhibit overt cardiac autonomic neuropathy, but 
are at risk of covert autonomic dysfunction associated with common conditions such 
as hypertension, ischaemic heart disease and undiagnosed cardiac failure, may 
have been missed in studies conducted to date.  This is despite plausible 
mechanistic processes that should link autonomic dysfunction to impaired 
postoperative outcome.  Similarly, global outcomes have not been examined in high-
risk patients with existing autonomic dysfunction presenting for surgery.  This thesis 
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therefore explores these outcomes in this important population.  How to define 
dysfunction in either limb of the ANS during the preoperative period is therefore an 
important question, which is addressed subsequently. 
 
1.10 Techniques for assessing autonomic function 
 
Various techniques have been used to detect alterations in autonomic function in a 
wide range of diseases and contexts.  The wide variety of techniques employed and 
variable cut-offs used to define AD have hampered comparison of outcomes 
between studies (Colombo et al. 2015).  In anaesthesia and critical care, commonly 
used modalities have chiefly focused on the autonomic modulation of heart rate 
(heart rate variability) and the arterial baroreflex (Mazzeo et al. 2011; McGrane et al. 
2014).  Interpretation of studies looking at autonomic function has been hampered by 
the lack of population norms, variable acquisition and analysis techniques, and in 
many cases, lack of long term follow up (Keet et al. 2011; Keet et al. 2014).   
 
There are a large number of tests of autonomic function available.  These tests 
variably describe different aspects of autonomic activity, covering 
parasympathetic/sympathetic, afferent/efferent and integrated reflex activity.  The 
majority of tests focus either on end organ ‘read-outs’ of autonomic activity (e.g. 
sudomotor skin tests) or integrated reflexes (such as blood pressure responses to 
head-up tilt).  The individual clinical or research question or paradigm determines the 
most appropriate approach to test selection for contextual assessment of autonomic 
function (Zygmunt & Stanczyk 2010).  
 
Many tests are affected by the state of hydration of the patient, or the medications 
that individual may be taking.  Several tests require a degree of control of 
environmental or patient factors (such as the need for paced breathing in accurate 
assessment of heart rate variability).   
 
The majority of tests use end organ function and responsiveness (e.g. heart rate 
dynamics) as a read out, rather than measuring central autonomic neural activity 
directly (e.g. using neuroimaging techniques such as fMRI), due to the technical 
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complexities of so doing in the intact individual (Zygmunt & Stanczyk 2010).  These 
difficulties include physiological noise artefacts affecting brainstem neuroimaging 
data, as well as difficulty in deriving non-invasive continuous assessments of 
autonomic modulation correlated with peripheral indicators of physiological response 
(Macey et al. 2016; Napadow et al. 2008).  
 
These challenges may lead to problems with interpretation, but in context, where 
clinical outcome correlates exist, end-organ readouts can supply large amounts of 
useful information (Zygmunt & Stanczyk 2010).  Over the past five years, over 1000 
publications have been produced where autonomic function has been assessed 
using cardiovascular testing and associated with altered outcomes in a variety of 
clinical conditions (Lankhorst et al. 2014).   
 
Broadly, autonomic function tests may be divided into the following categories: 
1. Cardiovagal innervation (parasympathetic):  Heart rate and heart rate 
variability dynamic responses to deep breathing, the Valsalva manoeuvre and 
postural change.  Heart rate recovery after exercise. 
2. Adrenergic (sympathetic):  Blood pressure responses to the Valsalva 
manoeuvre, sustained hand grip and postural change. 
3. Mixed (parasympathetic and sympathetic):  Heart Rate Variability, static and 
dynamic heart rate changes (such as resting heart rate and chronotropic 
incompetence) in response to stressors. 
4. Sudomotor: quantitative sudomotor axon reflex test (QSART), 
thermoregulatory sweat test (TST), sympathetic skin response (SSR) and 
silastic sweat imprint.  These tests are in general used in the context of 
peripheral autonomic neuropathies and will not be discussed further. 
 
1.10.1 Selection of an appropriate autonomic testing modality for use in the 
high-risk surgical patient 
 
Various techniques have been employed in the assessment of autonomic activity in 
surgical populations (Mustafa et al. 2012).  For the purposes of this thesis a testing 
modality was required that would measure the effects of either parasympathetic or 
sympathetic autonomic dysfunction on perioperative outcome. 
		  59 	
Introduction 
	
	 	
Such a test should be well established and validated in the general medical 
literature, both in terms of specific patient outcomes and in terms of physiological 
reliability.  It should be specific and reproducible and ideally be easily carried out in 
the preoperative period without extra inconvenience as part of the preoperative work-
up of the high-risk surgical patient.  The test selected should have been well 
explored in the contexts of cardiac risk and cardiac insufficiency in the wider 
population, and be well related to other established measures of cardiac function.  
Further considerations, for wider applicability in future studies and clinical practice, 
should ideally minimise the need for complex or expensive equipment and avoid 
over-reliance on proprietary software or mathematical algorithms.   
 
Several candidate tests, each with their potential limitations, which have previously 
been applied in the preoperative period and/or in the high-risk cardiac population, 
are outlined below: 
1.10.2 Heart Rate Dynamic Changes (deep breathing, Valsalva, postural 
change, sustained hand grip) 
 
Heart rate responses during controlled deep breathing, the Valsalva manoeuvre and 
during changes in posture are commonly used to assess autonomic integrity, in 
particular parasympathetic function.  There are only a limited number of reports 
detailing reference values for cardiovascular autonomic function in healthy subjects. 
(Keet et al. 2011; Keet et al. 2014; Voss et al. 2012; Ewing & Clarke 1982).   
 
In controlled deep breathing, the maximum and minimum ECG R-R intervals during 
each breathing cycle are measured.  This consists of 6 cycles of 5 seconds of 
inspiration and 5 seconds of expiration during a minute.  The R-R intervals during 
inspiration and expiration are subsequently determined and expressed as a ratio.   
 
A similar technique may be employed using a Valsalva manoeuvre, where a subject 
is asked to produce an intrathoracic pressure of 40 mmHg for 15 seconds by blowing 
into a manometer.  The Valsalva ratio is defined as the ratio between the longest and 
the shortest R-R intervals immediately post test.   
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R-R interval changes during postural change have also been used to assess 
autonomic cardiovascular integrity.  After standing up quickly from the sitting 
position, the R-R intervals at 15 and 30 beats are measured.  In healthy subjects, the 
ratio of the longest and shortest R-R intervals should be >1.04 (Keet et al. 2014; 
Keet et al. 2011; Ewing & Clarke 1982; Lankhorst et al. 2014). 
 
Whilst these tests are useful for the clinical assessment of cardiovascular autonomic 
neuropathy, they lack precision in terms of identifying specific impairments in 
parasympathetic or sympathetic function. 
 
1.10.3 Blood Pressure Responses 
 
Blood pressure responses during sustained handgrip have also been use to assess 
cardiovascular autonomic function, in particular sympathetic nervous activity.  One 
method employs a sustained contraction (at 30% of maximum contraction for 5 
minutes).  The diastolic blood pressure should rise by >16 mmHg in the opposite 
arm in healthy subjects.   
 
In the Schellong (quick-standing) test, systolic blood pressure is first measured in the 
supine resting state.  Two minutes after rapidly standing up, the systolic blood 
pressure is re-measured.  In healthy individuals, a drop in blood pressure of <10 
mmHg is expected.  In individuals who exhibit a drop of more than 20 mmHg in 
systolic blood pressure after standing, impaired autonomic cardiovascular function is 
indicated (Lankhorst et al. 2014).   
 
These tests are specific for sympathetic autonomic dysfunction, but are not very 
sensitive.  Ideally, the modality of testing used in the perioperative context would 
allow assessment of both parasympathetic and sympathetic autonomic testing in one 
sitting.  
 
1.10.4 Heart Rate Variability Analysis 
 
Heart Rate Variability (HRV) is commonly used in the assessment of cardiac 
autonomic dysfunction, but poses many challenges in interpretation.  In the general 
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population, a low HRV is associated with both morbidity and mortality from many 
causes, not all cardiac (Billman 2011).   
 
HRV refers to physiological variability in the timing between individual heartbeats 
(NN periods/RR intervals) and reflects oscillations between individual heartbeats.  It 
is measured over short term (classically 5 minutes) or longer (up to 24 hours) time 
periods.  Prior to the identification of beat-to-beat heart rate variability, the ability to 
estimate cardiac autonomic function was limited (Monfredi et al. 2014).  Two 
modalities of assessment are commonly used: frequency domain and time domain 
analysis.  Standard values exist and are widely accepted (Malik et al. 1996).  
 
Multiple papers (>17,000) encompassing a variety of methods for HRV analysis have 
been published indicating impaired outcomes associated with reduced variability in a 
wide array of pathology (Billman 2011; Monfredi et al. 2014), including in surgical 
patients (Mazzeo et al. 2011).  Measurement and interpretation of heart rate 
variability measures remain the basis of a significant volume of translational science 
publications to date (Monfredi et al. 2014).   
 
Some controversy remains over the exact interpretation of HRV measures, 
especially in relation to the precise limb of the ANS affecting change in variability 
parameters, and even whether or not HRV is a pure marker of cardiac autonomic 
activity (Monfredi et al. 2014).   
 
1.10.4.1 Time Domain Measures 
 
Time domain measures of heart rate variability reflect sinus node depolarisation or 
variations in the intervals between normal QRS complexes.  Various measures are in 
common use: 
• SDNN - standard deviation of normal RR intervals 
• SDANN - standard deviation averaged over 5 minutes 
• RRMSD - square root of mean square differences of successive RR intervals 
• NN50 - the number of interval differences of >50ms 
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Time domain measures are most frequently employed over shorter recordings (five 
minutes being the standard recording length).  Whilst alterations in variability of a 
variety of time domain measures has been implicated in poor prognosis and 
increased mortality across a wide range of disease states, the exact contributions of 
the parasympathetic and the sympathetic divisions of the autonomic nervous system 
to this variability are controversial and remain the subject of active investigation and 
debate (Billman 2011). 
 
Over time it has become apparent that variability in heart rate is not the product 
simply of a regular periodic oscillator (i.e. a sine wave), but actually exhibits complex, 
non-linear behaviour (Guevara et al. 1981).  This limits the applicability of simple 
statistical approaches to HRV to analyse non-linear changes.  Approaches 
employing fractal mathematics have been attempted with some success to 
overcome these limitations.  These approaches measure system complexity rather 
than HRV magnitude.  In several contexts, these approaches have proved superior 
to traditional methods in predicting outcome in the clinical context (Billman 2011; 
Pikkujämsä et al. 1999).  They are, however, mathematically complex and not 
immediately accessible or available to all researchers.  Pragmatic application of 
standard time domain measures therefore remains the default usage in clinical and 
research practice. 
1.10.4.2 Frequency Domain Measures 
 
Frequency domain measures are calculated either through the application of a fast 
Fourier transform to an NN series or by autoregressive spectral estimation (the 
maximum entropy method).  High frequency variations in sinus rhythm NN intervals 
(0.12 to 0.4 Hz) are thought to predominantly reflect vagal activity, whereas slower 
variations are thought to reflect a combination of both sympathetic and 
parasympathetic modulation, as well as non-autonomic factors.  The very low 
frequency band (0.00 to 0.04 Hz) is thought to most clearly represent sympathetic 
function and fluctuations in vasomotor tone.  Ascribing a single limb of the autonomic 
nervous system to any band of frequency domain analysis remains difficult for similar 
reasons to that used in time domain analysis. 
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The low frequency band (0.04-0.15 Hz) includes physiological oscillations associated 
with the baroreflex, whereas the high frequency band (0.15 to 0.40 Hz) 
encompasses respiratory sinus arrhythmia.  Interpretation of frequency domain 
powers must therefore be carried out with some caution as either arm of the 
autonomic nervous system may cause low frequency band power changes.  Despite 
widespread and popular usage, frequency domain descriptions of sympatho-vagal 
balance are increasingly thought not to accurately describe actual autonomic activity 
in patients (Billman 2013; Milicević 2005; Antelmi et al. 2008; Reyes del Paso et al. 
2013). 
 
Shorter recordings (most commonly over five minute periods) can and have been 
used and been thought to be adequate, in both research and clinical contexts, with 
both time and frequency domain analysis. Very low frequency analysis is however 
thought to be inaccurate over shorter time periods (Malik et al. 1996).   
 
The application of five-minute recordings to other bands remains a topic of 
discussion in research and clinical practice.  The optimum sampling period for 
frequency domain analysis therefore remains elusive.  It is highly unlikely that an 
individual will remain in steady state over a 24-hour period, casting doubt on the 
applicability of these longer-term recordings.  Indeed, the real-time capture of 
changes in autonomic parameters under altering conditions could be considered the 
holy grail of autonomic research.  Proprietary software exists that allows shorter-term 
frequency domain analysis (e.g. over five minute periods), but the utility of such data 
remains a moot point (Nunanet al. 2010; Keet et al. 2011).   
 
In one analysis of over 3100 papers dealing with all measures of heart rate 
variability, only 44 papers were found to be in agreement with Task Force 
recommendations for signal quality and normal values for healthy individuals.  Heart 
rate variability in these studies showed wide variability between healthy controls 
(Nunan et al. 2010).   
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1.10.5 . Heart Rate Variability as a measure of cardiac autonomic system 
activity 
 
A variety of confounders exist in the interpretation of heart rate variability, especially 
in the clinical context.  Respiratory changes can alter HRV independent of autonomic 
regulation; this creates the requirement for controlled or paced breathing for accurate 
interpretation.  It is not always possible to fulfil this requirement in the clinical context, 
where many recordings are analysed from Holter monitor tracings, with the subject 
going about their daily activities (Brown et al. 1993).   
 
HRV only provides an indirect readout of cardiac sympathetic and parasympathetic 
function in the absence of measures of central neurological activity (e.g. fMRI).  This 
is important, since a portion of heart rate variability occurs as a consequence of 
mechanical events, such as atrial stretch (e.g. the Bainbridge reflex).  In transplanted 
hearts, for example, a small (2-8%) change in HRV is detectable in concert with the 
respiratory cycle (Bernardi et al. 1989).   
 
Recent evidence derived from intact humans and animals (Langendorff-perfused 
hearts and single sinoatrial nodal cell preparations) further demonstrate that heart 
rate variability is not predominantly related to cardiac autonomic activity, but rather to 
primarily to underlying heart rate (i.e. there is a universal exponential decay-like 
relationship between HR and HRV, so as heart rate rises, R-R interval drops and 
vice-versa) (Monfredi et al. 2014).   
 
Conventionally, heart rate variability is calculated from differences between a 
sequence of R-R intervals rather than the underlying heart rate.  When HRV is 
calculated from HR, it depends less on the underlying heart rate for accuracy 
(Stauss 2014).  This key observation suggests that observed differences in morbidity 
and mortality due to alterations in HRV could just reflect the underlying heart rate; an 
increased heart rate is associated with increased mortality.  Certainly, any study 
using heart rate variability as a measure of cardiac autonomic activity should control 
for underlying mean heart rate during the recording period before interpretation.   
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Further complexity is added when a biophysical model of sinoatrial node 
depolarisation is considered.  This model demonstrates that the HR: RR interval 
relationship is not the only determinant of HRV, rather that changes in autonomic 
outflow at the sinoatrial node on heart rate depend on underlying heart rate.   
 
For a given perturbing ion current (generated by the autonomic nervous system) 
acting on phase 4 (diastolic depolarization) of the sinoatrial action potential, the 
resulting change in HR depends on the prevailing slope of the diastolic 
depolarization in a nonlinear manner (Stauss 2014; O Monfredi et al. 2014).  At lower 
heart rates, a change in perturbing current (which changes the slope of diastolic 
depolarization by a given amount) causes a greater effect on cardiac cycle length 
and heart rate than the same perturbation would at higher heart rates.  This 
phenomenon is independent of the inverse relationship between R-R interval and 
heart rate (Monfredi et al. 2014).   
 
Whilst, therefore, heart rate variability analysis is widely used as a measurement of 
cardiac autonomic control, and likely in many circumstances remains reflective of 
autonomic activity (Stauss 2014), many potential confounders exist that limit its use 
in the preoperative assessment of predominant parasympathetic or sympathetic 
autonomic dysfunction.  Monfredi et al. state that HRV “cannot be used in any simple 
way to assess autonomic nerve activity to the heart” (Monfredi et al. 2014).  Other 
testing modalities that are less influenced by other physiological parameters than 
autonomic activity may therefore be more accessible and applicable for more precise 
identification of dysfunction of either limb of the autonomic nervous system prior to 
major surgery.  Candidate modalities include dynamic heart rate responses elicited 
largely due to alterations in autonomic activity.   
 
1.10.6 Resting Heart Rate 
 
Resting heart rate is directly linked to survival.  This relationship is preserved across 
species, with life expectancy being close to 1,000,000 heart beats (Lauer 2009). In 
humans, large volumes of epidemiological data links resting heart rate to mortality 
(Wilhelmsen et al. 1986; Levine 1997; Eijgelsheim et al. 2010).  Increases in resting 
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heart rate in ischaemic heart disease are associated with morbidity and mortality, 
whilst decreases (e.g. with beta-blockade and ivabradine) are associated with 
improved survival.  Improved outcome is linked to the magnitude in reduction of 
heart rate in response to the intervention (Reil & Böhm 2007; Swedberg et al. 2010).  
It is not known whether resting heart rate directly impacts mortality or rather reflects 
other underlying subclinical pathophysiological processes.   
 
Resting heart rate is closely related to parasympathetic tone, as well as aerobic 
capacity (both modifiable; Kenney 1985).  Up to 32% of resting heart rate variation in 
the general population might be explained by heredity (Wilk et al. 2002), with twin 
studies suggesting an even greater influence (>50%; Dalageorgou et al. 2008).   
 
Recent genome-wide association studies (GWAS) have identified common variation 
at or near MYH6, CD34 & GJA1 (myosin heavy chain, a protein involved in bone 
marrow stem cell differentiation & connexin 43) associated with heart rate control.  
These chromosomal loci may represent novel risk factors for cardiovascular disease 
outcomes (Cho et al. 2009; Holm et al. 2010).   
 
In one genome wide study, several genes associated with resting heart rate are 
associated with cardiac ion channels and their regulatory proteins.  One locus 
encodes a thyroid receptor-interacting protein, and another (AChE) encodes 
acetylcholinesterase, which provides a potential link between parasympathetic 
function and resting heart rate at a genome level (Eijgelsheim et al. 2010).  Other 
genetic determinants have been associated with resting heart rate (also linked to risk 
of cardiovascular disease) which are related to other factors including basal 
metabolism, which is also under strong autonomic influence (Mezzavilla et al. 2014).  
The differentiation between epigenetic and genetic phenomenon affecting genetic 
studies (such as the influences of environmental factors such as training or anxiety) 
add noise to the phenotype, limiting utility in population risk prediction.   
 
In the perioperative population, a raised resting heart rate is strongly associated with 
perioperative adverse cardiac events (Abbott et al. 2016; Foëx & Higham 2016).  
Unfortunately, as a clinical measure of parasympathetic tone, resting heart rate 
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reflects environmental influences such as stress, dehydration and metabolism, 
limiting usage to large population studies not easily extrapolated to an individual at 
any particular point in time.  Raised resting heart rate may itself be causative of 
adverse outcomes, and/or be a marker of an underlying disease such as heart 
failure.   
1.11 Heart rate recovery after exercise:  a measure of parasympathetic 
autonomic function 
 
In light of the previously discussed potential limitations inherent in other common 
measuring modalities used to measure autonomic function, I considered heart rate 
recovery after exercise as a candidate test for the purposes of assessment of 
parasympathetic activity in the surgical patient.  This test was considered since it is 
very clearly representative of parasympathetic activity, is non-invasive, can be 
carried out as part of the normal work up of the high-risk surgical patient and has, in 
comparable populations, been associated with impaired short and long term 
morbidity and mortality.   
 
Heart rate recovery after exercise, which depends on the reactivation of 
parasympathetic tone (Imai et al. 1994), is a robust physiologic marker of established 
parasympathetic autonomic dysfunction (Lauer 2009).  Abnormal heart rate recovery 
is independently associated with long-term cardiovascular morbidity and all-cause 
mortality in the general medical population – independent of pathology 
conventionally associated with autonomic dysfunction (Jouven et al. 2005).  Key 
studies examining the relationship between abnormal heart rate recovery and 
outcome, including all cause mortality are summarised in Table 1-4.  Methods of 
determining abnormal heart rate recovery in these populations are also outlined in 
the same table.   
 
Heart rate variability measures require Holter ECG monitoring as well as dedicated 
interpretative software, whereas measurement of heart rate recovery is more 
straightforward to perform. 
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1.11.1 Abnormal heart rate recovery is due to impaired parasympathetic 
autonomic function 
 
During ramped exercise (where the external work performed is increased in a graded 
manner), heart rate increases in parallel with exertion, due initially to 
parasympathetic withdrawal at onset of exercise, followed by elevations in 
sympathetic tone as well as parasympathetic withdrawal during more vigorous 
activity.  In the first 30 to 120 seconds after cessation of exercise, heart rate drops 
rapidly due initially mostly to reinstitution of parasympathetic tone, followed by 
subsequent sympathetic deactivation (Lauer 2009; Pierpont et al. 2000; Figure 1-3).   
 
In healthy individuals and athletes, a biexponential drop in heart rate is observed at 
cessation of activity.  This comprises a log-linear decrease in heart rate over the first 
30 to 120 seconds that is not dependent on the intensity of exercise, followed by a 
slower latter recovery that is thought to be work load dependent (Lauer 2009; 
Buchheit et al. 2007).  This biexponential decline is abolished when atropine is 
administered (atropine as a muscarinic antagonist blocks vagal activity), and a more 
linear decline in heart rate is observed.  This pattern closely matches the expected 
heart rate recovery profile of individuals with heart failure (Imai et al. 1994; Savin et 
al. 1982).   
 
Heart rate recovery after exercise may be quantified by: (1) measuring the absolute 
difference between heart rate at the cessation of exercise and after 60 to 120 
seconds of recovery, (2) measuring the time constant of heart rate decay through 
fitting early heart rate recovery after exercise to a first order exponential decay curve, 
or (3) analysis of the first 30 seconds of post exercise heart rate recovery with 
semilogarithmic regression analysis (Buchheit et al. 2007). 
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Figure 1-3: The association between parasympathetic tone and heart rate recovery  (A) 
Absolute heart rate recovery (log transformed) in the first two minutes after cessation of graded 
exercise.  A biexponential heart rate recovery profile is seen in both normal individuals and athletes, 
which is absent in heart failure. (B) Heart rate recovery after administration of atropine.  The initial 
rapid reduction in heart rate is lost. Redrawn from (Lauer 2009). 
 
 
When pyridostigmine (an acetylcholinesterase inhibitor which increases the 
availability of acetylcholine) is administered to healthy untrained controls, but not 
athletes, immediate post exercise heart rate recovery is augmented, but not late 
heart rate recovery (Dewland et al. 2007).  
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Further evidence for return of parasympathetic activity predominating over 
sympathetic withdrawal in early recovery for exercise comes from the observation of 
no improvement in initial heart rate kinetics after beta blockade (Crouse et al. 1989).   
 
Known plasma norepinephrine kinetics also decrease the likelihood of sympathetic 
withdrawal underlying early heart rate recovery.  Levels of circulating catecholamines 
are not affected by the duration of exercise and in fact peak after the cessation of 
activity.  The plasma half-life of norepinephrine is around 3 minutes, easily outlasting 
the classically observed rapid initial recovery of heart rate, suggesting that late rather 
than early heart rate recovery is related to sympathetic withdrawal (Hagberg et al. 
1979; Pierpont et al. 2000; Perini et al. 1989).   
 
When compared with other commonly used measures of resting parasympathetic 
withdrawal, heart rate recovery performs well.  Abnormal heart rate recovery has 
been associated with resting heart rate variability indices of parasympathetic 
withdrawal in patients with known coronary arterial disease, diabetes and healthy 
middle aged subjects (Evrengul et al. 2006; Copie et al. 2003; Nunan et al. 2010; 
Turker et al. 2013).   
 
Before graded exercise, rMSSD and High Frequency Power used to capture 
instantaneous levels of parasympathetic reactivation have been directly related to 
the degree of heart rate recovery after exercise.  In these same individuals, 
parasympathetic withdrawal at all time points derived from HRV parameters appears 
greater in individuals with reduced HRR (Danieli et al. 2014; Chen et al. 2011).   
 
Although HRV measures such as HF-power and rMSSD appear to be predominantly 
generated by respiratory modulation of parasympathetic outflow (Malik et al. 1996), 
more recently it has become accepted that dynamic vagal-related HRV measures 
better reflect modulation of parasympathetic activity than overall vagal tone (Hedman 
et al. 1995).   
 
Since both rMSSD and HRR are thought to represent parasympathetic activity, it 
might be expected that the two measures be always correlated.  This, despite 
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evidence from studies such as those previously referenced, is not always the case 
(Buchheit, Papelier, et al. 2007).  After very intense exercise, heart rate recovery 
may be preserved, despite minimal parasympathetic reactivation (Buchheit, Laursen, 
et al. 2007).  HRV measures may be affected by respiratory parameters, underlying 
heart rate and the degree of sympathetic activation.  Indeed, HRV and HRR might 
characterise independent aspects of cardiac parasympathetic function (Buchheit, 
Papelier, et al. 2007). 
 
1.11.2 Abnormal heart rate recovery is predictive of mortality 
 
Established parasympathetic autonomic dysfunction (PAD) is not only related to 
morbidity and mortality, but is highly likely to provide the mechanism for the 
development of organ dysfunction.  Epidemiological studies using heart rate 
recovery as a marker of established PAD strongly support this assertion.   
 
Jouven et al., in 5,713 asymptomatic working men, referred for routine annual 
medical screening, found an increase in risk of sudden death of 2.1 times in subjects 
with a heart rate recovery of less than 25 beats per minute (the lowest quintile of the 
studied population), when compared with the highest quintile (representing a heart 
rate recovery of greater than 40 beats per minute) (Jouven et al. 2005).   
 
Cole et al. described a 1.5 times increase in likelihood of death in a population of 
5,234 individuals without known cardiovascular disease for subjects with a heart rate 
recovery at one minute of at less then 42 beats per minute (the lowest quartile in that 
population) (Cole et al. 2000; Iyer et al. 2009).  When conventional cardiovascular 
risk factors and exercise test parameters including aerobic capacity, chronotropic 
incompetence and abnormal heart rate recovery were examined across a population 
of 6,546 individuals without known cardiac disease, only aerobic capacity and 
abnormal heart rate recovery were predictive of 8 year mortality.  Predictive power 
was further increased when the two variables were combined (Dhoble et al. 2014).   
Across a further 9,454 patients referred for exercise testing, both exercise capacity 
and abnormal heart rate recovery were predictive of 5 year mortality.  No interaction 
was noted between these two measures (Nishime et al. 2000).  This independent 
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predictive capacity is preserved when impaired left ventricular systolic function is 
controlled for (Watanabe et al. 2001).   
 
In a 3,043 patient, 22-year outcome study, designed to identify exercise parameters 
that could be related to lower socioeconomic status and mortality, heart rate 
recovery and reduced functional status correlated best with mortality (Shishehbor et 
al. 2006).  
 
Heart rate recovery is linked with aerobic fitness.  Athletes tend to exhibit higher 
resting vagal tone and faster heart rate recovery than untrained individuals (Imai et 
al. 1994; Pierpont et al. 2000).  It is not, however always possible to improve heart 
rate recovery with aerobic exercise training (Danieli et al. 2014; Pierpont et al. 2000; 
Jolly et al. 2011).  Jolly et al. in their study of >1,300 patients referred for cardiac 
rehabilitation found that of those patients who presented with abnormal heart rate 
recovery, 41% improved (i.e. their HRR increased above 12bpm at 1 minute after 
cessation of exercise).  Those patients that entered and exited the study with an 
abnormal heart rate recovery exhibited the highest mortality, whereas those who 
improved their heart rate recovery after cardiac rehabilitation also improved their 10-
year mortality (HR 0.92).  Predictors of failure to improve heart rate recovery with 
training included advanced age, failure to increase exercise capacity, diabetes 
mellitus, prior congestive heart failure, use of nitrates, and peripheral arterial disease 
(Jolly et al. 2011). 
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Author & 
Year 
Population Outcome Heart rate 
recovery 
threshold/limit 
Conclusions 
(Cole	et	al.	
1999)	
Patients	without	known	
heart	disease	referred	for	
diagnostic	thallium	scan	
+	exercise	testing	
2,428	patients	
All	cause	mortality	
(6	years)	
1	minute	after	peak	
exercise	
</=	12	bpm	
	
The	maximal	value	
for	the	log-rank	
chi-square	test	
statistic	for	all	
possible	cut-off	
points	between	the	
10th	and	90th	
percentiles	for	the	
study	cohort.	
	
A	delayed	decrease	
in	the	heart	rate	
during	the	first	
minute	after	
graded	exercise	is	a	
predictor	of	overall	
mortality,	
independent	of	
workload,	the	
presence	or	
absence	of	
myocardial	
perfusion	defects,	
and	changes	in	
heart	rate	during	
exercise.	
(Cole	et	al.	
2000)	
Patients	with	no	known	
heart	disease	enrolled	in	
a	Lipid	research	cohort	
study.	Submaximal	
exercise	testing.	
5,234	patients	
All	cause	mortality	
(12	years)	
2	minutes	after	
peak	exercise	
<24	bpm	
When	other	known	
risk	factors	for	
cardiac	death	are	
controlled	for,	
impaired	HRR	
predicts	death	
(Shetler	et	al.	
2001)	
Patients	referred	for	
treadmill	stress	testing	
and	coronary	
angiography	
2,193	patients	
	
All	cause	mortality	
(6	years)	
	
findings	on	
coronary	
angiography	
12,18,42	bpm	at	1,	
2	and	3	minutes	
post	peak	exercise	
(published	criteria)	
	
2	minutes	after	
peak	exercise	HRR	
and	outcome	in	
proportional	
hazards	model	
<22	bpm		
HRR	independently	
predicted	death	at	
all	time	points	and	
in	all	models	
Did	not	perform	
better	than	other	
traditional	variables	
Failed	to	
discriminate	
coronary	
angiography	
findings	
(Watanabe	et	
al.	2001)	
Patients	referred	for	
exercise	
echocardiography	with	
no	history	of	cardiac	
disease	
5,438	patients	
All	cause	mortality	
(3	years)	
1	minute	after	peak	
exercise	
</=18	bpm	
	
A	series	of	Kaplan-
Meier	curves	was	
constructed	
describing	
mortality	rates	
above	and	below	
all	heart	rate	
recovery	values	
between	the	10th	
and	90th	
percentiles	of	the	
entire	cohort.	
A	cut-off	value	of	
After	accounting	for	
left	ventricular	
function,	heart	rate	
recovery	remains	
predictive	of	all	
cause	mortality	
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</=18	beats	per	
minute	was	
considered	
abnormal,	this	
value	yielded	the	
highest	log-rank	
score	
(Jouven	et	al.	
2005)		
Asymptomatic	working	
men	without	
cardiovascular	disease	
5,713	patients	
All	cause	mortality	
(5	years)	
1	minute	after	peak	
exercise,		
<26	bpm	(lowest	
quintile	and	2,	3	
minutes	after	
exercise)	
All	cause	mortality	
and	mortality	from	
sudden	death	
increased	in	lowest	
quintile	at	each	
recovery	time	
point.		No	excess	
incidence	of	
myocardial	
infarction	
(Shishehbor	et	
al.	2006)	
Patients	referred	for	
treadmill	stress	testing	
30,043	patients	
All	cause	mortality	
(6.5	years)	
Estimated	
functional	capacity	
and	heart	rate	
recovery,	
physiologic	
characteristics	that	
are	determined	
directly	from	
exercise	testing	and		
socioeconomic	
status	
1	minute	after	peak	
exercise	
<12	bpm	
	
Based	on	published	
criteria	
	
Impaired	functional	
status	and	heart	
rate	recovery	
associated	with	low	
socioeconomic	
status	and	account	
for	much	of	its	
relationship	with	
mortality	
(Kubrychtova	et	
al.	2009)(Sacre	
et	al.	2012)	
Heart	Failure	(Ejection	
Fraction	<45%)	
712	patients	
All	cause	mortality	
(6	years)	
1	minute	after	peak	
exercise	
<5,	<6,	<10	bpm	
(Quartiles)	
	
Ranked	HRR	
independently	
predicted	mortality	
(Dhoble	et	al.	
2014)	
Patients	referred	for	
exercise	testing	without	
known	cardiac	disease	
6,546	patients	
All	cause	mortality	
(8	years)	
	
1	minute	after	peak	
exercise	
<12	bpm	
	
Based	on	published	
criteria	
	
Both	functional	
aerobic	capacity	
and	heart	rate	
recovery	predicted	
mortality	in	the	
study	period	
 
Table 1-4 Large-scale epidemiological studies where morbidity and mortality have been related 
to heart rate recovery after exercise.  A significant degree of variation in measuring method for 
heart rate recovery is observed across these studies.  Several studies use the lowest quartile of 
recovery observed in the population studied.  Others use fixed definitions of abnormal HRR (such as 
12bpm at one minute of recovery).  Others stratify according to eventual outcome.  The range of 
measuring modalities and differing populations renders comparison more difficult, but across all the 
studies presented, impaired heart rate recovery after exercise is associated with worse outcomes 
both in terms of mortality and morbidity.  
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Age is another key consideration in terms of autonomic health.  With increasing age, 
autonomic dysfunction becomes more likely.  This is manifest in both reduced heart 
rate variability and impaired heart rate recovery regardless of aerobic fitness level.  
However, at any given age, improved aerobic fitness is associated with increased 
HRV and a more rapid heart rate recovery when compared with matched controls 
(Trevizani et al. 2012).   
 
Ultimately though, autonomic function and aerobic fitness do not represent the same, 
but rather interactive, physiological processes.  A role for intact parasympathetic 
activity can be hypothesised in the promotion and maintenance of cardiac 
contractility, which in turn will affect VO2 peak.  This relationship may become most 
important at the lower end of cardiac performance.  However, in fit individuals there 
appears to be either no relationship between aerobic endurance and cardiovascular 
autonomic control (Bosquet et al. 2007), or at least a variable relationship (Sugawara 
et al. 2001). 
 
1.11.3 Abnormal Heart rate recovery is predictive of impaired outcome across 
a range of pathologies 
 
The predictive value of HRR for morbidity, disease progression and mortality is 
sustained across a variety of pathologies.  PAD is strongly implicated in the 
development of cardiac dysfunction.  In heart failure, an abnormal heart rate 
recovery is associated with disease progression, mortality and elevated levels of 
serum inflammatory markers (Tang et al. 2009; Ritt et al. 2012; Arena et al. 2006; 
Arena & Sietsema 2011; Kubrychtova et al. 2009; Yilmaz et al. 2013; Bilsel et al. 
2006).  During cardiopulmonary exercise testing in individuals with known heart 
failure, an abnormal heart rate recovery is able to provide additional discriminatory 
predictive value for mortality risk over and above aerobic capacity (Ritt et al. 2012; 
Arena et al. 2006). 
 
Intact or augmented parasympathetic function is protective during myocardial 
ischaemia.  In patients with known ischaemic heart disease and patients referred 
with chest pain for exercising testing, an abnormal heart rate recovery is 
discriminatory for the presence of angiographic disease (Shetler et al. 2001) and 
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predictive of coronary arterial disease severity (Ghaffari et al. 2011).  Furthermore, 
along with chronotropic incompetence, abnormal heart rate recovery is predictive of 
abnormalities in myocardial perfusion (Georgoulias et al. 2003).   
 
In diabetes, an abnormal HRR is also related to reduced HRV, mortality, glucose 
control and inflammatory parameters (Turker et al. 2013; Cheng et al. 2003) and is 
therefore thought to represent, or at least predict, Cardiac Autonomic Neuropathy 
(Sacre et al. 2012). 
 
1.11.4 Heart rate recovery after exercise as a measure of established 
parasympathetic autonomic dysfunction in the perioperative period 
 
To date, no specific exploration of the impact of established parasympathetic 
autonomic dysfunction has been attempted in the high-risk surgical population.  
Studies examining autonomic dysfunction have suffered methodologically and in 
terms of content as follows: 
• The use of heart rate variability (the most commonly employed assessment 
technique in perioperative studies) to define autonomic dysfunction is 
burdened both with technical and interpretative difficulty. 
• Little or no corroborating physiological data has previously been collected that 
describes the impact of established PAD on cardiopulmonary fitness or 
intraoperative cardiac performance. 
• No systemic description of postoperative morbidity has been carried out. 
• Patient selection has focused on medical diagnosis (e.g. diabetes) rather than 
the high-risk surgical population as a whole. 
Planned surgery offers a unique opportunity to systematically phenotype an 
individual prior to a timed, predictable insult (Cain et al. 2015).  Cardiopulmonary 
exercise testing (CPET), a routine preoperative investigation for higher risk patients 
in many centres provides the means by which to achieve this goal.  By using CPET, 
a comprehensive battery of physiological parameters may be additionally described 
in the context of normal and abnormal heart rate recovery.   
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Heart rate recovery shows potential as a powerful, but low cost, low technology tool 
for the assessment of risk in the cardiac patient.  This thesis will explore its use in 
the surgical population.   
 
1.12 Sympathetic Autonomic Dysfunction 
 
The interaction between parasympathetic and sympathetic autonomic neural activity 
is complex and influenced by a multitude of different factors.  It is possible that ‘pure’ 
parasympathetic or sympathetic autonomic dysfunction does not exist, but rather the 
evolution of individual pathologies and disease states are influenced by differing 
degrees of predominantly parasympathetic or sympathetic impairment.   
 
As outlined previously, excessive sympathetic outflow may result in a variety of 
pathophysiological changes including cardiac dysfunction and immune paralysis 
(Ackland et al. 2015), myocardial cellular injury, perioperative haemodynamic 
instability and prolonged postoperative myocardial ischaemia (Ellison et al. 2007; 
Huang et al. 2006; Laitio et al. 2007).  Perioperative beta blockade has shown some 
promise in the reduction of major adverse cardiac events (MACE), though at the 
expense of an increased risk of perioperative CVA and hypotension in the surgical 
population at risk of adverse cardiac events (Devereaux et al. 2008; Fleisher et al. 
2014).   
 
Identification of surgical patients who demonstrate preoperative evidence of 
sympathetic autonomic hyperactivity may therefore be of benefit in terms of 
determining individuals who may, or may not benefit from pharmacological 
intervention such as beta-blockade.   
 
Impaired heart rate recovery after exercise and reduced heart rate variability may be 
influenced by high levels of sympathetic autonomic activity (Buchheit, Papelier, et al. 
2007).  It is important therefore to determine whether or not the phenotype of 
individuals with PAD, and any detriments in perioperative outcome associated with it, 
is the same as that seen in individuals who demonstrate excessive sympathetic 
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activity.  It is also important to determine whether or not these two populations are, in 
fact, composed of the same individuals.   
 
Anxiety disorders are associated with increased cardiac risk, thought to be due to 
chronic and cyclical sympathetic activation as evidenced by reduced heart rate 
variability and increased levels of circulating catecholamines in response to stressors 
(Rutledge et al. 2009; Rutledge et al. 2013; Dishman et al. 2000; Fiedorowicz et al. 
2011).  In the cardiac surgical population, anxiety is associated with impaired 
perioperative cardiac outcomes (Tully et al. 2011).   
 
Heart rate increases during mental stress, mostly as a result of sympathetic 
activation and is associated with reductions in heart rate variability (Taelman et al. 
2009).  Mild mental stress associated with impending exercise and resulting in an 
excessive heart rate rise is associated with an increased risk of sudden cardiac 
death (Jouven et al.2009).  No correlation has been described between pre-exercise 
anticipatory heart rate rise and heart rate dynamics during exercise.  However, in 
those individuals who demonstrate chronotropic incompetence, cardiac risk is further 
elevated (Jouven et al. 2009).  Anticipatory heart rate rise before exercise can 
therefore be used as a marker of sympathetic autonomic hyperactivity. 
 
The final results chapter of this thesis examines this relationship, in the light of 
findings in the same population of patients presented in preceding chapters dealing 
with PAD represented by impaired heart rate recovery after exercise.   
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1.13 Conclusion 
 
Postoperative morbidity is a major issue in global healthcare and is associated with 
increased short and long term mortality.  A minority of ‘higher risk’ individuals suffers 
the majority of adverse postoperative outcomes.  Accurate and individualised 
identification of these at-risk patients remains the subject of much research.  
Mechanistic explanations for the development of multi-system pathology are urgently 
needed, both in terms of the prediction of individual risk and to aid in the 
development of new therapeutic and management strategies to mitigate risk.   
 
One candidate mechanism for the production of postoperative morbidity is 
established autonomic dysfunction.  Both parasympathetic and sympathetic 
autonomic dysfunction could be hypothesised to predispose to adverse perioperative 
outcomes via independent and interdependent mechanisms.  Autonomic dysfunction 
is known to be materially related to prognosis and mechanistically underlie disease 
progression in a variety of multisystem pathologies relevant to the high-risk surgical 
patient.   
 
Heart rate recovery after exercise represents return of parasympathetic tone and is 
prognostic in a variety of relevant disease states as well as having potential as an 
appropriate preoperative test for the identification of PAD in high-risk surgical 
patients.  Other heart rate dynamic changes, such as anticipatory heart rate rise prior 
to exercise, which can also be measured at the time of exercise testing, can also be 
used to assess sympathetic autonomic dysfunction in the same patients.   
 
Whether established autonomic dysfunction is associated with perioperative cardiac 
impairment and impaired outcomes after surgery is unknown and warrants further 
exploration. 
 
1.14 Hypothesis 
 
Preoperative autonomic dysfunction is associated with increased postoperative 
morbidity and mortality in high-risk patients undergoing major surgery. 
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1.15 Plan of Investigation 
1.15.1 The impact of Parasympathetic Autonomic Dysfunction on exercise 
physiology 
 
Parasympathetic autonomic dysfunction, through a variety of mechanisms, would be 
predicted to result in impaired performance at Cardiopulmonary Exercise Testing.  
Impaired exercise performance is strongly associated with adverse perioperative 
outcomes.   
 
The first results chapter will examine the exercise physiology associated with PAD, 
as defined by impaired heart rate recovery, during formal cardiopulmonary exercise 
testing in a high-risk population presenting for major colorectal surgery.   
 
Abnormal heart rate recovery will be defined in this population according to 
population distribution.  Next, heart rate variability parameters will be examined in 
the same population and parameters currently associated with PAD in the general 
literature will be sought in patients with abnormal heart rate recovery.  Similarly, 
markers of cardiac dynamic performance during exercise testing associated with 
adverse outcomes, such as chronotropic incompetence, will be examined in 
individuals with and without PAD.   
 
Since PAD has previously been associated with cardiac ischaemia at stress testing, 
markers of ischaemia will be further examined in the same surgical population with 
PAD.  
 
Established PAD is associated with chronic physiological stress, including renin-
angiotensin-aldosterone system activation in both animal and human models.  One 
marker of this with important physiological associations, GRK2 in circulating 
lymphocytes, will be examined in this patient population. 
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1.15.2 The impact of Parasympathetic Autonomic Dysfunction on perioperative 
outcome 
 
Parasympathetic Autonomic Dysfunction, or vagal withdrawal has been associated 
with various adverse perioperative outcomes.  Similarly, acting through several 
plausible mechanisms including immune/inflammatory dysregulation and modulation 
of cardiac function, perioperative vagal withdrawal could be predicted to underlie the 
development of postoperative morbidity. The second results chapter will examine the 
relationship between PAD as defined by impaired heart rate recovery and relevant 
perioperative outcomes in the same population examined in the first results chapter.  
Specific attention will be paid to other established predictors of impaired 
perioperative outcome, including a reduced anaerobic threshold. 
 
1.15.3 The impact of Parasympathetic Autonomic Dysfunction on 
intraoperative haemodynamics 
 
Impaired performance at preoperative exercise testing is thought to translate into 
reduced intraoperative global oxygen delivery, which in turn is thought to result in 
increased postoperative morbidity.  It is not known whether any impairment in 
preoperative exercise performance in individuals translate to the intraoperative 
period.   
 
The third results chapter will investigate the relationship between preoperative 
exercise physiology and intraoperative cardiac output measured using the 
oesophageal Doppler monitor in a high-risk surgical population undergoing major 
colorectal surgery.  This will comprise a reanalysis of data from a previously 
published trial of intraoperative goal directed therapy and will therefore afford the 
opportunity to assess the response to fluid resuscitation in patients with and without 
PAD and relate intraoperative cardiac output to preoperative exercise physiology.   
 
To date, established cardiac autonomic dysfunction has been associated with 
intraoperative hypotension.  Confirmation of these findings in other surgical 
populations will be sought in this population with PAD defined through impaired heart 
rate recovery after exercise.   
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1.15.4 Sympathetic Autonomic dysfunction and perioperative outcome 
 
The first three results chapters focus on the impact of parasympathetic autonomic 
dysfunction on perioperative physiology and outcome.  What is not clear, however, is 
whether PAD always results in unopposed sympathetic activity. Similarly, the impact 
of preoperative sympathetic hyperactivity, predicted to be associated with 
immune/inflammatory dysregulation and increased cardiac risk in particular, is not 
known.   
 
The final results chapter will define increased sympathetic activity by an excessive 
heart rate increase prior to commencing loaded exercise at time of preoperative 
CPET.  Whether or not individuals with PAD, as defined by impaired heart rate 
recovery, also demonstrate sympathetic hyperactivity will be examined and the 
impact of sympathetic hyperactivity on perioperative outcomes will be examined, 
focusing on cardiac ischaemic pathophysiology most commonly associated with 
increased sympathetic outflow. 
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2 General	Methods	
2.1 Clinical Studies  
 
Clinical data presented in this thesis are derived from that recorded in patients at two 
centres (University College London Hospital (UCLH) and Derriford Hospital Plymouth 
(DHP)) presenting for major non-cardiac surgery who had undergone preoperative 
Cardiopulmonary Exercise Testing (CPET) and who were enrolled in the 
observational Perioperative Morbidity: Heart rate recovery (POM-HR: UKCRN 
13695) study which was composed of retrospective and prospective limbs.   
 
The Derriford Hospital Plymouth cohort results, incorporated in the retrospective limb 
of POM-HR, were derived from a novel analysis of data available from the Cardiac 
Output Monitoring and Pre-operative Exercise Testing for Colorectal surgery 
(COMPETE-C: UKCRN 7285) trial (Challand et al. 2012).    
 
Blood derived immune cells collected prospectively were evaluated in patients 
enrolled in the prospective limb of POM-HR at UCLH.   
 
Additional heart rate variability data was available for comparison from a subset of 
patients enrolled on the Perioperative Morbidity: Oxygen Delivery (POM-O: UKCRN 
8132) trial who had also undergone CPET as part of their routine clinical care.   
 
At UCLH, medical history and CPET data for patients referred for exercise testing 
based on local clinical and protocol grounds is collected in a database prospectively 
for research, audit and service improvement reasons.  This data was analysed for 
the retrospective limb of POM-HR. 
 
All patients enrolled in the studies described were seen in a nurse-led preoperative 
assessment clinic, typically two to four weeks pre-operatively.  Here, physical 
examination and investigations were carried out according to local protocol.  Where 
clinically necessary, a consultant anaesthetist review was undertaken and additional 
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relevant preoperative treatments and investigations were instigated according to 
local protocol. 
 
Routine blood samples including full blood count with differential white cell count 
(FBC) and renal function testing (U&Es) were carried out at this time. 
 
Consultants undertook surgery and anaesthesia.  Intraoperative fluid management 
depended on the individual study protocol, but in those studies where no protocol 
was stipulated, therapy was at the discretion of the treating anaesthetist.  No 
limitations were placed on the choice of anaesthesia or the usage of regional 
anaesthetic techniques though local consensus guidelines were available.  
Antibiotics and thromboprophylaxis were prescribed according to local practice and 
guidelines. 
 
The patients’ treating medical team provided postoperative care.  Admission to 
critical care was at the discretion of the surgeon or anaesthetist.  Postoperative 
blood testing was carried out according to local protocol and at the discretion of the 
treating medical team.  Routine physiotherapy was given according to local practice 
and acute pain team review was available for advice, all patients on parenteral 
analgesia were reviewed daily. 
 
Readiness for discharge, postoperative morbidity (Clavien-Dindo) (Clavien et al. 
2009) and return of bowel function data were collected prospectively at DHP only.  
Hospital length of stay data and mortality data were prospectively collected at both 
sites.  
 
A summary of the patient populations studied and the relevant thesis chapters in 
which these data are analysed is presented in Table 2-1. 
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Study title: Site: Number of 
patients: 
Heart Rate 
Parameters 
reported: 
Thesis results 
chapter: 
POM-HR 
(Retrospective 
limb) 
DHP 
(COMPETE-C) 
Derivation 
UCLH 
Validation 
 
814 
 
 
235 
 
HRR, aHRi 
 
 
HRR, aHRi 
 
3,4,5,6 
 
 
3,4,6 
POM-O UCLH 46 HRR, HRV 3,6 
POM-HR 
(Prospective 
limb) 
UCLH 20 HRR, aHRi 3 
Table 2-1: Populations studied in this thesis.  DHP:  Derriford Hospital Plymouth, UCLH:  
University College London Hospitals, HRR: Heart rate recovery, aHRi: abnormal heart rate increase, 
HRV: Heart Rate Variability. 
 
2.2 Perioperative Morbidity: Heart rate recovery (POM-HR) Study  
 
The Perioperative Morbidity: Heart rate recovery (POM-HR) study (UKCRN: 13695) 
is a multi-centre observational study of exercise-induced heart rate dynamics and 
their relationship to post operative morbidity in elective surgical patients undergoing 
cardiopulmonary exercise testing (CPET) as part of their routine preoperative 
workup.  
 
It is composed of both a retrospective limb (comprising a derivation (Derriford 
Hospital, Plymouth, DHP); and validation (University College London Hospital, 
UCLH) cohort) and a prospective limb (University College London Hospital, Derriford 
Hospital, Royal Bournemouth Hospital, Royal Surrey Hospital, Royal Preston 
Hospital).  
 
The Plymouth validation cohort comprised patients undergoing major colorectal 
surgery who participated in the COMPETE-C randomised controlled trial approved 
by the Cornwall and Plymouth Research Ethics Committee (Ref: 08/H0203/159) and 
conducted at Derriford Hospital, Plymouth, UK, between March 2009- April 2010 
(ISRCTN 14680495) (Challand et al. 2012).  A summary of the COMPETE-C 
protocol as relevant to POM-HR is presented subsequently. 
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2.2.1 Ethical approval 
 
Overall ethical approval for POM-HR was granted by the NRES Committee London; 
Camden & Islington (REC: 12/LO/0453).  Regulatory and Local Trust R&D approval 
was granted at all sites.  
The Cornwall and Plymouth Research Ethics Committee granted ethical approval for 
COMPETE-C on 09/09/2008 (ref: 08/H0203/159). 
For the retrospective study, written confirmation from the NIGB (Claire Edgeworth, 
Ethics and Confidentiality Committee) was obtained, confirming that non-identifiable 
morbidity and preoperative cardiopulmonary exercise testing data could be provided 
by clinical care teams, thus ensuring no breach of confidentiality.  Data from 
COMPETE-C had already been anonymised as part of the trial protocol.  Pre-
existing non-identifiable, fully anonymised morbidity, laboratory and preoperative 
cardiopulmonary test data are collected as part of clinical quality monitoring at UCLH 
(the UCL CPET database; London - South East REC (12/LO/0192).  The UK 
National Information Governance Board has confirmed that the routine haematology 
and biochemistry data collected for this study represents clinical audit and service 
evaluation and therefore did not require direct patient consent for evaluation.  
 
2.2.2 POM-HR Study objectives 
 
The primary objective of the study is to assess whether abnormal heart rate recovery 
representing parasympathetic autonomic dysfunction following cardiopulmonary 
exercise testing is related to postoperative complications including mortality and 
length of hospital stay.   
 
The trial secondary objective is to assess whether abnormal heart rate dynamics 
following cardiopulmonary exercise testing is related to immune-inflammatory 
phenotypes.   
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2.2.3 POM-HR Trial Design and Methods 
 
The full protocol for POM-HR (including prospective data collection, is available 
online at http://www.ucl.ac.uk/anaesthesia/trials.  The summary protocol as relevant 
to this work is presented below. 
 
2.2.3.1 Retrospective study 
 
Anonymised, individual and cohort laboratory, physiological and clinical data from 
patients undergoing routine preoperative cardiopulmonary exercise tests were 
provided by both centres in spreadsheet form.  Patients were assigned individual 
study numbers distinct from hospital number for CPET analysis.  At UCLH, individual 
CPET data was accessed on a non-networked computer using the anonymised 
database provided.  For each individual patient, heart rate dynamic and ECG data 
was calculated and CPET derived physiological data analysed blinded to outcomes 
data.  Either an experienced exercise physiologist or physician independently 
verified standard CPET variables. 
 
2.2.3.2 Prospective study 
 
Preoperative patients undergoing major surgery who had been routinely referred for 
CPET were approached and consented for participation.  Clinical Data was 
prospectively collected.  CPET data was collected and analysed as per usual clinical 
protocol at participating institutions.  Blood derived immune cells were collected at 
the UCLH site only prior to commencement of exercise on the day of CPET.  
Treatment and analysis of these samples is described subsequently. 
 
Heart rate dynamic data was analysed blinded to outcomes data. 
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2.2.3.3 Inclusion Criteria 
 
All surgical patients aged 18 or over routinely referred for cardiopulmonary exercise 
testing preoperatively undergoing major non-cardiac surgery.  For patients enrolled 
in DHP, additional limited inclusion and exclusion criteria were applied which are 
detailed subsequently. 
 
2.2.3.4 Exclusion Criteria 
 
• Unwillingness to participate 
• History of exercise induced angioedema 
• Pregnancy 
• Any contraindication to cardiopulmonary exercise testing (as outlined by the 
American Thoracic Society guidelines/ACCP (Weisman et al. 2003) 
 
A summary flow chart representing the study protocol is presented below (Figure 2-
1). 
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Figure 2-1: Summary flow sheet, POM_HR study protocol 
 
2.2.4 Retrospective Data Collection 
 
Preoperative clinical and demographic data were recorded prospectively as part of 
the COMPETE-C, and POM-HR clinical trials respectively.  These data included age, 
sex and comorbidities including diabetes, hypertension, ischaemic heart disease, 
cerebrovascular disease, heart failure and chronic kidney disease.  Perioperative risk 
scores were collected including American Society of Anesthesiologists (ASA) 
Physical Status Score and the Modified Lee Cardiac Risk Index. 
Hospital Discharge 
Post Operative Morbidity (POMS), Length of Stay and Complications Recorded 
Clavien-Dindo Score recorded 
Days 3,5,7,14 
Post-CPET 
Heart Rate Recovery 
Cardiopulmonary Exercise Test (CPET) 
Full standard Analysis of CPET Heart Rate Dynamics assessment 
Pre-CPET 
Baseline Clinical Information Documented Baseline Blood Samples Taken 
Prior to CPET  
Informed Consent Obtained 
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Postoperative data collected included hospital length of stay, readiness for discharge 
(DHP only), bowel dysfunction data (DHP only) and Clavien-Dindo grade (DHP only). 
Table 2-2: Summary Clinical Study Course for all patients presented in this thesis 
A summary of data collected at each site is presented in Table 2-2.  More detail is 
provided subsequently on definitions of sepsis, readiness for discharge, return of 
bowel function and Clavien-Dindo scoring. A table of types of surgery is available in 
supplemental materials 
 Cohort 1: 
Derriford Hospital 
Plymouth 
 
(Derivation) 
 
n = 235 
Cohort 2:  
University College 
London Hospital  
 
(Validation-
Retrospective) 
n = 814 
Cohort 2: 
University 
College London 
Hospital   
 
(Prospective) 
 
n = 46 (POM-O) 
Preoperative 
Parameters: 
Demographic Data 
Medical History 
Age/Sex/BMI 
Drug History 
Demographic Data 
Medical History 
 
Pre exercise Heart 
Rate Variability (POM-
O) 
Risk Scores: ASA grade 
RCRI 
RCRI Not presented here 
Laboratory 
Investigations: 
U&E, FBC, CRP U&E, FBC, CRP, 
Neutrophil: Lymphocyte 
ratio 
Blood Derived Immune 
cells (POM-HR) 
CPET parameters: Full standard CPET 
parameters 
Continuous 12-lead 
ECG:  ST-segment 
monitoring, Arrhythmia 
Heart Rate Dynamic 
Changes 
 
Full standard CPET 
parameters 
Continuous 12-lead ECG:  
ST-segment monitoring, 
Arrhythmia 
Heart Rate Dynamic 
Changes 
 
Full standard CPET 
parameters 
Continuous 12-lead 
ECG:  ST-segment 
monitoring, Arrhythmia 
Heart Rate Dynamic 
Changes 
 
Intraoperative 
Parameters: 
Cardiac Output 
Vasopressor use 
Goal directed therapy 
use 
Urine output 
Fluid administered 
Mode of Analgesia 
None None 
Postoperative 
Parameters 
Hospital Length of stay 
30 & 90 day mortality 
Clavien-Dindo 
Incidence of sepsis 
Ready for discharge 
Return of bowel 
function 
Return to Critical Care 
Hospital Length of stay 
30 & 90 day mortality 
Return to critical care 
 
Heart Rate Variability 
(POM-O) 
Laboratory 
Investigations 
 FBC, CRP, U&E  
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2.2.5 Lymphocyte Count and Perioperative Inflammation 
 
Perioperative blood samples were taken at UCLH as described previously and white 
cell count as well as differential were analysed (Sysmex XE2100 analyser, Sysmex, 
Milton Keynes, UK).  Neutrophil to lymphocyte ratio was calculated as a marker of 
established inflammation, both preoperatively and on the third postoperative day.  
CRP was similarly measured preoperatively and on the third postoperative day.  
 
 
2.3 The COMPETE-C trial 
 
The COMPETE-C trial was a prospective randomised controlled trial examining the 
impact of intraoperative goal directed fluid therapy (GDT) on patients categorised as 
‘low’ or ‘high risk’ based on preoperative CPET results.  The full protocol for 
COMPETE-C is available in the appendices and at 
http://www.isrctn.com/ISRCTN14680495. Raw data from the COMPETE-C trial was 
re-analysed as per the POM-HR protocol. 
 
CPET was carried out and analysed with reference to ATS/ACCP guidelines 
(Weisman et al. 2003). 
 
Intraoperative oesophageal Doppler monitoring was employed in all patients enrolled 
in the trial regardless of randomisation to GDT or standard of care.   
 
2.3.1.1 Inclusion criteria in addition to those recorded for POM-HR 
 
• Adult patients undergoing major colorectal surgery on an enhanced recovery 
after surgery (ERAS) pathway. 
• Patients with a measureable anaerobic threshold (AT) above 8ml/O2/min.   
There were no additional exclusion criteria to those recorded for POM-HR 
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2.3.1.2 COMPETE-C trial protocol as relevant to POM-HR 
 
Written informed consent was obtained from all participants prior to randomisation.  
Participants were risk stratified according to AT into aerobically unfit (8-10.9 
ml/O2/min) and aerobically fit >11ml/O2/min) groups.  Within these groups, 
individuals were randomised to receive either standard fluid management or GDT 
using random block allocation. 
 
Perioperative surgical care was conducted using local ERAS protocols.  
Perioperative anaesthetic care was carried out using local consensus guidelines. All 
patients had an Oesophageal Doppler (OD) probe (CardioQTM, Deltex Medical, 
Chichester, UK) placed immediately after induction of anaesthesia.  Doppler 
readings were taken and recorded both at pre determined times (pre and post 
incision, end of surgery) and every 15 minutes until the end of surgery.   
 
Intraoperative fluid therapy depended on randomisation.  Patients allocated to 
standard of care received intraoperative crystalloid or colloid based on estimated 
fluid requirements, intraoperative losses and measurement of standard 
haemodynamic variables without reference to oesophageal Doppler readings (HR, 
BP, CVP etc.).  A maintenance fluid rate of 10 ml/kg/h was targeted. 
 
Patients allocated to GDT received supplementary colloid (VoluvenTM; Fresenius 
Kabi Ltd, Cheshire, UK) targeting stroke volume maximisation according to the 
algorithm provided by the OD manufacturers (Figure 2-2).  Group allocation, OD 
readings and GDT colloid administration was concealed from the surgical team. 
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Figure 2-2: Intraoperative goal directed therapy protocol used in the COMPETE-C trial 
 
In patients allocated to the GDT arm of the study, the Stroke Volume (SV) response 
to an initial colloid bolus, given prior to surgical incision, but after induction of 
anaesthesia, was monitored.  Where fluid responsiveness was present (i.e. a SV 
increase of >10%), a further fluid bolus was administered.  Intraoperatively, a SV 
decrease of >10% prompted a further challenge. 
 
Intraoperative oesophageal Doppler monitoring provided cardiac output data 
throughout the case (Figure 2-3).  Parameters recorded at the start of surgery, prior 
to initial skin incision but after induction of anaesthesia and recorded at the end of 
surgery, after or during skin closure but prior to emergence from anaesthesia are 
presented in this thesis.  These parameters include: 
• Peak Velocity (PV)(cm/s): the highest blood velocity detected during systole; 
used as an indication of ventricular contractility. Typical range 50-80 cm/s for 
a 70 year old (Singer 1991). 
• Stroke Volume (SV) (ml):  The volume of blood ejected from the left ventricle 
per contraction of the heart.  Typical range 60 to 100ml. 
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• Flow Time Corrected (FTc)(ms):  the duration of flow during systole corrected 
for heart rate.  Used as an indication of LVEDV and both cardiac afterload and 
preload.  For any given level of inotropy, the time the heart takes to eject 
depends on SV, which in turn relies on LVEDV giving an indication of preload 
(a high preload results in a high LVEDV, increased SV and therefore 
increased ejection time). Similarly, increased resistance to ejection (increased 
afterload) alters time for ejection.  Typically a reduction in both PV and a 
reduction in FTc suggests increased afterload. Typical range 330-360 ms. 
• Cardiac Output (CO)(litres/min):  The total volume of blood ejected from the 
heart per minute.  Typical values 4 to 8 l/min. 
• Cardiac Index (CI):  The cardiac output indexed to body surface area. Typical 
values 2.5-4 l/min/m2.   
 
Analysis of Doppler derived cardiac output variables at the pre-specified time-points 
outlined above were linked to preoperative heart rate dynamic changes measured at 
CPET, representing parasympathetic or sympathetic autonomic dysfunction. 
 
 
Figure 2-3: A representative oesophageal Doppler trace Stroke Distance (SD) is the distance in 
cm that a column of blood moves along the aorta with each contraction of the left ventricle of the 
heart.  Values are age and size dependent.  Changes in SD are directly related to changes in stroke 
volume.  Flow time corrected (FTc) is representative of left ventricular afterload.  Mean acceleration 
and peak velocity are representative of cardiac contractility. Reproduced from ‘Oesophageal Doppler 
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monitor (ODM) guided individualised goal directed fluid management in surgery a technical review’ 
(Akc et al. 2010) 
 
 
Postoperative care was as described previously, at the discretion of the treating 
teams.  Enhanced Recovery protocols were specifically targeted at DHP.   
Postoperative outcomes were recorded prospectively and blinded to group 
allocation; additional outcome data not available at UCLH is outlined subsequently. 
 
2.3.2 Additional postoperative data derived from the COMPETE-C trial 
 
2.3.2.1 Postoperative Sepsis 
 
Prospective data on the incidence of sepsis was collected at DHP only.  Two or more 
of the following criteria, derived from the surviving sepsis campaign international 
guidelines 2012, being present defined postoperative sepsis (Dellinger et al. 2013): 
- Temperature <36oC or >38oC 
- Heart Rate >90 bpm 
- Respiratory Rate >20bpm 
- Acutely altered mental state 
- White cell count <4 or >12 
- Suspected infectious cause:  origin recorded 
- Plasma glucose >14 mMol/L 
 
2.3.2.2 Readiness for Discharge 
 
Readiness for discharge data was available from the Derriford Hospital Plymouth 
cohort and was assessed using internationally accepted criteria (Fiore et al. 2012) 
for colorectal surgery by observers blinded to the original intervention or CPET result 
(Table 2-3). 
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Criteria End points 
Tolerance of oral intake Patient can tolerate at least one solid meal 
without nausea, vomiting, bloating, or 
worsening abdominal pain.  Patient should be 
actively drinking and not require IV hydration 
Recovery of lower gastrointestinal 
function 
Patient should have passed flatus 
Adequate pain control with oral analgesia Patient should be able to rest and mobilise 
without significant pain (Pain < 4 on a scale 
of 1 to 10) 
Ability to mobilise and self care Patient should be able to sit up, walk, and 
perform activities of daily living. 
Clinical examination and laboratory tests 
show no evidence of complications or 
untreated medical problems 
Temperature should be normal 
Pulse, blood pressure and respiratory rate 
should be stable and consistent with 
preoperative levels 
Haemoglobin should be stable and within 
acceptable levels 
Patient should be able to empty the bladder 
without difficulty or match preoperative level 
of bladder function 
Table 2-3: Criteria for assessment as fit for discharge.  When the criteria outlined above have 
been met, the patient is considered to have reached short-term postoperative recovery and should be 
considered ready for discharge (Fiore et al. 2012). 
 
2.3.2.3 Postoperative return of normal bowel function 
 
This was assessed at DHP as a component of Readiness for Discharge scoring.  
Aside from the presence of flatus, patients were expected to have passed stool and 
be tolerating a light diet normally to be considered as having resumed normal bowel 
function. 
 
2.3.2.4 Clavien-Dindo grade 
 
Postoperative morbidity scoring was carried out daily at DHP using the Clavien-
Dindo scoring system.  A Clavien-Dindo grade of >3 at any time in the postoperative 
period was taken as representative of major postoperative morbidity for POM-HR 
(Table 2-4). 
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Grade Classification 
Grade 1 Any deviation from the normal postoperative course without the need for 
pharmacological treatment or surgical, endoscopic or radiological intervention.  
Allowed therapeutic regimens include: antiemetics, antipyretics, analgesics, 
diuretics, electrolytes and physiotherapy.  This grade also includes wound 
infections opened at the bedside. 
Grade 2 Requiring pharmacological treatment with drugs other than allowed for grade 1 
complications.  Blood transfusions and total parenteral nutrition included 
Grade 3a Surgical, endoscopic, or radiological intervention that is not under general 
anaesthesia 
Grade 3b Surgical, endoscopic, or radiological intervention that is under general 
anaesthesia 
Grade 4a Life threatening complication requiring intermediate care or intensive care unit 
management, single organ dysfunction (including dialysis, brain haemorrhage, 
ischaemic stroke, and subarachnoid bleeding) 
Grade 4b Life threatening complication requiring intensive care unit management, multi-
organ dysfunction (including dialysis) 
Grade 5 Death of a patient 
Table 2-4: The Clavien-Dindo classification of postoperative complications (Clavien et al. 2009) 
 
 
2.4 Perioperative Morbidity: Oxygen-Delivery (POM-O) Study 
 
Immediate pre- and postoperative Holter monitor data from 46 high risk patients who 
had undergone preoperative Cardiopulmonary exercise testing and were enrolled in 
the POM-O study, were examined for association with heart rate recovery data.  
 
The Perioperative Morbidity: Oxygen-Delivery (POM-O) study (Ackland et al. 
2015)(UK NIHR CSP 22346, www.ucl.ac.uk/anaesthesia/trials) is a multi centre 
(University College London Hospital, Royal Free Hospital, Royal Surrey County 
Hospital, Guildford and St George’s Hospital, London) prospective randomised 
placebo controlled trial of postoperative goal directed therapy, targeting oxygen 
delivery, in patients undergoing major non-cardiac surgery.  The trial was carried out 
between May 2010 and February 2014.  The primary trial hypothesis being that 
restoring oxygen delivery (DO2) in the immediate post-operative period to baseline 
would result in a reduction of patient morbidity.  Ethical approval was gained for this 
trial (Outer South East London REC- South London REC Office, 12/2009, ref: 
09/H0805/58). 
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I used heart rate variability data from 46 patients collected preoperatively (prior to 
any intervention) at University College London Hospital during this trial to test the 
association of exercise induced heart rate dynamics with recognised HRV measures 
of parasympathetic autonomic dysfunction.   
 
My involvement in the execution of this trial was as investigator for the initial three 
months.  Subsequent involvement included data collection and analysis of Holter 
monitor recordings and CPET test results carried out as part of the trial protocol (this 
included source recording clean up and editing with subsequent Heart Rate 
Variability analysis (as detailed later)) as well as the review and analysis of primary 
data collected during the course of the trial as well as at the time of CPET.  Analysis 
of outcomes relating to goal directed therapy and other related measures has been 
carried out elsewhere as part of the final analysis of results and do not form part of 
this thesis. 
 
2.4.1 POM-O Trial protocol  
 
The full trial protocol is available at http://www.ucl.ac.uk/anaesthesia/trials. A flow 
chart indicating the summary trial protocol as relevant to this thesis is presented 
below (Figure 2-4). 
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Figure 2-4: POM-O Protocol Flowchart (modified). Data presented in this thesis are derived from 
recording made up to admission to PACU. 
 
2.4.2 Subject Selection 
 
2.4.2.1 Inclusion Criteria 
 
Adult patients undergoing major elective surgery expected to last for at least 120 
minutes were eligible for recruitment provided they satisfied one of the following 
inclusion criteria for being of high surgical risk:  
a) ASA ≥ grade 3. 
b) Surgical procedure planned with an estimated/documented risk of 
postoperative morbidity (as defined by the Post Operative Morbidity Survey) 
exceeding 5%. 
c) A modified Revised Cardiac Risk Score ≥3 (Fleisher et al. 2014), as defined 
by age ≥70 years, a history of cardiovascular disease (myocardial infarction, 
PACU (Before randomisation to Goal 
Directed Therapy or Standard of Care) 
Holter Monitor Cardiac Output Monitoring 
Immediately Prior to Surgery 
Holter Monitor Cardiac Output Monitoring 
CPET Test 
Heart Rate Dynamics Blood Tests 
Informed Consent 
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coronary artery disease, cerebrovascular accident, electrocardiographic 
evidence for established cardiac pathology), cardiac failure, poor exercise 
capacity (anaerobic threshold <11ml.kg.min-1 assessed by cardiopulmonary 
exercise testing and/or Duke Activity Status Index), renal impairment (serum 
creatinine ≥130 µmol/l) and/or diabetes mellitus.  
 
2.4.2.2 Exclusion Criteria 	
a) Refusal of consent. 
b) Pregnancy.  
c) Lithium therapy or allergy. 
d) Recent myocardial ischaemia (within previous 30 days). 
e) Acute arrhythmia. 
f) Acute bleeding. 
g) Patients receiving palliative treatment only. 
 
All patients enrolled in the study at UCLH underwent Holter Monitor recording on the 
day of surgery (pre- and immediately postoperatively and for the duration of the 
intervention). On the day of surgery, Holter monitoring was instituted preoperatively 
in a quiet area in the preoperative assessment unit.  Recordings were also taken for 
two to four hours on postoperative days 2, 5, 7, and on the day of discharge where 
clinically possible. 
 
A proportion of patients enrolled in the POM-O trial, as dictated by standard clinical 
protocols at the UCLH, underwent preoperative symptom limited maximal 
cardiopulmonary exercise testing (CPET).  The protocol for CPET exercise testing is 
described subsequently in this chapter.  The CPET test data from these patients was 
analysed for heart rate dynamics relating to autonomic function as described later in 
the methods section.  It is from these patients that Holter monitor data was analysed 
for association with heart rate recovery as a measure of parasympathetic autonomic 
dysfunction. 
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2.5 Cardiopulmonary Exercise Testing (CPET) 
 
CPET testing was carried out at University College London Hospital and Derriford 
Hospital, Plymouth.  Prior to every test, appropriate calibration measurements were 
undertaken.  These included: 
- Ambient pressure and temperature. 
- Oxygen cell calibration (Room air (20.95% O2 and 0.05% CO2) and 
Calibration gas (15% O2, 5% CO2).  Maximum error: ± 0.05% for O2, ± 0.02% 
for CO2. 
- Flow-volume sensor calibration:  3 litre syringe, three different computer 
generated flow rates (maximum error: ± 100 ml). 
 
CPET was carried out on stationary, electronically braked cycle ergometers in both 
Derriford Hospital (Zan, nSpire, CO, USA) and UCLH (Corival, Lode, Gronigen, 
Netherlands).  In-line breath-by-breath gas analysis, non-invasive blood pressure 
measurement, Oxygen Saturation (SpO2) and 12-lead ECG monitoring were 
recorded continually throughout all tests.  All CPET data was freely available to 
treating clinical teams.   American Thoracic Society guidelines were adhered to 
throughout testing.  Contraindications to CPET testing used at both centres are listed 
in Table 2-5 (Weisman et al. 2003).  
 
Absolute Relative 
Acute Myocardial Infarction (3 to 5 days) Left coronary stenosis or equivalent 
SpO2 <85% on room air Moderate stenotic valvular heart disease 
Symptomatic, uncontrolled arrhythmias or 
syncope 
Severe arterial hypertension at rest (>200 mmHg 
systolic, >120 mmHg diastolic)  
Thrombosis of lower extremities Tachyarrhythmias or bradyarrhythmias 
Active endocarditis, myocarditis or pericarditis 
Uncontrolled asthma 
Orthopaedic impairment that compromises 
exercise performance 
Symptomatic severe aortic stenosis Hypertrophic Cardiomyopathy 
Uncontrolled heart failure Significant pulmonary hypertension 
Acute Pulmonary Embolism or Infarction Advanced or complicated pregnancy 
Pulmonary oedema Electrolyte abnormalities 
Acute non cardiopulmonary disorder affecting or 
aggravated by exercise 
High degree AV block 
Mental impairment with the inability to cooperate  
Table 2-5: Contraindications to CPET testing 
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Prior to CPET, patients were fasted and were asked to refrain from caffeine on the 
day of testing.  A full medical and exercise history was taken prior to each test, as 
were basic anthropometric measurements including weight, height and blood 
pressure.  All patients underwent spirometry (Forced Vital Capacity (FVC), Forced 
Expiratory Volume in 1 second (FEV1) and Maximal Voluntary Ventilation (MVV) 
prior to testing in order to calculate predicted maximal values for ventilatory capacity 
amongst other parameters.  A haemoglobin value was taken prior to each test in 
order to calculate oxygen delivery values (HemoCue, Radiometer, Copenhagen, 
Denmark). 
 
12-lead ECG, blood pressure, breath-by-breath gas analysis and pulse oximetry 
measurement was continually recorded throughout every test. 
 
Appropriate exercise intensity (incremental wattage ramp test, 5 to 35 Watts/minute) 
was determined by trained exercise physiologists and physicians and based upon 
population norms, informed by details from the individual medical histories and 
reported activity levels of trial participants.  Wasserman equations were used to help 
guide the determination of the work rate increment (Wasserman & Mcilroy 1964): 
1. VO2 (ml/min) = 150 + (6x weight (kg)) 
2. Peak VO2 (ml/min) Males = (height (cm) – age (years)) x 20 
3. Peak VO2 (ml/min) Females = (height (cm) – age (years)) x 14 
4. Work rate increment (W/min) = (Peak VO2 – VO2 Unloaded) / 100) 
 
Subjects cycled at a cadence of 60 rpm, the ergometers, which are electronically 
braked, allowed some freedom around pedal speed.  Tests generally lasted 10 to 15 
minutes and were symptom limited. 
 
The limit of tolerance (maximum) was defined as the point at which the subject could 
not maintain a cadence of 60 rpm despite encouragement and/or where symptoms 
(e.g. chest/leg pain or shortness of breath) precluded continuation of exercise.  Full 
criteria for stopping the tests are based on American Thoracic Society guidelines 
(Weisman et al. 2003) and are presented in Table 2-6. 
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Criteria for Cardio Pulmonary Exercise Test termination 
- Chest pain suggestive of ischaemia 
- Ischaemic ECG changes (Significant ischaemia >1mm ST depression in chest leads or 
>2mm ST depression in limb leads or ECG pattern consistent with myocardial infarction 
or evolving ischaemic changes) 
- Complex ectopy 
- Second or third degree heart block 
- Fall in Systolic blood pressure >20 mmHg  
- Hypertension (>250 mmHg systolic, >120 mmHg diastolic) 
- Severe desaturation (SpO2 ≤ 80%) ± signs and symptoms of hypoxia 
- Sudden pallor, dizziness or faintness 
- Loss of coordination or mental confusion 
Table 2-6: ATS/ACCS Criteria for stopping Cardio Pulmonary Exercise Tests 
 
A period of familiarisation and resting baseline measurements were taken for a 
baseline of 3 minutes sat on the cycle ergometer, followed by 3 minutes of unloaded 
pedalling with subsequent initiation of incremental loading of the wattage ramp (for 
approximately ten minutes).  Following symptom limited cessation of exercise a 
three-minute period of unloaded pedalling was undertaken, during which time full 
physiological monitoring was continued, prior to dismounting from the apparatus 
(Figure 2-5, Figure 2-6).  Heart rate recovery values were measured during this 
period. 
 
CPET physiological data were recorded continually (and latterly exported to an Excel 
spread sheet) and also expressed visually as the standard nine-panel plot (Figure 2-
7). 
 
The Anaerobic Threshold (AT) was measured as body-mass corrected oxygen 
consumption (ml.kg-1.min-1).  AT was determined by modified V-slope technique and 
confirmed with the ventilatory equivalents method (Figure 2-8; Beaver, Wasserman 
et al. 1986).   
 
Peak oxygen consumption (VO2 peak), oxygen pulse (VO2/HR), and ventilatory 
equivalents for carbon dioxide (VE/VCO2) and Oxygen (VE/VO2) were also recorded. 
 
12 lead ECG recordings were continually analysed and assessed for ischaemia and 
arrhythmias. (Pathfinder SL. Spacelabs Healthcare, Hertford UK). Baseline ECG 
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tracings were assessed for ST segment neutrality.  ST segment depression was 
assessed in lead II and defined as abnormal when depression of 0.1 mV or more 
occurred (Weisman et al. 2003).  Other leads were available but not specifically 
assessed. 
	
Figure 2-5 Conduct of Cardiopulmonary Exercise Testing 
 
 
	
Figure 2-6. Cardiopulmonary exercise test apparatus at UCLH 
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The test can be categorised as: i) Pre-Test, ii) Acclimatisation, iii) Ramped work, iv) 
Recovery.  
 
	
Figure 2-7. The standard nine panel CPET plot 
Reproduced from preoperative cardiopulmonary exercise testing (Agnew 2010).   
Numbered 1-9 from top left to bottom right.  Panels 2,3,5 relate to the cardiovascular system, panels 
1,4 and 7 treat ventilation and panels 6, 8 and 9 display ventilation/perfusion relationships. 
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Figure 2-8 Methods for determining the Ventilatory Anaerobic threshold (VAT) 
A) The modified V-slope technique:  The VAT is the point at which the two regression lines 
explaining VCO2 as a function of VO2 intersect.  It is expressed as the VO2 where the residual 
sum of squares is minimised. 
B) The Ventilatory equivalents method.  The VAT is the point at which the VE/VO2 begins to 
increase without an accompanying increase in VE/VCO2 and is expressed as the VO2.   
Derived from Weissman I. “Clinical Exercise Testing”.  4th Ed. Philadelphia: WB Saunders; 
1997. 
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Unless otherwise stated, normal ranges and predicted values for CPET parameters 
quoted in this thesis are those used routinely at UCLH in the clinical interpretation of 
Exercise Tests and are outlined in Table 2-7. 
 
Table 2-7: Normal values and ranges used at University College London Hospital for the 
interpretation of CPET tests 
 
 
2.5.1 Dynamic Heart Rate variables collected at time of CPET 
 
The heart rate at rest was determined whilst sitting on the cycle ergometer during the 
three minutes of rest at the start of the test. 
 
Parameter  Predicted Value  Range  
VO2 max  
(ml/min)  
Based on gender, age, height  Lower limit of normal < 80% 
predicted  
Resting VO2  
(ml/min)  
150 + (6 X weight in kg)  250 -300 (larger in obese 
individuals)  
Peak Heart Rate  
(bpm)  
220- age  
 
90% predicted + 15 bpm  
Oxygen pulse  
(ml/beat)  
(Predicted VO2 max)÷ (predicted 
max HR)  
80% predicted (~ 15 ml/beat in 
men; ~ 10 ml/beat in women)  
Minute Ventilation  
(L/min)  
 Peak Exercise: 70-80% of MVV  
Maximum Tidal 
Volume  
60% of the FVC  
VE/VCO2  
(early exercise)  
 25-35  
VE/VO2  
(early exercise)  
 25-35  
VD/VT   0.25-0.35 at rest 
Should decrease with exercise  
PETCO2  
(mm Hg)  
 38-42 (Should decline after 
ventilatory threshold) 
PETO2  
(mm Hg)  
 95-100 (Should rise after 
ventilatory threshold) 
A-a O2 Difference  
(mm Hg)  
 Rest: 10 - 20 
Peak Exercise: 15-30  
SaO2  
(%)  
 > 95% (Should remain constant 
with exercise) 
Respiratory Exchange 
Ratio  
Rest: 0.8  
Peak Exercise: > 1.15  
Rest: 0.6-1.0  
Peak Exercise: 1.1-1.3  
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Anticipatory heart rate increase (AHRi) was defined as the difference between the 
resting heart rate, and the heart rate immediately before the start of loaded exercise. 
 
Peak heart rate was defined as the highest heart rate at the maximum work rate. 
 
This allowed calculation of the heart rate gradient ((HRg):  HRg = Peak Heart Rate – 
Resting Heart Rate). 
 
Chronotropic incompetence was assessed by calculating the adjusted heart rate 
reserve, which controls for confounding factors including age and resting heart rate. 
(Brubaker & Kitzman 2011): 
 
(Heart Rate Peak Exercise) – (Resting Heart Rate) 
(220-age) – (Resting Heart Rate) 
 
Pre-exercise heart rate increase was assessed as the difference between the heart 
rate at rest and the heart rate measured just before starting ramped loaded pedalling 
after 3 minutes of 0 Watt (no resistance) exercise (Figure 2-9).  Excessive heart rate 
increase (EHRi) was defined according to population distribution as described in 
Chapter 6. 
 
Heart rate recovery was defined as the reduction in rate from the heart rate at peak 
exercise to the heart rate one minute after cessation of loaded exercise (Figure 2-9). 
 
Abnormal heart rate recovery (HRR) was also defined according to population 
distribution as described in Chapter 3.   
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Figure 2-9 Heart Rate dynamics during Cardiopulmonary Exercise Testing 
A) Heart Rate increase during unloaded pedalling prior to ramped exercise.  Excessive Heart Rate 
increase (EHRi) was derived from the population distribution of this measurement.  B) Heart rate 
recovery in the first minute after cessation of loaded exercise. Abnormal heart rate recovery (HRR) 
was derived from the population distribution of this measurement PAD = Parasympathetic Autonomic 
Dysfunction, bpm= beats per minute. 
 
 
2.6 Holter Monitoring 
 
Three-lead electrocardiographic recordings were made preoperatively in POM-O trial 
patients using Lifecard CF digital Holter monitors (Spacelabs Healthcare, Hertford 
UK) Holter data cleaning and analysis was undertaken blinded to CPET data.  
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Analysis of Holter monitor data was carried out using Pathfinder Sentinel Software 
(Spacelabs Healthcare, Hertford UK).  Raw ECG recordings were manually reviewed 
for quality.  Patients in Atrial Fibrillation or in other arrhythmias were excluded from 
analysis (to preserve the validity of heart rate variability analysis).  Individual ectopic 
beats or bursts of ectopy were excluded, as were bursts of arrhythmia (Figure 2-10).   
 
	
Figure 2-10 Arrhythmias and Ectopic beats were manually edited during Holter analysis 
This recording illustrates a ventricular ectopic beat (PVC) captured and edited in an otherwise sinus 
recording 
 
 
Following raw data review and editing, files were converted to .RR format (Del 
MarTMReynoldsTM Holter Binary File) for export to specialised Heart Rate Variability 
analysis software (Spacelabs HRV Tools Software, Hertford, UK). 
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2.6.1 Heart Rate Variability Analysis  
Heart rate variability (HRV) analysis is routinely used to assess cardiac autonomic 
regulation through quantification of sinus rhythm variability (hence exclusion of 
patients in any rhythm other than sinus).   
 
Derivation of the sinus rhythm time series is achieved through the identification of the 
QRS to QRS interval sequence (RR) and then extracting only normal sinus-to-sinus 
(NN) interbeat intervals.  Whilst the strict definition of the time interval between 
successive beats would be that interval measured from the start of one QRS 
complex to the start of the next (QQ), this point can be difficult to measure in noisy or 
low amplitude ECG recordings.  I therefore used the R-wave peak as the reference 
point for analysis (true R-R; Figure 2-11). 
 
	
Figure 2-11 R-R interval variation was used as the reference point for heart rate variability 
A) Represents heart rate variability (bpm) in an individual over a five-minute reference recording.  B) 
Represents R-R interval (ms) variation over the same five-minute reference recording. 
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Valid segments of recordings were identified from patients in a quiet environment 
before the operation.  Patients in atrial fibrillation, with frequent ectopy (>1 ectopic 
beat/minute) and/or other dysrhythmias were excluded.  Data quality criteria were in 
accordance with ACC/ACCS Task Force guidelines (European Society of Cardiology 
et al. 1996).  I assessed time-domain measures from 5-minute recordings, which are 
preferred to frequency domain methods when only short-term recordings are 
possible. 
 
All RR files imported from Del MarTMReynoldsTM Holter analysis had aberrant, HRV 
inhibited, excluded and paced beat filtration features that had been incorporated into 
the original Holter edited analysis switched on. 
 
Preoperative and day of surgery Holter data in patients who had been recruited to 
POM-O and had also undergone routine preoperative CPET testing were selected. 
 
The statistical analysis package incorporated into the Spacelabs software was used 
to analyse all HRV data.  Automatic data editing was enabled to exclude 
unphysiological or anomalous data.  For preoperative variables, data was manually 
assessed for stability prior to analysis.  Five-minute segments of data were analysed 
for time domain variables.   
 
2.7 Statistical Analysis for Clinical Data 
 
Categorical data were compared using Fisher’s exact test or Pearson’s Chi squared 
test and are presented as absolute values (with percentage).  Continuous data are 
presented as median with interquartile range (IQR), or mean with 95% confidence 
intervals (CI) for normally distributed data.  For continuous data, tests for skew were 
performed to assess normality of distribution.  They were compared using the 
student’s t-test for normally distributed data and the Mann-Whitney U test or 
Kriskall-Wallis test, where appropriate, for non-normally distributed data.  
Comparisons across grouped variables were made using analysis of variance 
(ANOVA) with Tukey’s post-hoc test for comparisons of pairings within a group.  All 
reported p values are two-sided. 
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Differences in mortality, length of stay and time to become free of morbidity were 
tested using the log-rank test.  Kaplan-Meier curves were plotted for time to hospital 
discharge, accounting for in-hospital deaths.  Adjustment for baseline data was 
made using a Cox proportional hazards model including age, heart rate recovery, 
risk factors for cardiopulmonary disease (revised cardiac risk index) and random 
effect of site.  Baseline variables were selected for inclusion in the adjusted analysis 
according to anticipated relationship with outcome including all variables used in the 
minimisation algorithm.  The Cox model is appropriate for identifying risk factors for 
prolonged LOS as it does not assume an underlying normal distribution of LOS data 
(Austin et al. 2002). 
 
The covariates entered into the regression models (age, HRR, AT <11, BMI, RCRI) 
were chosen either due to association with worsened post operative outcome or 
due to known influences on cardiac or autonomic performance (Ackland 2009; Khuri 
et al. 2005; Ackland et al. 2015).  
 
The use of a relatively small number of covariates ensured that the models were 
adequately powered for the sample populations.  Moons recommends that at least 
10 subjects are included for each covariate in a regression model (Moons et al. 
2009).   
 
Results relating to length of hospital stay and mortality are reported as Hazard 
Ratios (Mantel-Cox) (HR) with 95% confidence intervals. 
 
Results of the logistic regression model are also reported as adjusted hazard ratios 
(HR) with 95% CI and Wald test for comparison.  
 
Where and HRR and EHRi were being calculated, the population results were split 
into quartiles.  These are not of even size as heart rate is a whole number.  Multiple 
analyses one-way-analysis-of-variance (ANOVA) was used with post-hoc Tukey 
test for multiple comparisons of means.  Where data was non-Gaussian, a Kruskal-
Wallis test was used with Dunn’s multiple comparison of quartiles.  To compare the 
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final quartile with the rest of the population an unpaired T-test was used with 
Welch’s correction. 
 
Analyses were performed using SPSS version 20 (IBM, USA). Where appropriate, 
statistical analysis and graphs were produced using Graphpad Prism (GraphPad 
Prism version 7.00 for Windows, GraphPad Software, La Jolla California USA) 
Significance was set at p<0.05 (two-tailed). 
 
2.7.1 Sample Size Calculation and Statistical Advice 
 
Dr Steve Harris, Department of Health Services Research and Policy, London 
School of Hygiene and Tropical Medicine provided statistical advice. 
 
Power calculations for the retrospective analysis of heart rate recovery and 
excessive heart rate increase are included in the methods sections of the relevant 
chapters (4 and 6). 
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2.8 Laboratory work 
2.8.1 Miscellaneous Drugs, Chemicals and Reagents 
 
Reagent 
(batch no. For drugs and antibodies) 
Supplier 
(product no.) 
Address 
Dulbeccos’ Phosphate-Buffered Saline (Calcium and 
Magnesium-free)(PBS) 
Invitrogen Ltd 
(14190-094) 
Paisley, UK 
Ficoll-Paque PLUS (Ficoll sodium diatrizoate) GE Healthcare 
(17-1440-03) 
Buckinghamshire, 
UK 
Dulbecco’s Modified Eagle Medium with GlutaMAX, Sodium 
Pyruvate and 1 g.L-1 or 4.5 g.L-1 D-glucose (DMEM) 
 
Stored at 4oC 
Invitrogen Ltd 
(21885025 & 
3196-021) 
Paisley, UK 
Blood Lysis Buffer: 
0.84 g NaHCO3 
7.7g NH4CL 
1000 ml sterilised H2O (passed through 0.2µm filter) 
 
Stored at 4oC 
Chemicals from 
Sigma Aldrich 
Dorset, UK 
BCA protein assay kit: 
Reagent A (contains sodium carobonate, sodium 
bicarbonate, bicinchoninic acid, sodium tartrate in 0.1M 
sodium hydroxide) 
Reagent B (contains 4% cupric sulphate) 
Reagent mixture 50:1 
Novagen Merck, Germany 
Heparin sodium 1000iu.ml-1 
 
Stored at 4oC in sterile ampoules 
Leo laboratories 
Ltd 
Buckinghamshire, 
UK 
Trypan Blue solution (0.4%) Sigma Aldrich 
(C2272) 
Dorset, UK 
Bovine Serum Albumin 
(lot 099K1447) 
 
Stock Solution 2% (w/v) in sterile PBS 
 
Stored at 4oC 
Sigma Aldrich 
(B4287) 
Dorset, UK 
Tris base (tris(Hydroxymethyl)Aminomethane) Chemicals from 
Sigma-Aldrich 
Dorset, UK 
Tween Sigma-Aldrich 
(P1379) 
Dorset, UK 
Distilled Water   
Hydrochloric acid (1M and 5M) Chemicals from 
Sigma-Aldrich 
Dorset, UK 
Phosphate buffered Saline (PBS) pH 7.5: Chemicals from 
Sigma-Aldrich 
Dorset, UK 
Tris-buffered saline (TBS) pH 7.6 
8g Sodium Chloride 
20ml 1M Tris HCl, pH7.6 
1000ml distilled water 
Chemicals from 
Sigma-Aldrich 
Dorset, UK 
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Methanol   
Transfer buffer (10x stock), 1L 
Tris 25mM 30g/L 
Glycine 192 mM 144 g/L 
Chemicals from 
Sigma-Aldrich 
Dorset, UK 
Transfer buffer (1x) 
400 ml distilled H20 
50ml 10x transfer stock 
50ml methanol 
Chemicals from 
Sigma-Aldrich 
Dorset, UK 
10x Running buffer 
1000 ml distilled H2O 
30g TRIS base 
144g Glycine 
10g SDS 
Chemicals from 
Sigma-Aldrich 
Dorset, UK 
Laemmli 2x Loading buffer 
200 ul 4% SDS 
200 ul 10% 2-mee 
200 ul 20% glycerol 
200 ul 0.125 M Tris HCl 
Chemicals from 
Sigma-Aldrich 
Dorset, UK 
TEMED Sigma-Aldrich 
(T9281) 
Dorset, UK 
30% Acrylamide Sigma-Aldrich 
(A3699) 
Dorset, UK 
10% SDS Sigma-Aldrich 
(L3771) 
Dorset, UK 
10% ammonium persulphate (APS) Sigma-Aldrich 
(A3678) 
Dorset, UK 
PBS-Tween (PBS-T)  
0.1% Tween in PBS 
Sigma-Aldrich 
(P1379) 
Dorset, UK 
5% Non-fat dried milk (blocking reagent) in PBS-T Marvel milk 
powder 
Premier foods, St 
Albans, UK 
Cell Lysis buffer (RIPA buffer) 
 
150 mM sodium chloride  
1.0% Triton X-100 0.5% sodium deoxycholate  
0.1% SDS (sodium dodecyl sulphate)  
50 mM Tris, pH 8.0 
 
Chemicals from 
Sigma-Aldrich 
Dorset, UK 
Protease inhibitor GE Healthcare, 
(80-6501-23) 
(Sigma) 
Dorset, UK 
ECL Western Blotting substrate Pierce ThermoFIsher 
Scientific, UK 
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2.8.2 Antibodies (Western Blot) 
 
Antibody  Clone 
(product/batch) 
Supplier Utility 
GRK2 sc-13143 
mouse monoclonal  
raised against GRK2 of 
human origin 
IgG2a 
Santa Cruz, 
Heidelberg, 
Germany 
Immunoblot 
identification in 
lysed human 
lymphocytes 
α -tubulin sc- 53646 
mouse monoclonal 
raised against full length 
α –tubulin of human 
origin 
IgM 
Santa Cruz, 
Heidelberg, 
Germany 
Housekeeping 
Protein.  
Reference for 
Immunoblotting 
Peroxidase 
linked 
secondary 
antibody 
Rabbit IgG Horeseradish 
Peroxidase-linked whole 
antibody 
GE 
healthcare, 
Amersham, 
UK 
For detection of 
mouse membrane 
bound primary 
antibodies 
 
2.8.3 Miscellaneous equipment and disposables 
 
Equipment Supplier Address 
Centrifuge: Haraeus Megafuge 1.0R Kendro Laboratory products Langenselbold, 
Germany 
Centrifuge: ALS PK 120 ALC Cologno Monzese 
Italy 
Centrifuge: Eppendorf 5415 C Eppendorf  Hamburg, Germany 
15ml Falcon polypropylene tubes BD Biosciences Oxford, UK 
50 ml Falcon polypropylene tubes BD Biosciences Oxford, UK 
250 ml Falcon polypropylene tubes BD Biosciences Oxford, UK 
1.5 ml microcentrifuge tubes  StarLab GmBH Ahrensburg, 
Germany 
Costar disposable serological pipettes 
(10, 25ml) 
Corning International NY, USA 
10, 200 and 1000uL Diamond 
sterilised pipette tips 
Gilson Inc Middleton, USA 
96-well plates: Nunclon Nalge Nunc International NY, USA 
3 ml sterile Pasteur pipettes Ramboldi Ltd Limassol Cyprus 
Biological Safety Cabinet Class II 
Holten LaminAir Model 1.2 
Thermo Scientific Waltham, USA 
Bench microscope: Zeiss Axiovert 25 Zeiss Oberkochen, 
Germany 
Neubauer improved haemocytometer Assisstent Germany 
Synergy Mx monochromator-biased 
multi-mode microplate reader 
BioTek Winooski, USA 
Gel Electrophoresis Apparatus Mini ProteanTM tetra vertical hand Bio-Rad UK 
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cast electrophoresis cell sytem 
Semi-dry blotting apparatus TransblotTM semi-dry transfer cell Bio-Rad UK 
Orbital shaker   
X-ray film cassette   
X-ray film   
Blotting Membrane HybondTM Amersham ECL 
(nitrocellulose) 
GE Healthcare, 
USA 
Full range Rainbow molecular weight 
marker, natural 
RPN800, Amersham GE Healthcare, 
USA 
Heating Block   
Filter paper for Western Blot Bio-Rad UK Bio-Rad UK 
 
 
2.8.4 Isolation of human mononuclear cells  
 
Twenty ml blood was drawn at rest from patients on the day of CPET, prior to 
exercise testing.  This blood was subsequently heparinised (final concentration 50 
iu.ml-1) and placed on ice until leucocyte separation (within 1 hour of blood draw). 
 
For separation, the blood was diluted in a 2:1 ratio with PBS at room temperature 
and carefully pipetted onto Ficoll-Paque in a 50ml centrifuge tube (30ml blood: 15 ml 
Ficoll-Paque).  This blood was centrifuged for 30 minutes at 20oC (1400 rpm) without 
centrifuge brake (Figure 2-12).   
 
The plasma layer was subsequently aspirated using a sterile Pasteur pipette.  The 
layer containing peripheral blood mononuclear cells  (lymphocytes and monocytes) 
was then carefully aspirated to avoid mixing with Ficoll-Paque and washed twice 
(mixed with 3x volume of PBS at 4oC and centrifuged at 300 x g for five minutes).   
 
The resulting cell pellet was then resuspended in a set volume of DMEM and a 
manual cell count established with Trypan Blue dye and a Neubauer-improved 
haemocytometer.  The cells were then resuspended and frozen at a concentration of 
1000,000 cells/ml. 
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Figure 2-12 Ficoll density gradient separation of mononuclear cells 
Lymphocytes were isolated from human whole blood using Ficoll density grade separation.  The 
Mononuclear layer settles above the Ficoll layer and is used for immunoblotting. 
 
 
2.8.5 Preparation of human mononuclear cells for Immuno- (Western) blot 
analysis: cell lysis 
 
Isolated human mononuclear cells, pelleted and frozen at 1000,000 cells/ml were 
brought to room temperature and subsequently mixed with lysis (RIPA) buffer & 
protease inhibitor (manual disruption of cells was encouraged with vigorous pipetting 
and continual assessment of pellet viscosity).  RIPA buffer was chosen since GRK2 
is often membrane-bound (Thermo-Fisher Scientific cell and protein isolation 
technical handbook 2014).  Tris-Triton buffer was also assessed during protocol 
development and found inferior.  
 
Following room temperature lysis, samples were heated to 950C in a heating block 
for 5 minutes, centrifuged, the supernatant being transferred to clean Eppendorf 
tubes and then allowed to cool on ice.  
 
Samples protein concentrations were subsequently assessed by BCA protein assay. 
 
		  121 	
 
General Methods 
 
  
2.8.6 Preparation of human lymphocytes for Immuno- (Western) blot analysis: 
BCA Protein Assay 
 
The BCA Protein Assay is used to determine protein concentrations in the range of 
20 to 20,000 ug/ml.  The standard manufacturer’s assay was used to determine 
protein concentrations in isolated lymphocyte pellets (as per user protocol TB380 
Rev.D0111JN (Novagen, Merck, Germany, 2011)). 
 
2.8.7 Preparation of human mononuclear cells for Immuno- (Western) blot 
analysis:  SDS-PAGE gel preparation and loading 
 
All Immunoblot techniques were carried out in reference to the Amersham ECL 
Western blotting detection reagents and analysis system protocol handbook 
(RPN2106/8/9).   
 
10% SDS-Page gels were prepared using standard gel recipes (Sigma-
Aldrich/Amersham healthcare).  Lysed protein samples were loaded with Laemmli 
buffer (1:1) into wells produced using 4% stacking gel (Mini ProteanTM tetra vertical 
hand cast electrophoresis cell system).  20 micrograms of protein were loaded per 
cell.  A standard protein ladder was also loaded.   
 
Gels were then run for 45 to 60 minutes at 150v (0.05 Amp maximum). 
 
2.8.8 Western (Immuno-) blotting 
 
SDS-PAGE separated proteins were transferred electrophoretically to a support 
matrix or membrane.  The proteins were then visualized by application of a specific 
primary antibody (in this case GRK2) after blocking of unoccupied sites (5%-milk-
PBS-T), to the membrane.  Visualisation was achieved by binding of a secondary 
antibody to the primary that is conjugated to a chemiluminescent molecule 
(horseradish peroxidase).  Subsequent activation and exposure to X-ray film was 
followed by development.  Semi-quantitative measurement of specific protein 
abundance could then be carried out, with reference to the molecular weight 
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indicated by a standard protein ladder, using densitometry normalized to an internal 
standard (alpha-tubulin). 
 
Following SDS-PAGE gel electrophoresis, samples were transferred onto a 
nitrocellulose membrane for 45-60 minutes at 15V using SD Semi-dry Transblot 
Apparatus (Bio-Rad).  
 
Following rinsing and washing in PBS-T (3x 10 minutes), membranes were blocked 
at room temperature on a rocker for 1 hour in 5% milk-PBS-T.   
 
Membranes were then washed in PBS-T again and incubated overnight at 3oC with 
8ul of GRK2 antibody in PBS-T (1:250).   
 
The following morning, membranes were washed and incubated with appropriate 
secondary-HRP antibodies (1:2000) for one hour on a rocker at room temperature.  
Membranes were subsequently rinsed and washed as above.   
 
Blotting substrate (PierceTM chemiluminescent substrate) was then applied to 
membranes according to manufacturer’s specifications.  Membranes were 
developed in a dark room on to X-ray film.  
 
Subsequent re-probing of developed membranes was carried out using alpha-tubulin 
as an internal control standard.  Again, membranes were developed and catalogued 
as above. 
 
2.8.9 Densitometry 
 
Developed membranes were scanned and catalogued.  Densitometry was performed 
using Image-J (Abràmoff et al. 2004), referenced to alpha-tubulin (internal standard)
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3 Exercise	physiology	in	Parasympathetic	Autonomic	
Dysfunction	
 
3.1 Introduction 
 
Heart rate recovery after exercise, which reflects reactivation of 
parasympathetic tone (Imai et al. 1994), is a robust, readily obtainable marker 
of parasympathetic autonomic function.  Abnormal recovery, representing 
parasympathetic autonomic dysfunction (PAD), is independently associated 
with long-term cardiovascular morbidity and all-cause mortality in the general 
medical population (individuals otherwise asymptomatic) (Cole et al. 2000; 
Shishehbor et al. 2006; Jouven et al. 2005).   
 
To date, no assessment has been made of the impact of established PAD on 
surgical outcomes.  Impaired preoperative exercise physiology, in particular a 
reduced Anaerobic Threshold (AT), has been associated with increased 
postoperative morbidity (Older et al. 1999).  Plausible mechanisms, outlined 
below, exist to suggest that PAD could cause impaired exercise performance. 
 
3.1.1 Heart rate recovery and PAD 
 
Determination of normal ranges for heart rate recovery after exercise in adult 
surgical patients referred for CPET has not been carried out previously.  
Previous studies in other contexts have stratified values for heart rate 
recovery according to quintile or quartile of decrease in heart rate after 
cessation of activity (Jouven et al. 2005; Cole et al. 1999) or by fitting values 
for heart rate recovery to first order exponential decay curves (Pierpont et al. 
2000; Imai et al. 1994).  The value used to represent abnormal heart rate 
recovery depends very much on the population studied.  In otherwise healthy 
patients, values below 18 bpm and 24 bpm have been defined as abnormal.  
In athletes, even greater reductions could be considered abnormal (Imai et al. 
1994). 
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The situation is different in patients with known or suspected cardiac 
morbidity.  In 2,428 cardiac patients referred for diagnostic symptom limited 
exercise testing, a heart rate recovery of less than 12 beats per minute, 
representing the lowest quartile measured, was independently associated with 
a two times increase in risk of all cause death (Cole et al. 1999).  Similarly, in 
9,454 patients referred for exercise ECG testing, using a cut off heart rate 
recovery of 12 beats per minute, an increase in risk of all cause mortality of 
2.1 times was seen, independent of other known risk factors (Nishime et al. 
2000).   
 
In general, patients referred for preoperative CPET fall into increased risk 
categories either by virtue of existing comorbidity and/or high-risk surgery.  It 
might therefore be expected that in this group, the spread of heart rate 
recovery values could reflect this risk. 
 
In order to determine thresholds for normal and abnormal heart rate recovery 
in surgical patients referred for preoperative CPET, the same approach, 
extensively adopted across the wider literature, of stratifying values according 
to quartile of heart rate recovery was taken in a derivation cohort and a larger 
validation cohort.   
 
Since abnormal heart rate recovery has not been previously used as a 
method for determining risk prior to surgery, association of heart rate recovery 
as a marker of reduced cardiac parasympathetic activity using established 
values for heart rate variability was carried out in a subset of patients. 
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3.1.1.1 Impaired heart rate recovery after exercise may signify 
functional cardiac impairment 
 
Convincing evidence from clinical and laboratory studies conducted in other 
populations indicate that PAD is strongly associated with, and may be 
mechanistically responsible for, impaired cardiac performance and therefore 
reduced exercise performance.   
 
Impaired heart rate recovery after exercise is associated with cardiac failure 
and reduced exercise capacity (Imai et al. 1994; Ritt et al. 2012).  Although 
the predictive value of reduced heart rate recovery for mortality persists even 
when impaired left ventricular systolic function, estimated by 
echocardiography, is controlled for, it remains most strongly associated with 
functional cardiac impairment (Watanabe et al. 2001). 
 
Formal cardiopulmonary exercise testing allows assessment of the cardiac 
contractile response to stress (increasing external work done) through 
measurement of the oxygen pulse, a robust proxy measure of left ventricular 
stroke volume (Whipp et al. 1996).  Oxygen pulse, adjusted for age and sex, 
at peak VO2 was therefore used to identify any contractile impairment in 
response to physiological stress, in individuals with PAD. 
 
3.1.2 Heart Rate Dynamic changes in PAD 
 
Chronotropic incompetence, or the inability of the heart to increase its rate 
commensurate with increased activity or demand, has frequently been 
described in both PAD and heart failure (Brubaker & Kitzman 2011) and is in 
itself associated with increased long term mortality in cardiac patients (Lauer 
et al. 1999; Dhoble et al. 2014).   
 
Using heart rate dynamic changes recorded during exercise in high-risk 
surgical patients, the majority without a formal diagnosis of cardiac failure, an 
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association of chronotropic incompetence with PAD was sought in a novel 
context. 
 
3.1.3 Cardiac Ischaemia and Parasympathetic Autonomic Dysfunction 
 
Abnormal heart rate recovery is associated with an increased risk of all cause 
death in cardiac patients (Cole et al. 2000; Nishime et al. 2000).  In those with 
known ischaemic heart disease, abnormal heart rate recovery has been used 
to predict the severity of coronary artery disease (Ghaffari et al. 2011).   
 
Adequate vagal activity is likely to be protective during myocardial ischaemia 
(Kakinuma et al. 2014; Frank et al. 2012; Zhang et al. 2014).  Vagal 
withdrawal occurs both before and during cardiac ischaemia (Sroka et al. 
1997) and is predictive of impaired outcome (La Rovere et al. 1998).  
Abnormal heart rate recovery has been associated with myocardial ischaemia 
as assessed by myocardial perfusion imaging (Georgoulias et al. 2003).  
Restoration of vagal tone, or markers thereof, in models of cardiac ischaemia 
results in preservation of the ischaemic myocardium and reduction in the risk 
of post-reperfusion arrhythmias (Kakinuma et al. 2009; Kakinuma et al. 2005; 
Ando et al. 2005; Kakinuma et al. 2013; Li et al. 2011). 
 
It is not known whether established vagal withdrawal is related to 
electrocardiographic or functional markers of cardiac ischaemia during 
exercise testing in human surgical patients.  Perioperative myocardial 
ischaemia is clearly associated with impaired outcome (Devereaux, Chan, et 
al. 2014; Landesberg et al. 2009), but not always associated with a formal 
preoperative diagnosis of ischaemic heart disease (Devereaux et al. 2012; 
Devereaux, Chan, et al. 2014).  Alternative predictors of myocardial ischaemia 
at times of physiological stress would therefore be of value.   
 
Abnormal heart rate recovery after exercise was therefore investigated as one 
such marker. 
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3.1.4 Alterations in G-protein receptor kinase activity underlie 
functional changes in both myocardial and immune cells  
 
G protein-coupled receptors (GPCRs) are diverse, therapeutically important 
and play multiple central roles in the physiology of various organs, including 
the heart.  The beta adrenoreceptor and angiotensin II type-1 receptor are key 
and relevant examples.  Signalling initiated by binding of an agonist to the 
receptor is terminated in part by phosphorylation of the receptor by the family 
of G-protein coupled receptor kinases (GRKs) (receptor desensitisation) 
followed by subsequent β-arrestin binding, which uncouples the 
phosphorylated receptor and G protein and subsequently targets the receptor 
for internalisation (Lymperopoulos 2011). 
 
In both cardiac failure and critical illness related myocardial dysfunction, beta 
adrenergic signal transduction is reduced secondary to receptor 
desensitisation and internalisation, modulated in large part by GRK2 
(Lymperopoulos et al. 2013; Lymperopoulos 2011; de Montmollin et al. 2009). 
 
Beta adrenoreceptor expression in circulating lymphocytes mirrors that seen 
in cardiomyocytes in heart failure.  Similarly, GRK2 expression in 
lymphocytes, which is increased in human cardiac failure, has been 
demonstrated to not only mirror expression in the cardiomyocyte, but to be 
related to both the severity of the underlying pathology and its pathogenesis 
(Iaccarino et al. 2005; Liggett 2005; Maisel et al. 1990). 
 
Vagal withdrawal is strongly associated with and likely mechanistically linked 
to human cardiac failure.  Abnormal heart rate recovery in surgical patients, if 
representative of impaired cardiac function, would be expected to be 
associated with neurohormonal activation (including elevations in both adrenal 
catecholamine release and activation of the renin-angiotensin-aldosterone 
axis (RAAS) – well described in known heart failure (Anker 1998)), and would 
be expected to be associated with alterations in the dynamics of beta 
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adrenoreceptor recycling mediated through GRK2 and its downstream effects 
(Lymperopoulos 2011).  
 
Preoperative blood samples taken from surgical patients referred for CPET 
provided an opportunity to assess circulating lymphocytes for evidence of 
alterations in GPCR modulation thorough a G protein coupled receptor kinase 
(GRK2) commonly elevated in cardiac failure and link these changes to 
alterations in vagal activity as assessed by heart rate recovery.  
 
3.1.5 Assessment of the exercise phenotype associated with PAD 
 
Exercise represents an integrated cardiometabolic and respiratory response 
to physiological stress.  To date, the majority of studies that have used heart 
rate recovery after exercise to define PAD, have used the Bruce protocol, or 
similar, to investigate heart rate dynamic changes.  None have used formal 
Cardiopulmonary Exercise Testing (CPET).  This has not allowed full 
examination of integrated physiology associated with PAD.  
 
The use of CPET to define PAD allows a thorough examination of the 
exercise phenotype associated with parasympathetic withdrawal and the 
opportunity to investigate cardiac performance in a controlled clinical setting. 
 
Using currently accepted physiological parameters, routinely recorded during 
standard preoperative cardiopulmonary exercise testing, I set out to describe 
physiological and electrocardiographic patterns of response to graded 
exercise in patients with heart rate recovery defined PAD. 
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3.2 Hypothesis 
 
Individuals with Parasympathetic Autonomic Dysfunction demonstrate a 
distinct physiological phenotype in response to exercise. 
 
 
3.3 Aims 
 
Primary 
• Describe the physiological response to exercise in surgical patients 
with PAD using standard CPET variables. 
 
Secondary 
• Describe the distribution of heart rate recovery values at preoperative 
exercise testing in a surgical population. 
• Associate abnormal heart rate recovery, as a measure of PAD, with 
heart rate variability measures indicative of cardiac parasympathetic 
autonomic dysfunction. 
• Describe heart rate dynamic changes during exercise testing in a 
surgical cohort with PAD. 
• Identify whether electrocardiographic markers of cardiac ischaemia are 
more common during exercise in individuals with PAD than in those 
with normal heart rate recovery. 
• Assess circulating lymphocytes from patients with varying degrees of 
PAD for evidence of alterations in G-protein receptor kinase 2 
expression commonly observed in heart failure. 
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3.4 Methods 
3.4.1 Patient Population 	
Two cohorts at separate centres were studied before planned elective 
surgery.  Patients scheduled to undergo major colorectal surgery were 
enrolled at Derriford Hospital Plymouth (DHP) and University College London 
Hospitals (UCLH) having obtained IRB approval (MREC: 11/H0805/58).  
Informed written consent was obtained from patients undergoing preoperative 
CPET as routinely requested by their clinical teams prior to major elective 
surgery.  Inclusion criteria were any surgical patient referred for preoperative 
CPET.  Exclusion criteria were according to American Thoracic Society 
guidelines (Weisman et al. 2003).   
 
All patients enrolled underwent routinely requested maximal, incremental, 
symptom limited CPET prior to surgery.  The full protocol for CPET is in 
General Methods.   
 
3.4.2 Assessment of Heart rate recovery 
 
The expected heart rate profile during exercise of individuals with and without 
PAD is illustrated in Figure 3-1.  Heart rate recovery was defined as the 
reduction in rate from the heart rate at peak exercise to the heart rate one 
minute after cessation of loaded exercise. 
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Figure 3-1: Heart rate recovery Profiles in Parasympathetic Autonomic Dysfunction 
(PAD) and Normal individuals.   
Heart rate recovery after peak exercise is normally biphasic with a rapid recovery in the first 
two minutes after exercise, representing return of vagal tone (pink box), being followed by a 
slower recovery over subsequent minutes to baseline.  Individuals with reduced 
parasympathetic autonomic activity exhibit delayed heart rate recovery (HRR; red line) as 
compared to normal individuals (blue line).  Heart rate recovery at 1 minute after cessation of 
exercise was recorded and assessed as measure of return of vagal activity. 
 
3.4.3 Association of Heart rate recovery with heart rate variability 
measures of Parasympathetic Autonomic Dysfunction in surgical 
patients 
 
Association of Heart rate recovery with Heart Rate Variability (HRV) measures 
of parasympathetic autonomic dysfunction was carried out on a subset of 46 
patients who had prospectively undergone Holter heart rate variability analysis 
and preoperative cardiopulmonary exercise testing at University College 
London Hospital.  These patients were enrolled between May 2010 and 
February 2014 in the POM-O trial of early postoperative goal directed therapy 
(full protocol and publications related to trial available in general methods and 
supplemental materials) (Ackland et al. 2015).    
 
Three-lead electrocardiographic recordings were made preoperatively in a 
quiet environment between 07:00 & 09:00 on the day of surgery using 
Lifecard CF digital Holter monitors (Spacelabs Healthcare, Hertford UK).  
Patients in atrial fibrillation, or with frequent ectopy (>5/minute) were 
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excluded.  Data quality criteria were in accordance with task force guidelines ( 
Malik et al. 1996).  Holter data cleaning and analysis was undertaken blinded 
to all other physiological and perioperative outcome data. 
 
Immediate postoperative recordings of heart rate variability on arrival in the 
post anaesthetic care unit (PACU) were also taken.  These recordings were 
taken at time points free of any other acute medical intervention.  
 
Time domain measures were selected based on signal stability and analysed 
from at least one stable five minute recorded segment per hour (Spacelabs 
HRV Tools Software, Hertford, UK).  Frequency domain parameters were not 
assessed, as only short-term recordings were available, potentially reducing 
the validity of frequency domain measures.   
 
The square root of the mean of the sum of squares of the successive 
differences between adjacent beat-to-beat intervals (RMSSD) was assessed 
as being most representative of parasympathetic activity (Nunan, Sandercock, 
et al. 2010). 
 
Outcome measures were not recorded from these patients since immediate 
postoperative management was dictated by trial protocol and has been 
reported elsewhere (Ackland et al. 2015). 
 
3.4.4 Assessment of Heart Rate Dynamic changes in PAD 
 
Chronotropic incompetence was assessed by calculating the adjusted heart 
rate reserve, which controls for confounding factors including age and resting 
heart rate (Brubaker & Kitzman 2011). 
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3.4.5 Electrocardiographic assessment of cardiac ischaemia at peak 
exercise 
 
Continual three lead ECG recording was carried out throughout exercise 
testing.  Lead II was chosen for investigation as the most easily and reliably 
obtained during exercise. 
 
The nadir ST value at any time during exercise testing was taken as 
representing the most significant cardiac ischaemia.  ST depression was 
defined as abnormal when ST depression of 0.1 mV (1mm) or more was 
recorded (Lurati Buse et al. 2009).   
 
Patients in whom baseline (resting) ST segments were recorded as abnormal 
were excluded from further analysis.  In order to control for the effects of 
dynamic heart rate changes on the ST segment in ischaemia during exercise, 
the ST-heart rate (ST/HR) index was calculated (Kligfield 2008; Okin et al. 
1996): 
ST nadir (mV)        *     100 
                                   Heart Rate Gradient 
 
Postoperative laboratory blood test data was available from UCLH only.  Any 
cardiac troponin test result requested during the first postoperative week was 
recorded as evidence of clinical suspicion of myocardial ischaemia in the 
immediate postoperative period. 
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3.4.6 Immuno- (Western) blot analysis of circulating mononuclear cells 
for GRK2  
 
Peripheral blood samples were taken from 20 randomly selected patients prior 
to cardiopulmonary exercise testing.  These samples were placed on ice and 
transferred immediately to the laboratory for processing. 
 
Mononuclear cells were isolated using Ficoll density gradient centrifugation, 
as described in general methods. 
 
Immunoblot analysis was carried out as described in general methods.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
		  135 	
 
Exercise physiology in Parasympathetic Autonomic Dysfunction 
	
	 	
3.5 Results 
3.5.1 Definition of Abnormal Heart rate recovery (HRR) 
 
The distributions of heart rate recovery values recorded at both sites and 
combined are displayed in Table 3-1 and Figure 3-2.  The 25th centile for 
Heart rate recovery was 12 bpm, corresponding to similar distribution in other 
medical populations (Cole et al. 2000; Nishime et al. 2000; Shetler et al. 
2001).  Mean Heart rate recovery for the entire cohort was 18 (17-21) bpm.  A 
heart rate recovery of ≤12 bpm was therefore taken as abnormal when 
comparisons were made between normal and abnormal parasympathetic 
autonomic function. 
 
Descriptor DHP UCLH Combined 
Total Number of values 235 814 1048 
Total Number of excluded values: 0 0 0 
Minimum HRR (bpm): -7 -10 -10 
25% Percentile HRR (bpm): 12 12 12 
Median HRR (bpm): 17 16 16 
75% Percentile HRR (bpm): 27 26 26 
Maximum HRR (bpm): 71 92 92 
Mean Heart rate recovery (bpm): 19 (17-21) 18 (16-19) 18 (17-19) 
Table 3-1: Frequency Distribution Statistics for Heart rate recovery.   
bpm= beats per minute. 
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Figure 3-2: Frequency Distribution for Heart rate recovery after cessation of exercise. 
 
The 25% Percentile is marked and is used from now on as the delineator for 
abnormal heart rate recovery.  
 
3.5.2 Association of abnormal Heart rate recovery with Heart Rate 
Variability measures of cardiac Parasympathetic Autonomic 
Dysfunction. 
 
46 individuals who had undergone preoperative CPET testing and Holter ECG 
recording in the POM-O trial were classified according to heart rate recovery.  
As described previously, a heart rate recovery of 12 bpm or below was 
classified as abnormal.  Baseline preoperative Holter recordings were 
analysed in these same individuals for heart rate variability characteristics.  
 
Reduced heart rate recovery after exercise was associated with relative 
reductions in resting Heart Rate Variability (Table 3-2, Figure 3-3). In the 
recordings examined, patients classified as having normal heart rate recovery 
demonstrated values for rMSSD below that of the reported population norm of 
42 ms (36.6ms (± 1.9) for HRR >12). 
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On arrival to PACU, patients without preoperative PAD demonstrated 
relatively increased heart rate variability as compared with their counterparts 
with PAD (p=0.07).  Neither individuals with PAD nor those with normal 
preoperative heart rate recovery demonstrated significant drops in heart rate 
variability on immediate postoperative Holter recordings in PACU (p=>0.1) 
 
Characteristic Normal HRR 
(HRR >12) 
PAD 
(HRR ≤12) 
P-value 
Preoperative 
rMSSD (ms) 
36 ± 2.3 23.4 ± 4.4 0.02 
Postoperative 
rMSSD (ms) 
31 ± 3.2 21±3.8 0.07 
Table 3-2: Comparison of Heart rate recovery (HRR) and Heart Rate Variability as 
measures of Parasympathetic Autonomic Dysfunction. MSSD = root mean square of 
standard deviation of heart rate. PAD = Parasympathetic Autonomic Dysfunction. Values 
shown are mean (Standard Error of the mean) unless otherwise stated.  P-values are for 
student’s unpaired t-test. 
 
 
 
Figure 3-3: Association of Heart rate recovery (HRR) with preoperative Heart Rate 
Variability as measures of Parasympathetic Autonomic Dysfunction. rMSSD = root 
mean square of standard deviation of heart rate. Values shown are mean (95% CI). 
Comparisons were made with Student’s un-paired t-test.   Asterisk signifies a p <0.05.  
 
Pre and Immediate postoperative values for rMSSD were positively correlated  
(n=120, Pearson r (95% CI): 0.42 (0.25-0.56); p=<0.001) that is, a low value 
for heart rate recovery was associated with a low immediate postoperative 
value and vice-versa (Figure 3-4). 
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Figure 3-4: Correlation of Preoperative and Postoperative heart rate variability (rMSSD 
(ms)).  rMSSD = root mean square of standard deviation of heart rate.  R2 is for Pearson’s 
correlation coefficient. Asterisk signifies significance (p=<0.05 
 
3.5.3 CPET characteristics in PAD 
 
Baseline CPET characteristics for the two hospital cohorts are displayed in 
Table 3-3.  Full demographics divided according to heart rate recovery are 
available in Table 4-5. 
 
When combined, the median age across the two cohorts was 66 years, 
though the Plymouth cohort was older (64 vs. 70 years).   
 
The greater proportion of patients studied were male (62%).  Median 
Anaerobic threshold across both cohorts was low, approaching the 
prognostically important value of 11 ml.kg.min-1.  Values for other commonly 
recorded CPET variables were comparable across cohorts and appropriate 
for the population studied (Figure 3-10). 
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CPET Physiology University College 
London Hospital 
(n=817) 
Derriford Hospital 
Plymouth 
 (n=235) 
Combined 
 (n= 1052) 
Age, years 
(median, IQR) 
64 (55-72) 70 (60-76) 66 (56-73) 
Male (n, [%]) 573 (65) 133 (56) 706 (62) 
Resting Heart 
Rate (bpm)  
81 (72-93) 82 (73-92)  82 (72-93) 
Peak Heart Rate 
(bpm)  
137 (121-153) 142 (124-159)  138 (122-154) 
Anaerobic 
Threshold  
ml.kg-1min-1 
11.2 (9.3-13.3) 12.2 (10.4-14.4)  11.3 (9.5-13.5) 
Peak VO2  
ml.kg-1min-1 
17 (13 – 20) 19.1 (15.5 – 23)  17.5 (14-21) 
Peak VO2 (% 
Predicted) 
74 (58-88) 76 (60-90) 75 (59-89) 
Oxygen Pulse at 
AT ml.beat-1 
11 (8.9-13.6) 10.6 (8.2-13.4)  10.9 (9-13.5) 
VE /VCO2 at AT  29.4 (26.5-33.6) 26.6 (22.2-30.6) 28.3 (25.3-31.4) 
Table 3-3: CPET characteristics of the two study populations. Values shown are median 
and interquartile range (IQR) unless otherwise stated.  N=number; bpm, beats per minute; 
AT, Anaerobic threshold; VO2, oxygen uptake; VE/CO2, Ventilatory Equivalents for Carbon 
Dioxide. 
 
CPET physiological characteristics for both cohorts combined, divided 
according to heart rate recovery are presented in Table 3-4 and Figure 3-10. 
 
Proportionately a greater number of patients with PAD had an AT <11 (55% 
vs. 40% in patients with HRR >12), which has been previously associated 
with poor postoperative outcomes (RR 1.26 (95% CI 1.1 to 1.6); p=0.02).  
PAD was also associated with a 10% reduction in peak VO2 as predicted by 
age and sex when compared with individuals with normal heart rate recovery 
(% of predicted VO2 66% (63.8-69.4) in PAD as compared with 76% (74.8-
78.5) in normal HRR). 
 
Oxygen pulse, a validated surrogate for left ventricular stroke volume (Whipp 
et al. 1996; Crisafulli et al. 2007), was reduced in patients with PAD at peak 
exercise.  Ventilatory equivalents for CO2 at anaerobic threshold fell within 
normal range (25-35) for both groups. 
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CPET Physiology 
(UCLH and DHP 
combined): 
Normal HRR 
N=729  
(HRR >12) 
PAD  
N=317 
(HRR ≤12) 
P-value 
AT (mean, 95% CI) 13.2 (12-14) 11.1(10.6-11.6) <0.0001 
Peak VO2  
(mean, 95% CI) 
18.8 (18.4-19.2) 15.2 (14.8-15.8) <0.0001 
% of Predicted Peak 
VO2 (mean, 95% CI) 
76 (74.8-78.5) 66  (63.8-69.4) <0.0001 
Oxygen Pulse 
(mean, 95% CI) 
14.6 (13-16) 10.6 (10-11) <0.0001 
VE /CO2 at AT  
(mean, 95% CI) 
26 (25-27) 26.3 (24-28) 0.77 
Table 3-4: Cardiopulmonary exercise testing (CPET) physiological and autonomic 
characteristics for individuals with and without Parasympathetic Autonomic 
Dysfunction (PAD).  University College London and Derriford Hospital Plymouth data 
combined. bpm= beats per minute.  AT = Anaerobic threshold (ml O2 kg-1 min-1).  VO2 = 
Oxygen uptake (ml O2 kg-1 min-1).  Oxygen Pulse (ml O2 beat-1). VE/VCO2 = ventilatory 
equivalents for Carbon Dioxide (Normal range 25-35).  Values shown are mean (95% 
Confidence Interval) unless otherwise stated.  P-values are for student’s unpaired t-test. 
 
When categorised by quartile of heart rate recovery, peak oxygen pulse 
increased with each step change in heart rate recovery, plateauing between 
quartile 3 and 4 (Figure 3-5, Table 3-5). 
 
 
Figure 3-5: Oxygen Pulse (ml.O2.beat -1) classified according to quartile of heart rate 
recovery.  Mean + SD.  UCLH data. Heart rate recovery:bpm.  * signifies p <0.05 (ANOVA) 
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Oxygen Pulse  
(ml.O2.beat-1) 
Quartile 1:  
HRR <12 bpm 
Quartile 2: 
HRR 12-17 bpm 
Quartile 3: 
HRR 17-27 bpm 
Quartile 4: 
HRR >27  
bpm 
Mean 9.2 9.6 10.6 10.7 
95% CI of mean 8.8-9.5 9.2-10 10.1-11 10.2-11.1 
Table 3-5: Oxygen Pulse (ml.O2.beat -1) classified according to quartile of heart rate recovery 
(UCLH data).  HRR: Heart rate recovery.  Equivalent data for Anaerobic threshold is available in 
supplemental materials. 
 
A reduced AT (<11 ml.kg.min-1) was similarly associated with reduced oxygen 
pulse at peak exercise dropping with each quartile (p=0.02, two-way ANOVA, 
Supplementary Data), but PAD remained associated with greater reductions 
in oxygen pulse when compared with individuals with a reduced AT alone 
(p=0.03, two-way ANOVA).  Individuals with both PAD and a low AT 
demonstrated the lowest values for oxygen pulse (Figure 3-6, Table 3-6).  
 
Figure 3-6: Oxygen Pulse (ml.O2.beat -1) classified according to presence or absence of 
PAD and/or aerobic fitness (Anaerobic threshold > or < 11 ml.kg.min-1). Mean + SD.  
UCLH data. One way classic ANOVA p <0.05. 										
No
rm
al'
HR
R
AT
>1
1
AT
<1
1
PA
D'
PA
D'+
'AT
'<1
1
7
8
9
10
11
12
13
m
ls/
O
2/
be
at
		  142 	
 
Exercise physiology in Parasympathetic Autonomic Dysfunction 
	
	 	
 
Oxygen Pulse  
(ml.O2.beat-1) 
Normal 
Heart rate 
recovery 
(>12 bpm) 
Aerobically 
‘Fit’:  AT > 11 
ml.kg.min-1 
Aerobically 
‘Unfit’: AT 
<11 
ml.kg.min-1 
PAD 
(HRR <12 
bpm) 
PAD + 
Low AT  
Mean 11.4 10.3 9.5 8.8 8.4 
Median 10.8 9.9 8.8 8.4 8.1 
95% CI of 
mean 
10.8-11.8 10-10.5 8.8-10.2 8.5-9 8-8.9 
Table 3-6: Oxygen Pulse (ml.O2.beat -1) classified according presence of PAD and/or 
aerobic fitness (Anaerobic threshold > or < 11 ml.kg.min-1).  (UCLH data).  HRR: Heart 
rate recovery.  AT: Anaerobic Threshold. PAD: Parasympathetic Autonomic Dysfunction. 
 
3.5.4 Heart Rate Dynamic Changes in PAD 
 
Individuals with PAD demonstrated chronotropic incompetence, with higher 
resting heart rates (p=0.03) and blunted peak heart rates (p=<0.001) (Table 3-
7).   
 
The majority of published studies have used a failure to attain ≥80% of 
adjusted heart rate reserve, measured during a graded exercise test, as the 
primary criterion for chronotropic incompetence (Brubaker & Kitzman 2011).  
Patients with PAD demonstrated a reduced adjusted heart rate reserve both 
in absolute terms and when compared to normal HRR (adjusted heart rate 
reserve: 77 (73-81)%, p=0.009).  The cohort without PAD did not demonstrate 
chronotropic incompetence (achieving 88 (82-94)% of their adjusted Heart 
Rate Reserve). 
 
CPET Physiology 
(UCL and DHP 
combined): 
Normal HRR 
N=729 
(HRR >12) 
PAD 
N=317 
(HRR ≤12) 
P-value 
Resting Heart Rate 
(mean, 95% CI) 
81 (78-84) 88 (84-93) 0.003 
Peak Heart Rate 
(mean, 95% CI) 
146 (142-150) 133 (128-138) < 0.0001 
Adjusted Heart Rate 
Reserve (%) (mean, 
95% CI) 
88 (82-94) 77 (73-81) 0.009 
Table 3-7: Heart Rate Dynamic Changes in PAD.  University College London and Derriford 
Hospital Plymouth data combined. Heart Rates are min-1. Values shown are mean (95% 
Confidence Interval) unless otherwise stated.  P-values are for Student’s unpaired t-test. 
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3.5.5 Electrocardiographic evidence of cardiac ischaemia in PAD 
 
No differences in electrocardiocardiographic markers of cardiac ischaemia 
during exercise, in terms of nadir ST depression in lead II at peak exercise, 
were seen between groups (Table 3-8, Figure 3-7).  However, an increase in 
risk for a prognostically significant rise in ST/HR index (>1.6 (Okin et al. 
1996)) was seen in the PAD group (RR 1.03 (1.001 to 1.045) p=0.001).  
 
CPET Physiology 
(UCL and DHP 
combined): 
Normal HRR 
N=729  
(HRR >12) 
PAD  
N=317 
(HRR ≤12) 
P-value 
ST segment Nadir 
(LEAD II, microV) 
(mean, 95% CI) 
-0.06 (-0.08- -0.03) -0.06 (-0.07- -0.04) 0.8 
ST/HR index  
(mean, 95% CI) 
1.054 (0.7-1.4) 1.473 (1-1.8) 0.12 
Table 3-8: Electrocardiographic markers of exercise induced myocardial ischaemia in 
PAD.  Values shown are mean (95% Confidence Interval) unless otherwise stated. P-values 
are for student’s unpaired t-test. 
 
 
Figure 3-7: ST/HR index at preoperative exercise testing in individuals with (normal 
heart rate recovery) and without PAD (abnormal heart rate recovery).  Values plotted are 
mean (95% CI). 
 
At UCLH, individuals with PAD were more likely to undergo postoperative 
troponin testing for suspected perioperative cardiac ischaemia than their 
counterparts (RR 1.03 (1 to 1.06), p=0.02). 
Normal Abnormal
0.0
0.5
1.0
1.5
2.0
m
icr
ov
ol
ts
/b
pm
		  144 	
 
Exercise physiology in Parasympathetic Autonomic Dysfunction 
	
	 	
3.5.6 GRK2 and PAN-Arrestin expression in circulating lymphocytes 
 
Heart rate recovery values were assessed in 20 patients.  GRK2 expression 
in whole cell lysate, as measured by immunoblot, was increased in PAD 
(Figure 3-8).   
 
 
Figure 3-8: Group data for patient immunoblots performed in 20 separate subjects 
demonstrating each HRR phenotype (10 per group).  Median (25th–75th centile) HRR 
values shown below the bars.  *Significant difference (p < 0.05). IQR = interquartile range.  
 
GRK2 expression appeared to increase in PAD in a dose dependent manner 
(Figure 3-9). 
 
 
Figure 3-9: Immunoblot for G-
protein–coupled receptor- kinase 2 
(GRK2) protein expression in 
isolated mononuclear cells 
obtained from three consecutively 
recruited surgical patients 
undergoing preoperative 
cardiopulmonary exercise testing 
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Figure 3-10: Cardiopulmonary exercise performance in patients with parasympathetic 
autonomic dysfunction (PAD).  Abnormal signifies abnormal heart rate recovery after 
exercise (PAD).  Data are presented as mean ± SD.  AT = Anaerobic Threshold.  The dotted 
line on the anaerobic threshold figure illustrates the ‘high risk’ cut off for postoperative 
complications in common usage.  All comparisons made by ANOVA. Asterisk denotes P ≤ 
0.05.   
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3.6 Discussion 	
3.6.1 Key findings 
 
1. The distribution of heart rate recovery after exercise in surgical patients 
corresponds well to that seen in other medical populations. 
2. Abnormal heart rate recovery at preoperative exercise testing is 
associated with reduced heart rate variability in the same individuals, 
both pre- and immediately post-operatively. 
3. Parasympathetic Autonomic Dysfunction as defined by reduced heart 
rate recovery, was associated with a distinct exercise phenotype, 
characterised by a reduced stroke volume (as represented by oxygen 
pulse) at peak exercise, reduced AT and VO2 peak, and chronotropic 
incompetence.   
4. Parasympathetic Autonomic Dysfunction as defined by reduced heart 
rate recovery, was associated with evidence for increased risk of 
electrocardiographically defined ischaemia at preoperative exercise 
testing, and for clinical suspicion of perioperative myocardial 
ischaemia. 
5. PAD was associated with increased expression of both GRK2 in 
circulating lymphocytes taken from patients preoperatively.  These 
increases appeared related to the degree of impairment in heart rate 
recovery after peak exercise or the severity of PAD. 
 
3.6.2 Discussion of Key findings 
 
3.6.2.1 The distribution of heart rate recovery values corresponds well 
to other medical populations 
 
The distribution of heart rate recovery values recorded in both cohorts 
correlated well with those recorded in other medical populations (Cole et al. 
2000), although, as when comparing otherwise healthy individuals to those 
with suspected cardiovascular disease, the lowest quartile was reduced when 
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compared with the general population (Jouven et al. 2005; Cole et al. 1999), 
perhaps reflecting increased levels of preoperative comorbidity across both 
cohorts.   
 
The majority of patients undergoing preoperative exercise testing are already 
suspected as being ‘high-risk’, either by virtue of comorbidity and/or type of 
surgery prior to referral.  That heart rate recovery values across the 
population reflect this is perhaps unsurprising. 
 
3.6.2.2 Impaired heart rate recovery after exercise is associated with 
reduced heart rate variability both pre- and post-operatively 
 
Heart rate recovery after exercise, measured before hospital admission, was 
associated with a reduction in heart rate variability, commonly associated with 
parasympathetic autonomic dysfunction, preoperatively on the day of surgery.  
This has two important implications: 
 
First, abnormal heart rate recovery is associated, in the same individuals, at a 
later time point, with another widely accepted marker of vagal withdrawal, 
namely reduced heart rate variability (rMSSD).  This supports the assertion 
that reduced heart rate recovery represents parasympathetic autonomic 
dysfunction. 
 
Second, the presence of reduced heart rate variability preoperatively on the 
day of surgery, in the same patients who demonstrated reduced heart rate 
recovery days to weeks before, implies that vagal withdrawal is established at 
the time of surgery. 
 
These observations are made in the light of several caveats. Heart rate 
variability analysis, particularly time domain analysis, despite widespread 
usage, cannot in itself be considered as the gold standard method for 
determining vagal activity (Malik et al. 1996).  Indeed, evidence from 
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pharmacological blockade studies indicates that heart rate recovery is 
possibly a better measure of dynamic vagal activity (Pierpont et al. 2000). 
 
The interaction between heart rate variability and heart rate recovery is 
complex.  All heart rate variability measures reflect both spontaneous 
sympathetic and parasympathetic activity as well as heart rate at time of 
measurement (Monfredi et al. 2014), whereas heart rate recovery represents 
reinstitution of vagal tone from a position of negligible parasympathetic activity 
at maximal exercise.  
 
Limited evidence comparing athletes and healthy control individuals has 
shown a variety of relationships between resting HRV, including rMSSD, and 
heart rate recovery.  These range from strong (Danieli et al. 2014; Evrengul et 
al. 2006) to moderate (Nunan et al. 2010) to none at all (Bosquet et al. 2007).   
 
In one study, where pre exercise HRV values did not correlate well with heart 
rate recovery data, dynamic changes in heart rate variability after exercise 
during recovery (i.e. return of complexity and variability) did mirror heart rate 
recovery (Javorka et al. 2002).  Another study showed no relationship 
between heart rate recovery and resting heart rate variability in the first two 
minutes after cessation of exercise, but a strong relationship from the third 
minute of recovery onwards (Antelmi et al. 2008).  
 
Even the mode of exercise testing (treadmill vs. stationary cycle ergometer) 
can influence the rate of heart rate recovery (Maeder et al. 2009) and heart 
rate variability (Abrantes et al. 2012). 
 
Evrengul et al. showed a strong correlation between resting measures of 
heart rate variability and heart rate recovery after exercise in individuals with 
known coronary artery disease without heart failure, both being reduced 
(Evrengul et al. 2006).  This may better represent the high-risk surgical 
population than studies on marathon runners and otherwise young healthy 
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individuals. Simply put, HRV “cannot be used in any simple way to assess 
autonomic nerve activity to the heart” (Monfredi et al. 2014).   
 
Heart rate variability data are however easily accessible in the clinical setting.  
Evidence that reductions in HRV represent vagal withdrawal measured by 
HRR, could prove useful in the continual assessment of the high-risk patient 
in the perioperative period.  In this study, HRV did not significantly change 
from preoperative values in the immediate postoperative period in either PAD 
or normal individuals.   However, the observations that HRV indices remained 
low in patients with preoperative PAD and that a positive correlation existed 
between patients who presented with low preoperative heart rate variability 
and immediate postoperative heart rate variability may have some bearing on 
the development of postoperative morbidity.  Indeed, in the POM-O trial, 
reduced parasympathetic activity after goal directed therapy (GDT) was 
associated with a failure of GDT to improve postoperative outcomes (Ackland 
et al. 2015). 
 
3.6.2.3 Parasympathetic autonomic dysfunction is associated with a 
distinct exercise phenotype characterised by impaired cardiac 
contractility. 
 
Parasympathetic autonomic dysfunction appears to be associated with 
functional cardiac failure in surgical patients as illustrated by performance of 
these patients at perioperative cardiopulmonary exercise testing. 
 
i) Reduced VO2 peak and chronotropic incompetence 
 
Both AT and VO2 peak were observed to be reduced in PAD, in the context of 
normal ventilatory equivalents for oxygen and carbon dioxide, likely reflecting 
impaired cardiac performance.  The ability to perform physical work is 
normally enabled by an up to four-fold increase in VO2 during exercise in 
healthy humans.  This is achieved by a 2.2 fold increase in heart rate and 0.3 
fold increase in stroke volume.   
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Chronotropic incompetence, a well described characteristic of both 
parasympathetic autonomic dysfunction and cardiac failure (Brubaker & 
Kitzman 2011), was demonstrated in this cohort of PAD patients.  Whilst a 
reduced peak heart rate in PAD therefore goes some way to explaining the 
observed reduction in peak VO2, it cannot fully be explained by alterations in 
heart rate dynamics alone, since VO2 is also strongly influenced by cardiac 
contractility.   
 
ii) Reduced oxygen pulse at peak exercise 
 
The reduced oxygen pulse noted in PAD at peak exercise is suggestive of 
reduced stroke volume and therefore cardiac contractility, (the oxygen pulse is 
equivalent to the slope of the VO2/Heart Rate relationship; Whipp et al. 1996).   
  
Values for oxygen pulse in patients with normal heart rate recovery agreed 
well with those reported elsewhere in surgical patients, but those recorded in 
PAD were equivalent to the lowest quintile recorded in cardiac patients 
referred for exercise testing (Oliveira et al. 2011; Oliveira et al. 2009).  A 
reduced oxygen pulse in itself has been demonstrated to be a powerful 
predictor of mortality in patients with cardiovascular diseases (Ritt et al. 2012; 
Oliveira et al. 2009; Laukkanen et al. 2006). 
 
PAD is particularly common in cardiac failure, where impaired ventricular 
remodelling and increased levels of inflammation in cardiomyocytes have 
been noted and associated with vagal withdrawal (Floras & Ponikowski 2015; 
Li & Olshansky 2011).  Strategies to improve cardiac performance through 
vagal modulation have met with mixed results (Klein & De Ferrari 2010; 
Zannad et al. 2015), though there is an increasing body of basic science 
evidence to suggest that vagal activity, acting through ventricular muscarinic 
receptors, directly increases cardiac contractility (Vatner et al. 1988; Kitazawa 
et al. 2009; Hussain et al. 2009). 
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Oxygen pulse appeared related to PAD in a ‘dose-dependent’ manner.  This 
supports the concept of role for vagal activity in the promotion of positive 
inotropy.  Unfortunately, resting values for oxygen pulse were not available.  
These would help determine whether intact parasympathetic function is a pre-
requisite for an increase in cardiac contractility during exercise. 
 
3.6.3 Evidence for myocardial ischaemia in PAD 
 
There was no clear relationship between PAD and exercise induced 
myocardial ischaemia in terms of nadir ST segment depression.  This 
supports the findings of previous studies in cardiac populations which showed 
no interaction between Bruce Protocol elicited ST depression and heart rate 
recovery (Nishime et al. 2000).  An abnormal heart rate recovery has however 
been associated with inducible impaired left ventricular systolic function during 
exercise, presumed in part due to myocardial ischaemia, but remaining 
independently predictive of death (Watanabe et al. 2001). 
 
Patients with PAD were more likely to demonstrate a ST/HR index score 
suggestive of ischaemic heart disease, putting these individuals at increased 
risk of positive coronary angiography, cardiac morbidity and mortality (Kligfield 
2008; Okin et al. 1996).  Indeed, in a non-surgical population, abnormal heart 
rate recovery has independently been associated with a 59% prevalence of 
significant coronary artery disease at angiography (Shetler et al. 2001). 
 
Given the prevalence of chronotropic incompetence in PAD, ST/HR index, 
which allows for ST segment depression due to tachycardia, may be a more 
appropriate measure of cardiac ischaemia in PAD than nadir ST segment 
depression.   
 
Further support for inducible cardiac ischaemia in PAD is provided by the 
observation of a reduced peak oxygen pulse.  A reduced oxygen pulse is 
strongly associated with the presence of myocardial ischaemia during 
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exercise, possibly due to a flattening of the VO2/Heart rate curve at the onset 
of ischaemia due to a reduced stroke volume (Belardinelli et al. 2003).   
 
Taken together, surgical patients with heart rate recovery defined PAD do 
manifest certain key features suggestive of myocardial ischaemia during 
exercise testing.  This lends support to the concept that PAD is associated 
with covert cardiac failure in surgical patients, manifest by impaired cardiac 
performance during CPET. 
 
3.6.4 Parasympathetic Autonomic Dysfunction is associated with 
increases in GRK2 expression in circulating mononuclear cells 
 
Evidence for increased GRK2 expression in circulating mononuclear cells in 
PAD has several implications:   
 
First, GRK2 elevation is strongly associated with both adrenergic stimulation 
and RAAS activation.  This implies a degree of neurohormonal activation with 
consequent alterations in G protein receptor kinase expression in surgical 
patients with PAD that is similar to that described in other populations where 
evidence of vagal withdrawal is common (e.g. cardiac failure and critical 
illness).     
 
Second, when combined with observations of impaired cardiac contractile 
function and chronotropic incompetence in PAD, elevated GRK2 would be 
expected to be associated with beta adrenoreceptor and angiotensin II 
receptor internalization and desensitization.  This expected desensitization 
may partly explain the failure of individuals with PAD to increase both their 
cardiac contractility and their heart rate in response to endogenous increases 
in sympathetic activity initiated by exercise.  
 
Third, the combination of elevated GRK2 with impaired exercise performance 
in PAD suggests that there is a large population of patients with a degree of 
undiagnosed, functional heart failure routinely presenting for major surgery.   
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Evidence for increases in GRK2 expression in circulating mononuclear cells 
alongside increasing degrees of PAD mirror similar severity related increases 
observed in individuals with known heart failure (Iaccarino et al. 2005).  In 
heart failure, elevations in lymphocyte GRK2 have a prognostic value (Rengo 
et al. 2016) that could be explored in PAD in the perioperative context.   
 
Use of CPET elicited heart rate dynamic variables may therefore be of some 
use in identifying these patients prospectively and initiating medical 
optimization.  This raises questions with regard to targeted beta blockade and 
the introduction of other drugs, such as angiotensin II antagonists and GRK2 
blockers, shown to be associated with amelioration of cardiac dysfunction in 
heart failure.  Similarly, improvements in GRK2 expression in circulating 
lymphocytes after exercise training in patients with heart failure appear to 
predict survival (Rengo et al. 2014) and may therefore show potential for 
quantifying response to exercise based prehabiliation strategies. 
 
Fourth, evidence of increased, or at least unopposed sympathetic activity 
associated with vagal withdrawal has not been specifically investigated here, 
though it is highly likely.  Abnormal heart rate recovery is very specifically 
associated with delayed restoration of vagal tone, however, it does not 
exclude concomitant sympathetic activation, and reduced heart rate variability 
is also associated with increased sympathetic activity.  The high prevalence of 
increased sympathetic activity in heart failure would further suggest the 
presence of the same in individuals with PAD.   
 
Finally, vagal withdrawal is associated with altered immune function, 
specifically mediated through obtundation of the vagal anti-inflammatory 
reflex, with clear negative implications for the perioperative period.   
 
Additional observations of elevated GRK2 expression in mononuclear cells in 
PAD may carry further implications for the immune response to surgery. 
Elevated GRK2 is strongly implicated in the modulation of pro-inflammatory 
toll like receptor signalling, as well as in impaired monocyte chemotaxis 
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(Vroon et al. 2006).  The observation of elevated GRK2 expression in PAD 
could provide a supplementary explanation for the pro-inflammatory 
phenotype noted in vagal withdrawal, and carry implications for the 
development of postoperative morbidity.   
 
3.6.5 Conclusions  
 
PAD is known to be an independent predictor of morbidity and mortality 
across several patient populations.  PAD is also known to be both associated 
with and mechanistically contribute to heart failure and the response to 
myocardial ischaemia.  This study has supported these latter observations in 
a new (surgical) population.  Addition of heart rate recovery to preoperative 
CPET testing could add further prognostic value and aid targeted, 
personalized preoperative medical optimisation. 
 
3.6.6 Further work 
 
Focused further study should investigate the temporal relationships between 
time and frequency domain measures of vagal activity at baseline and heart 
rate recovery before, during and after exercise, as well as in the perioperative 
period, in greater numbers of surgical patients.  This could help distinguish 
static and dynamic components of alterations in autonomic activity, including 
vagal withdrawal.  The rate of recovery of heart rate variability measures in 
the perioperative period, particularly related to therapeutic interventions, may 
also provide useful information about the influence of vagal withdrawal on 
postoperative outcome (Ackland et al. 2015). 
 
Correlation with baseline oxygen pulse (rest) and the oxygen pulse curve 
would be useful in determining whether parasympathetic withdrawal results in 
dynamic contractile failure, and in describing the contribution of heart rate to 
the reduction in peak oxygen pulse.  Similarly, echocardiography would add 
value in determining dynamic alterations in left ventricular systolic function in 
PAD. 
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Use of the non-standard CM5 ECG lead may be more sensitive in detecting 
myocardial ischaemia and should be considered in future studies examining 
electrocardiographic evidence of myocardial ischaemia.  Global measurement 
of cardiac biomarkers such as troponin and BNP, both at baseline, after 
exercise and in the post-surgical period would be more sensitive at 
determining the effect of PAD on myocardial ischaemia. 
 
Further exploration of evidence for both sympathetic and RAAS activation in 
PAD may help target patients who would benefit from perioperative beta 
blockade and/or Angiotensin II inhibition.  Mechanistic animal studies could 
help differentiate the role of GRK2 in the development of the cardiac 
phenotype described here.  Detailed immunophenotyping would be of benefit 
in the assessment of the immune implications of vagal withdrawal in these 
surgical patients. 
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4. Parasympathetic	Autonomic	Dysfunction	and	Surgical	
Outcome	
4.1 Introduction 
 
Vagal withdrawal has been associated with a pro-inflammatory state, 
metabolic dysregulation (Pavlov & Tracey 2012) impaired cardiac 
performance (Olshansky et al. 2008), gastrointestinal dysfunction (Karmali et 
al. 2015) and impaired outcomes across various inflammatory insults, 
including during the perioperative period (Lankhorst et al. 2014), trauma 
(Colombo et al. 2008; Ryan et al. 2011) and sepsis (Schmidt et al. 2005).  
 
Studies in these contexts to date have not directly examined the influence of 
established, or pre-existing Parasympathetic Autonomic Dysfunction (PAD) on 
outcome. 
 
Whether established PAD is detrimental to outcome following surgery, an 
inflammatory insult where the timing of onset can be predicted, in human 
patients is unknown.  Higher risk individuals, more susceptible to developing 
significant perioperative morbidity and mortality (Khuri et al. 2005) are of 
particular interest. 
 
In order to explore any association between preoperative PAD and clinically 
relevant adverse outcomes to surgical trauma, high-risk patients, in two well-
characterised populations undergoing major surgery were studied.  Heart rate 
recovery immediately after routine preoperative Cardiopulmonary Exercise 
Testing (CPET) was used as an indicator of parasympathetic autonomic 
function.   
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4.1.2 PAD and outcome after major surgery  
 
PAD is strongly associated with several plausible mechanisms, outlined 
previously, for the development of postoperative complications.   
 
Data from preoperative exercising testing suggest that individuals with PAD 
display a distinct physiological phenotype that could additionally affect 
perioperative outcome in several ways: 
 
i) Reduced anaerobic threshold.  In itself, in similar populations, an 
anaerobic threshold of <11 ml.kg.min-1 is strongly predictive of 
impaired postoperative outcomes (Older 2013; Older et al. 1999; 
Forman et al. 2010).  Individuals with PAD defined by reduced heart 
rate recovery after exercise were more likely to demonstrate an AT 
of < 11. 
ii) Reduced cardiac contractility at peak exercise.  As a component of 
oxygen delivery, should this reduced contractility translate to 
reduced cardiac output at times of increased metabolic demand, 
then perioperative tissue hypoperfusion with resultant 
consequences may be more likely (Rhodes et al. 2010; Lees et al. 
2009a). 
iii) In itself, reduced exercise capacity, in the absence of a diagnosis of 
heart failure, is associated with increases in markers of 
inflammation (Sultan et al. 2014).  Vagal withdrawal, a pro-
inflammatory stimulus, may support or even augment this process. 
iv) Increased GRK2 expression, noted previously in circulating immune 
cells in patients with PAD, is also associated with a dysregulated, 
pro-inflammatory immune response; potentially further increasing 
the risk of postoperative immune complications.   
 
PAD was associated with cardiac impairment at the time of preoperative 
exercise testing.  In heart failure, parasympathetic withdrawal is strongly 
associated with myocardial inflammation (Li & Olshansky 2011).  
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Lymphopaenia, likely secondary to sympathetic activation, is prevalent in 
heart failure and strongly linked to outcome.  Reduced circulating lymphocyte 
counts, which when expressed as a neutrophil to lymphocyte ratio (NLR) 
reflect systemic inflammation (Zahorec 2001; Venkatraghavan et al. 2015), 
are also associated with poor prognosis in cardiac failure (Benites-Zapata et 
al. 2015), and in other inflammatory conditions such as cancer (Jung et al. 
2011; De Martino et al. 2013; Walsh et al. 2005), sepsis and critical illness 
(Salciccioli et al. 2015; Akilli et al. 2014).   
 
Preoperative changes in the neutrophil to lymphocyte ratio have also been 
shown to be predictive of postoperative outcome in colorectal surgery 
(Malietzis et al. 2013; Walsh et al. 2005; Cook et al. 2007).  Since established 
vagal withdrawal is hypothesised to produce an inflammatory state, resultant 
changes in NLR could be predicted and would, if present, be expected to be 
associated with impaired postoperative outcome. 
 
Postoperative complications are strongly associated with increased length of 
stay and resource utilisation (Khan et al. 2006; Odermatt et al. 2015; Clavien 
et al. 2009).  
 
In particular, postoperative gastrointestinal dysfunction (PGID; most 
commonly manifest as ileus) is strongly associated with systemic 
inflammation, sympathetic activation and vagal withdrawal in both 
gastrointestinal and remote site surgery (Karmali et al. 2015; Holte & Kehlet 
2000a).  Indeed, several current strategies to treat ileus focus on restoration 
or augmentation of vagal activity (Van Den Heijkant et al. 2015; The et al. 
2011).  Prolonged postoperative ileus is common and is associated with 
discomfort, patient dissatisfaction and prolonged hospitalization (Artinyan et 
al. 2008).  The contribution of preoperative or existing PAD to the 
development of this important postoperative complication is not known.   
 
I set out, therefore, to determine whether preoperative parasympathetic 
autonomic dysfunction as represented by impaired heart rate recovery after 
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exercise was associated with impaired postoperative outcomes in the same 
populations of patients investigated previously with preoperative 
cardiopulmonary exercise testing. 
 
4.2 Hypothesis 
 
Preoperative Parasympathetic Autonomic Dysfunction is associated with 
increased postoperative morbidity after major surgery. 
 
4.3 Aims 
 
This hypothesis was addressed by exploring the effect of preoperative 
parasympathetic autonomic dysfunction on the following primary and 
secondary outcomes: 
 
Primary: 
 
• Delayed postoperative recovery, represented by length of hospital stay. 
 
Secondary: 
 
• Major postoperative morbidity as defined by Clavien-Dindo Score. 
• Return of bowel function. 
• Episodes of sepsis and changes in Neutrophil to Lymphocyte ratio. 
• Mortality. 
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4.4 Methods 
 
4.4.1 Patient Population 
 
One thousand and fifty two patients scheduled to undergo major colorectal 
surgery, as described previously, were enrolled at University College London 
and Derriford Hospital Plymouth.   
 
The Derriford Hospital cohort of patients comprised patients undergoing major 
colorectal surgery who also participated in the COMPETE-C randomized 
controlled trial (ISRCTN 14680495).  Preoperative CPET data, intraoperative 
physiological data and extensive postoperative outcome data was available 
from this group, which acted as a derivation cohort. 
 
Patients recruited at UCLH acted as a validation cohort.  Less complete 
postoperative morbidity data was available from these patients. A larger 
number of patients, more information on preoperative medication and medical 
history and blood results, not available from Plymouth, were however 
available. 
 
The protocol used for CPET is described in General Methods.  The full 
protocol and primary analysis for the COMPETE-C trial is included in the 
appendix (C Challand et al. 2012).  
 
CPET data from both sites was combined and classified according to heart 
rate recovery in the first minute after cessation of maximal symptom limited 
exercise.  A heart rate recovery of 12 bpm or below (the lowest quartile of the 
tested population) was classed as abnormal based on population distribution 
statistics and published literature as described previously.  Primary and 
Secondary outcomes were examined after dividing the patients into normal 
(N) and abnormal (HRR) heart rate recovery groups.   
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4.4.2 Primary Outcome:  Hospital Length of stay 
 
Hospital Length of stay, available from both cohorts, is frequently used as a 
marker of delayed recovery (Librero et al. 2004).  Since hospital length of stay 
may be affected by non-complication related factors such as availability of 
social services, or rehabilitation facilities, readiness for discharge (RfD) has 
been used in many studies assessing post operative morbidity and may be a 
better measure of postoperative complications (Challand et al. 2012; Noblett 
et al. 2006; Gan et al. 2002).   
 
Readiness for discharge data was available from the Derriford Hospital 
Plymouth cohort and was assessed using internationally accepted criteria 
(Fiore et al. 2012) for colorectal surgery by observers blinded to the original 
intervention or CPET result (Table 4-1). 
 
Criteria End points 
Tolerance of oral intake Patient can tolerate at least one solid meal 
without nausea, vomiting, bloating, or 
worsening abdominal pain.  Patient should be 
actively drinking and not require IV hydration 
Recovery of lower gastrointestinal 
function 
Patient should have passed flatus 
Adequate pain control with oral analgesia Patient should be able to rest and mobilise 
without significant pain (Pain < 4 on a scale 
of 1 to 10) 
Ability to mobilise and self care Patient should be able to sit up, walk, and 
perform activities of daily living. 
Clinical examination and laboratory tests 
show no evidence of complications or 
untreated medical problems 
Temperature should be normal 
Pulse, blood pressure and respiratory rate 
should be stable and consistent with 
preoperative levels 
Haemoglobin should be stable and within 
acceptable levels 
Patient should be able to empty the bladder 
without difficulty or match preoperative level 
of bladder function 
Table 4-1: Criteria for assessment as fit for discharge. When the criteria outlined above 
have been met, the patient is considered to have reached short-term postoperative recovery 
and should be considered ready for discharge (Fiore et al. 2012). 
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4.4.3 Secondary Outcome measures 
 
i) Clavien-Dindo Grade 
 
Data on major postoperative morbidity at any time in the postoperative 
course, as classified by a Clavien-Dindo grade ≥3 were available from the 
DHP cohort.   
 
A Clavien-Dindo grade of ≥ 3 was chosen as being most representative of 
major postoperative morbidity (including life threatening complications 
requiring intensive care management, single organ dysfunction or multi-organ 
dysfunction) (Clavien et al. 2009).   
 
ii) Return of bowel function 
 
This was assessed at DHP as a component of ready for discharge criteria.  
Aside from the presence of flatus, patients were expected to have passed 
stool and be tolerating a light diet normally to be considered as having 
resumed normal bowel function. 
 
iii) Postoperative sepsis and neutrophil to lymphocyte ratios 
 
Prospective data on the incidence of sepsis was collected at DHP only.  Two 
or more of the following criteria, derived from the surviving sepsis campaign 
international guidelines 2012, being present defined postoperative sepsis 
(Dellinger et al. 2013): 
- Temperature <36oC or >38oC 
- Heart Rate >90 bpm 
- Respiratory Rate >20bpm 
- Acutely altered mental state 
- White cell count <4 or >12 
- Suspected infectious cause:  origin recorded 
- Plasma glucose >14 mMol/L 
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iv) White Cell Count, Neutrophil to Lymphocyte ratio 
 
Full blood counts were analysed at our institution’s haematology laboratory on 
a Sysmex XE2100 analyser (Sysmex, Milton Keynes, UK).   
 
v) Mortality  
 
Ninety day mortality was recorded, since recent data demonstrate that 
morbidity at this time point has the greatest impact on long term outcome after 
surgery for colorectal malignancy (Visser et al. 2009).  
 
4.4.4 Sample Size and Statistical Analysis 
 
Abnormal heart rate recovery was defined as described previously by 
categorizing the distribution of values for heart rate recovery into quartiles and 
choosing the 25th centile or lower quartile as the cut off for abnormality. 
 
The assumption was made that a heart rate recovery in the lowest quartile 
(<12 bpm) would confer around a two-fold relative risk of adverse outcomes 
(Cole et al. 2000; Cole et al. 1999; Jouven et al. 2005).  Given that the serious 
morbidity prevalence was 15% in COMPETE-C, a total of at least 59 patients 
would be required to detect a 2-fold increase in major morbidity in PAD 
patients, with 90% power at a two-sided 5.0% significance level. 
 
A Cox proportional hazards regression model was constructed for length of 
stay at UCLH.  Age, heart rate recovery, a Revised Cardiac Risk Index (RCRI) 
>3 (representing significant heart disease and/or diabetes) (Lee et al. 1999) 
and low AT (<11 ml.kg.min-1) were incorporated.  Length of stay data was 
censored from 50 days (based on ROUT analysis of length statistical outliers 
(Q=1%), mortality data (15 deaths at 90 days) was included and treated as a 
competing risk (Brock et al. 2011).  
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Log-rank analysis of length of stay under various conditions was also carried 
out.  Patients who died in this analysis were right-censored as longest length 
of stay, which was again censored at 50 days.   
 
General statistical analysis of data was carried out as described in General 
Methods. 
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4.5 Results 
 
4.5.1  Patient clinical and demographic variables 
 
Patient clinical and demographic variables for both cohorts are displayed in 
Table 4-2.  A total of 1,052 patients were studied with a median age of 67 
years. 50% of DHP and 46% of UCLH patients had a primary diagnosis of 
carcinoma.  Proportionately, the UCLH cohort was composed of more male 
patients (65%) and was younger (mean age 64 years at UCLH vs. 70 years at 
DHP). 
 
Both cohorts had low median anaerobic threshold values, (UCLH median AT 
11 ml.kg-1.min-1, DHP median AT 12.2 ml.kg-1.min-1) and had median BMI 
values that are classified as overweight.   
 
Baseline Patient 
Characteristics 
Derriford Hospital Plymouth  University College London 
Hospital  
Total Number 235 817 
Age, years (median, IQR) 70 (60-76) 64 (55-72) 
Male (n, [%]) 133 (56) 573 (65) 
BMI (median, IQR) kg.m2 27.4 (25-31)  27.2 (23-30) 
RCRI (mode, range) 1 (1-4) 1 (1-4) 
ASA grade (mode, 
range) 
2 (1-3) 1 (1-3) 
Carcinoma (%) 50 46 
AT (median, IQR) 
ml.kg-1min-1 
12.2 (10.4-14.4)  11 (9-13) 
Peak VO2 (median, IQR) 
ml.kg-1min-1 
19.1 (15.5 – 23)  17 (13 – 20) 
Oxygen Pulse (median, 
IQR) ml.beat-1 
10.6 (8.2-13.4)  11 (8.9-13.6) 
VE /VCO2 at AT (median, 
IQR) 
26.6 (22.2-30.6) 29.4 (26.5-33.6) 
Table 4-2: Clinical and demographic features of the whole study cohort (University 
College London Hospital – UCLH; Derriford Hospital Plymouth- DHP). Values shown are 
median and interquartile range (IQR) unless otherwise stated.  N=number; BMI, Body Mass 
Index; RCRI, Revised Cardiac Risk Index; ASA, American Society of Anesthesiologists grade; 
bpm, beats per minute; AT, Anaerobic threshold; VO2, oxygen uptake; VE/CO2, Ventilatory 
Equivalents for Carbon Dioxide. 
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4.5.2 Global length of stay day data 
 
Unadjusted length of stay data and 30- and 90-day mortality for both sites is 
presented in Table 4-3. Mortality data in both cohorts was reduced as 
compared with population based studies (Byrne et al. 2013). 
 
Postoperative  
Outcome 
Derriford Hospital 
Plymouth  
University College London 
Hospital  
Hospital LOS, days 
(median, IQR) 
7.8 (5.75-9.9)  9 (6-16)  
Clavien-Dindo ≥3 (%) 9.8 Not collected 
30-day mortality (%) 1.28 1.4 
90-day mortality (%) 3.4 2.4 
Table 4-3: Postoperative outcome data for the whole study cohort (University College 
London Hospital; Derriford Hospital Plymouth). LOS; Length of stay. 
 
Length of stay data was significantly skewed by the presence of a small 
number of outliers, potentially affecting the validity of survival analysis (Figure 
4-1) 
 
 
Figure 4-1: Raw length of stay data for both study cohorts.  Length of stay was 
significantly skewed by outlying values. 
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When outliers were excluded as described in the methods section (ROUT; 
Q=1%), length of stay data reflected nationally reported data (Figure 4-2, 
Table 4-4). 
 
 
Figure 4-2: Length of stay distribution after exclusion of significant outliers for both 
study cohorts. 
 
Postoperative Outcome Derriford Hospital 
Plymouth 
University College London 
Hospital 
Hospital Length of stay, 
days (median, IQR) 
7 (5-9) 8 (5-13) 
Mean LOS (SD) 8 (7-8) 10  (9-10) 
Table 4-4: Postoperative outcome data, outliers excluded (University College London 
Hospital; Derriford Hospital Plymouth). LOS; Length of stay. 
 
4.5.3 Patient Clinical and demographic variables. PAD vs. Normal 
 
30% of all patients studied exhibited PAD.  Patients with PAD were, in 
general, older (p=<0.001), more likely to be hypertensive (RR 1.38 (95% CI 
1.06-1.79); p=0.03), have a diagnosis of cardiac failure (RR 1.02 (95% CI 0.9 
to 1.043); p=0.04) or to be Diabetic (RR 1.1 (95% CI 1-1.185); p=0.03).  Aside 
from age, perioperative demographics, types of surgery and analgesic 
techniques were similar between normal and PAD groups (Table 4-5).   
 
0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30
0
50
100
150
Days%elapsed
N
um
be
r o
f v
al
ue
s
		  169 	
 
Parasympathetic Autonomic Dysfunction and Surgical Outcome  
	
	 	
In the UCLH cohort, similar numbers of patients with and without PAD were 
taking Beta blocking medication (12% vs. 10%), however more were taking 
ACE inhibitors (16% vs. 23%), reflecting the increased likelihood of a 
diagnosis of hypertension.  Data was not available for other antihypertensive 
medications. 
 
 DHP 
Normal 
HRR  
(HRR>12) 
 
 
PAD  
(HRR≤12) 
 
 
 
P 
UCLH 
Normal 
HRR  
(HRR 
>12) 
 
 
PAD  
(HRR≤12) 
 
 
 
P 
Number (%) 153 (65.1) 82 (34.9%) - 576 (60) 235 (40%) - 
Age (years) 63.3 
(61-65) 
71.4   (68-
74) 
<0.001 59.8  
(58-61) 
66 
(64-68) 
<0.001 
Male (n,[%]) 91 (61%) 42 (51%) - 160 
(68%) 
235 (64%) - 
BMI 28.2  
(27.5-28.9) 
29 .3 
(28.6-29.7) 
0.06 26.6  
(26.2-
27.1) 
27.3 (26.5-
28.1) 
0.3 
RCRI (mode, 
range) 
1 (1-4) 1 (1-3) - 1 (1-4) 1 (1-4) - 
ASA grade (mode 
range) 
2 (1-3) 2 (1-3) - n/a n/a - 
Carcinoma (%) 51 49 - 46 46 - 
Pack Year History 
Smoking 
n/a n/a - 15.5 
(13.7-16) 
25 (23-27) <0.001 
Epidural (%) 45 55 - n/a n/a - 
Beta Blockers (%) n/a n/a - 12 10 - 
ACE inhibitors (%) n/a n/a - 16 23 - 
Nitrates (%) n/a n/a - 4 4  
Hypertension (%) n/a n/a - 32 45 - 
Angina (%) n/a n/a - 5 6 - 
Cardiac Failure (%) n/a n/a - <1 2.5 - 
Diabetes (%) n/a n/a - 8 18 - 
Table 4-5: Baseline demographic Characteristics for patients with and without 
Parasympathetic Autonomic Dysfunction (PAD).  Values shown are mean (95% 
Confidence Interval) unless otherwise stated.  P-values are for two-way ANOVA , ASA = 
American Society of Anesthesiologists grade.  BMI = Body Mass Index.  RCRI = Revised 
Cardiac Risk Index. n/a= not available.  
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4.5.4 Primary Outcome – Hospital Length of stay 
 
PAD was associated with prolonged hospital length of stay at both sites in 
those patients who subsequently underwent major surgery (Table 4-6).  The 
finding of prolonged length of stay in PAD at DHP was supported by an 
increased time until ready for discharge (PAD was associated with a five-day 
delay until assessment of readiness for discharge (p=0.001). 
 
 
 Derriford Hospital 
Plymouth (n=235) 
University College London 
(n=811) 
Characteristic: Normal 
HRR 
(HRR 
>12) 
PAD 
(HRR 
≤12) 
P value Normal 
HRR 
(HRR 
>12) 
PAD 
(HRR 
≤12) 
P value 
Length of stay (days) 
(mean, 95% CI) 
10  
(8-12) 
19 
(10-27) 
0.018 14  
(12-15) 
20  
(16-23) 
0.0004 
Ready for Discharge (days) 
(mean, 95% CI) 
7  
(6.9-8) 
12  
(10-14) 
0.001 n/a 
 
 
n/a n/a 
Table 4-6: Primary Outcome:  Hospital Length of stay, divided by cohort. Values shown 
are mean (95% Confidence Interval) or median (range). P-values are for ANOVA for means. 
 
PAD remained associated with prolonged hospital length of stay when data 
from both sites were combined (combined 12 ± 11 days (9-16) vs. 8 ± 5 days 
(6-8.5), p=0.01) in those patients who subsequently underwent major surgery 
(unadjusted Hazard Ratio 1.48 (95% CI: 1.15-1.95); p=0.0027) (Table 4-7, 
Figure 4-3).   
 
 Normal HRR 
(HRR >12) 
PAD 
(HRR ≤12) 
P value 
Length of stay 
(days) (mean, SD, 
95% CI) 
8 ± 5 (6-8.5) 12 ± 11 (9-16) 0.001 
Table 4-7: Primary Outcome:  Hospital Length of stay, both cohorts combined. Values 
shown are mean (95% Confidence Interval) or median (range). P-values are for ANOVA for 
means, Mann-Whitney for Medians. 
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Figure 4-3: Increased postoperative length of stay in Parasympathetic Autonomic 
Dysfunction (A: DHP Only; B: UCLH Only; C: DHP and UCLH cohorts combined).  Log-
rank (Mantel-Cox) test: DHP p=0.018, UCLH p=<0.001, combined p=0.0027.  DHP= Derriford 
Hospital Plymouth, UCLH – University College London Hospitals. 
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4.5.5 Length of hospital stay by quartile of heart rate recovery 
 
In order to assess whether a heart rate recovery of <12 bpm best reflects 
increased risk of postoperative morbidity, hospital length of stay data from 
UCLH was categorised according to quartile of heart rate recovery. 
 
A heart rate recovery of <12 bpm remained the best predictor of increased 
hospital length of stay (ANOVA p=0.005, Bartlett’s test for homogeneity of 
variances p=< 0.001). 
 
Length of stay 
(days) 
Quartile 1:  
HRR <12  
bpm 
Quartile 2: 
HRR 12-17 bpm 
Quartile 3: 
HRR 17-27 bpm 
Quartile 4: 
HRR >27  
bpm 
Mean 20 14 15 13 
Median 11 (7-21) 9 (5-16) 8 (5-14) 8 (5-14) 
95% CI of mean 16-23 12-16 12-18 10-15 
Table 4-8: Primary Outcome:  Hospital Length of stay (days), UCLH classified by 
quartile of heart rate recovery. Values shown are mean (95% Confidence Interval) or 
median (interquartile range). P-values are for ANOVA for means, Mann-Whitney for Medians. 
 
There was no reduction in hospital length of stay between the second and 
fourth quartiles of heart rate recovery after exercise (p=0.5).  Between the first 
and fourth quartile there was a one-week difference in mean length of stay 
and a three-day difference in median length of stay (p=< 0.01) (Table 4-8, 
Figures 4-4 & 4-5). 
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Figure 4-4: Mean (SD) length of stay (days) classified by quartile of heart rate recovery. 
* represents a P-value of  <0.001 (ANOVA). 	
 
Figure 4-5: Length of hospital stay classified according to quartile of preoperative 
heart rate recovery.  A heart rate recovery of <12 remains the best predictor of increased 
hospital length of stay (Log-rank (Mantel-Cox) test for trend: p=<0.001). 
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4.5.6 Does anaerobic threshold independently predict an increased 
hospital length of stay? 
 
For these analyses, the UCLH cohort was chosen.  This was in order to avoid 
the possible effects of inclusion in the COMPETE-C study (DHP).  The 
inclusion criteria of COMPETE-C precluded inclusion of patients with a range 
of relevant AT’s.  
 
An anaerobic threshold of <11 was also predictive of an increased hospital 
length of stay (Hazard Ratio (Mantel-Cox): 1.28 (95% CI: 1.14-1.49); 
p=0.0002) (Figure 4-6, Figure 4-7). 
 
 
 
 
Figure 4-6: Increased postoperative length of stay with a preoperative anaerobic 
threshold (AT) of <11 ml.kg.min (University College London Hospitals). Log-rank 
(Mantel-Cox) test p=0.0002). 
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Figure 4-7: Both an abnormal heart rate recovery and an anaerobic threshold (AT) of 
<11 ml.kg.min are predictive of increased hospital length of stay (data from University 
College London Hospitals cohort). 
 
After analysing only patients with an anaerobic threshold of <11, PAD 
remained predictive of a prolonged length of hospital stay (Hazard Ratio 
(Mantel-Cox): 1.3 (95% CI: 1.1-1.7); p=0.013) (Figure 4-8). 
 
 
Figure 4-8: Postoperative length of stay remains increased in Parasympathetic 
Autonomic Dysfunction when anaerobic threshold (AT) is controlled for (University 
College London Hospitals cohort). Log-rank (Mantel-Cox) test: p=0.013. 
The presence of both PAD and an AT of <11 were most strongly predictive of 
a prolonged hospital length of stay when compared with patients with normal 
HRR (HR 1.5 (Mantel-Cox) (95% CI: 1.3-1.8; p=<0.0001) (Figure 4-9) 
(supplemental materials). 
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Figure 4-9: An increased postoperative length of stay is most strongly predicted by an 
anaerobic threshold of <11 ml.kg.min-1 and PAD (University College London Hospital 
cohort). Log-rank (Mantel-Cox) test: p= <0.0001. 
 
4.5.7 Cox Proportional Hazards Model  
 
Cox proportional hazards analysis indicated that PAD was independently 
associated with delayed hospital discharge (HR: 1.22 (95% CI 1.19-1.55); 
p=0.002).  Age and an anaerobic threshold <11 ml.kg.min-1 were also 
independently associated with delayed discharge (p=0.003 and 0.004 
respectively; Table 4-9) 
 
 Hazard Ratio 95% Confidence 
Interval 
Wald  
Test 
p-value 
Heart rate recovery 
<12 bpm 
1.22 1.19-1.55 10 0.02 
Age 1.07 1.01-1.13 9 0.03 
Anaerobic 
Threshold <11 
ml.kg.min-1 
1.19 1.12-1.26 8.3 0.04 
BMI 1.01 0.99-1.03 0.57 0.45 
RCRI ≥3 1.13 0.97-1.29 0.64 0.43 
Table 4-9: Cox Proportional Hazards Model. BMI = body mass index, RCRI= revised 
cardiac risk index. 
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4.5.8 Secondary Outcomes – Morbidity and Mortality 
 
Clavien-Dindo grades and bowel function data were collected at DHP only. 
 
4.5.8.1 Clavien-Dindo grade 
 
Prospectively gathered morbidity data demonstrated a greater likelihood of 
major complications in the PAD group (Clavien-Dindo Score >3) in the 
postoperative period (RR: 1.75 (95% CI: 1.16-2.66; p=0.044).  Postoperative 
complications were associated with a failure to be fit for discharge and 
therefore prolonged hospital stay (Log-rank (Mantel-Cox) test p=0.0001).  
Patients with preoperative PAD were more likely to require further critical care 
following initial postoperative discharge (OR 2.9 (95% CI: 1.1 -8.8; p=0.05)).  
This was not attributable to reoperation, rates of which were similar between 
groups (p=0.78). 
 
4.5.8.2 Return of bowel function 
 
Postoperative ileus (no return of bowel function at 5 days) was also more 
likely in PAD (HR 1.4 (1.03-2.1), Mantel-Cox log rank p=0.0492).  The median 
time for return of bowel function after major colorectal surgery in patients with 
PAD was 3 days (2.3-4.1).  In those with normal heart rate recovery, median 
time for return of bowel function was 1.9 days (1.9-2.6) p=0.003) (Figure 4-
10). 
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Figure 4-10: Delayed Postoperative Return of bowel function in patients with 
Parasympathetic Autonomic Dysfunction.  Log-rank (Mantel-Cox) test: p=0.003. 
 
4.5.8.3 Postoperative sepsis and perioperative white cell counts in 
PAD 
 
Episodes of sepsis (sources: chest, urine, wound) were more common in 
patients with PAD (RR 1.3 (1.02-2.4), p=0.049).  
 
Postoperative white cell counts were higher at day 3 in PAD (15.9 (14.7- 
16.3)) as compared with patients with normal heart rate recovery (12.2 (10.5-
13.9); p=0.02).  Similarly, Neutrophil to Lymphocyte ratio on day 2, was raised 
in PAD (14.1 (12.5-15.4) when compared with patients with normal heart rate 
recovery (11.2 (10.3-12.2), p=0.05.  
 
Preoperative Neutrophil to Lymphocyte ratios were not different between 
groups (Table 4-10). 
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 Normal HRR 
N=576  
(HRR >12) 
PAD  
N=235 
(HRR ≤12) 
P-value 
Preoperative White Cell 
count (x109/L) 
10.76 (10.5-11.1) 11.09 (10.5-11.7) 0.3 
Day 3 Postoperative 
White Cell Count (x109/L) 
12.2 (10.5-13.9) 15.9 (14.7-16.3) 0.02 
Preoperative 
Neutrophil:Lymphocyte 
Ratio 
3 (2.8 – 1.3) 3.4 (3 – 3.7) 0.16 
Day 3 postoperative 
Neutrophil:Lymphocyte 
Ratio 
11.2 (10.3-12.2) 14.1 (12.5-15.4) 0.05 
Table 4-10: Preoperative white cell counts and neutrophil:lymphocyte ratios for 
individuals with and without Parasympathetic Autonomic Dysfunction (PAD).  
University College London Hospital data. Values shown are mean (95% Confidence Interval) 
unless otherwise stated.  P-values are for ANOVA. 		
CRP was not different between PAD and normal groups preoperatively or on 
day 3 postoperatively (p=0.55 for day 3 CRP). 
 
 
 
Figure 4-11: Preoperative neutrophil: lymphocyte ratio (NLR) was not different between 
PAD and normal heart rate recovery groups. Data shown as mean + SD Postoperative day 
3 NLR was increased in PAD (p=0.05), as was total white cell count (p=0.02).  D0 = day 0, D3 
= postoperative day 3.  Count = Number x 109 cells/ml. 
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4.5.8.4 90 day mortality 
  
90-day mortality was increased in patients with PAD as defined by abnormal 
heart rate recovery when compared with individuals with normal heart rate 
recovery (RR 1.1 (1.01 to 1.41), p=0.008) (Table 4-11).   
 
Postoperative outcome:  Parasympathetic Autonomic Dysfunction (PAD) compared 
with normal heart rate recovery. 
90 day Mortality: Overall Mortality: 3% 
Normal HRR: 1% 
Abnormal HRR: 8% 
Relative Risk 1.1 (1.04 to 1.41) p = 0.008 
Any morbidity 
(Clavien-Dindo >3) 
Relative Risk 1.75 (1.16 – 2.66) p=0.044 
Sepsis Relative Risk 1.3 (1.02-2.4) p = 0.049 
Delayed return of 
bowel function (5 
days) 
 
Hazard Ratio 1.4 (1.03-2.1) p=0.0492 
 
Median return of 
bowel function 
3 days (0 to 9) (vs. 1.9 days (0 to 8) in normal HRR) 
Return to Critical 
Care 
Relative Risk 3.11 (1.6-6.07) p= 0.0003 
Table 4-11: Summary of postoperative outcome in Parasympathetic Autonomic 
Dysfunction.  Values shown are median (range) unless otherwise stated.  P-values are for 
Mann-Whitney test for Medians or Fisher’s exact test for proportions (90 day mortality, 
Clavien-Dindo defined morbidity, return to critical care), alpha <0.05 taken as significantly 
significant.  The Log-rank (Mantel-Cox) test was used to calculate a Hazard Ratio for return of 
bowel function within 5 days.   
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4.6 Discussion 
 
4.6.1 Key findings 
 
1. Parasympathetic Autonomic Dysfunction is common in the high-risk 
surgical population.  
2. Parasympathetic Autonomic Dysfunction is independently associated 
with increased postoperative morbidity, reflected in increased incidence 
of major complications, episodes of sepsis, delayed return of bowel 
function, increased hospital length of stay and increased mortality. 
 
 
4.6.2 Parasympathetic Autonomic Dysfunction is associated with 
morbidity across a variety of domains 
 
4.6.2.1 Parasympathetic Autonomic Dysfunction is common 
 
These data indicate that established parasympathetic dysfunction, as defined 
by impaired heart rate recovery after exercise testing, is common and 
associated with increased postoperative morbidity and mortality in individuals 
undergoing major colorectal surgery.   
 
The association of certain key co-morbidities with PAD is perhaps 
unsurprising.  Impaired heart rate recovery and autonomic dysfunction have 
been described in diabetes (Turker et al. 2013; Cheng et al. 2003; Sacre et al. 
2012), heart failure (Imai et al. 1994b; Nanas et al. 2006; Arena & Sietsema 
2011), hypertension (Best et al. 2014) and with increasing age (Shetler et al. 
2001; Trevizani et al. 2012), though there is some question as to whether 
impairment in the elderly is due to the increased likelihood of other 
confounding comorbidities (Darr et al. 1988; Dawson et al. 1999; Thayer et al. 
2010).  In all of these conditions, reduced heart rate recovery is independently 
associated with impaired outcomes. 
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Although impaired heart rate recovery after exercise has not frequently been 
described in hypertension; autonomic dysfunction, particularly baroreceptor 
dysfunction, is however common (Schroeder et al. 2003; Singh et al. 1998; 
Thayer et al. 2010; Thayer & Lane 2007). 
 
4.6.2.2 Parasympathetic autonomic dysfunction is associated with 
increased postoperative morbidity 
 
Hospital length of stay data was comparable with other similar surgical 
populations (Cohen et al. 2009) (Odermatt et al. 2015; Ma et al. 2011).   
 
PAD was associated with increased postoperative morbidity as reflected by 
an increased hospital length of stay in both cohorts studied.  In the DHP 
cohort, indirect support for an increase in morbidity causing an increased 
length of stay was provided by an observed delay in readiness for discharge 
in PAD. 
 
A heart rate recovery of <12 bpm appears to best predict impaired 
postoperative outcome.  Length of stay data did not reduce in a ‘dose 
dependent’ manner with more rapid reductions in heart rate. 
 
4.6.2.3 Is the increased length of stay noted in PAD due to 
association with other common comorbidities? 
 
The preoperative comorbidities associated with PAD, both in this study and in 
the general literature, (diabetes, congestive heart failure, hypertension) have 
all previously been associated with an increased incidence of postoperative 
complications (Khuri et al. 2005).   
 
However, a relative risk reduction of 36% for a prolonged hospital length of 
stay was noted in the absence of PAD in patients with a Revised Cardiac Risk 
Index of >3 (which accounts for age, diabetes mellitus and known ischaemic 
heart disease), when compared with patients with PAD, suggesting an 
independent role for PAD in the development of postoperative morbidity. 
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Indeed, when other known major contributors to increased postoperative 
length of stay were either excluded from analysis (Anaerobic Threshold), or 
included in a proportional hazards model (AT, RCRI, BMI, increased age), 
PAD remained the strongest independent predictor or impaired postoperative 
outcome.  When combined with a reduced AT (<11 ml.kg.min-1), the risk of 
adverse postoperative outcomes with PAD increased. 
 
4.6.2.4 Are the impaired outcomes seen in PAD secondary to 
reduced aerobic fitness? 
 
Reduced heart rate recovery and reduced heart rate variability are both 
associated with reduced aerobic fitness in otherwise healthy individuals. Both 
can be improved with aerobic training (De Meersman, 1993; Jin et al. 2005; 
Streuber, Amsterdam, & Stebbins, 2006; Trevizani et al., 2012).  The reduced 
anaerobic threshold noted in this study in individuals with PAD, at first 
assessment, supports these observations.   
 
However, the mean AT of 12.2 ml.kg-1min-1 recorded across all patients 
enrolled, regardless of heart rate recovery after exercise, is low and 
corresponds with a NYHA cardiac failure class of 1 (Hansen et al. 2012), 
suggesting that the entire population studied was aerobically deconditioned 
(The mean AT of 11.5 ml.kg-1min-1 seen in the PAD cohort corresponds to an 
NYHA class of 2, corresponding only with slight limitation of ordinary physical 
activity, and not falling below the commonly accepted prognositically 
important value in the perioperative period of 11 ml.kg-1min-1 (Older 2013)).  
 
On the other hand, the peak VO2 of 19.1 ml.kg-1min-1 recorded across all 
patients is age appropriate (the population median age being 67 years); 
Wasserman equation predicted VO2 max for this age group being:  19.7 ml.kg-
1min-1.  Peak VO2, described previously, was statistically different across 
between PAD patients and those with normal heart rate recovery, but 
practically the difference measured (2.2 ml.kg-1min-1) is likely to be 
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unimportant and could represent the age difference between groups (peak 
VO2 reducing with age and the PAD group being older).   
 
When combined with the observation that impaired heart rate recovery 
continues to be predictive of postoperative morbidity where a reduced AT 
(<11) is absent, and that the combination of a low AT with a low heart rate 
recovery further increases risk, PAD remains an independent risk factor for 
post-operative complications instead of simply mirroring reduced aerobic 
fitness. 
4.6.2.5 Delayed return of bowel function as a consequence of PAD 
 
Postoperative gastrointestinal dysfunction (PGID) has repeatedly been shown 
to increase hospital length of stay (Doorly & Senagore 2012; Iyer et al. 2009; 
Van Acht et al. 2010; Holte & Kehlet 2000b; Karmali et al. 2015) . 
 
The role of intact vagal activity in normal gastrointestinal function is well 
established (Hall & Guyton 2006).  Even under normal conditions, 
gastrointestinal vagal activity may be impaired in the perioperative period by 
circulating inflammatory mediators, commonly administered drugs (such as 
Propofol and morphine) and prolonged perioperative starvation (X. Wang et 
al. 2004; Schwartz 1983; Havel et al. 1992).  Reduced vagal tone in the 
postoperative period may delay restoration of normal gastrointestinal function 
(Lubbers et al. 2010).  Delayed return of gastrointestinal function secondary to 
vagal withdrawal occurs even in surgeries distant from the gastrointestinal 
tract (Karmali et al. 2015).  
 
Strategies to treat PGID through augmentation of vagal activity have included 
direct vagal stimulation and early administration of lipid rich feed (Lubbers et 
al. 2010) as well as sham feeding (which has been shown to beneficially 
modulate autonomic activity as measured by heart rate variability) (Karmali et 
al. 2015) and avoidance of morphine (Tu et al. 2014).  
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To date no study has been made of the influence of established PAD on 
postoperative gastrointestinal function, though a plausible role in the 
pathogenesis of PGID could be hypothesised.  Confirmation of this role is 
proffered by the recorded delay in resumption of bowel function in this study. 
 
4.6.2.6 The incidence of sepsis is increased in PAD, alongside 
alterations in neutrophil to lymphocyte ratio 
 
Many plausible mechanisms for immune dysregulation in PAD have already 
been put forward.  These appear to be supported by evidence for an 
increased likelihood of developing septic complications in the postoperative 
period in PAD.  Whilst no specific assays of white cell function were carried 
out in this study, circumstantial evidence derived both from the observations 
of increased GRK2 expression in circulating lymphocytes in PAD and from 
alterations in perioperative NLR, support the concept of immune dysregulation 
in surgical patients presenting with established vagal withdrawal.   
 
Though preoperative neutrophil to lymphocyte ratios were not different 
between cohorts, they were elevated in both patients with normal heart rate 
recovery and PAD as compared with population norms (Azab et al. 2014; 
Venkatraghavan et al. 2015). 
 
A low anaerobic threshold at preoperative CPET has been associated with a 
raised preoperative NLR, and down regulation of monocyte CD14+ 
expression, representing chronic inflammation.  Values for preoperative NLR 
seen here are equivalent to those seen in high risk patients as defined by low 
AT in a similar surgical context (Sultan et al. 2014). 
 
Postoperatively however, greater elevations in NLR were noted in individuals 
with PAD, reflecting acquired lymphopenia in these patients.  Perioperative 
acquired lymphopenia has been associated with global bioenergetic 
impairment as well as NLRP1 inflammasome activation and increased risk of 
postoperative infectious complications (Edwards et al. 2015). Whilst no 
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difference in CRP was noted between groups in the postoperative period, 
more subtle interrogation of perioperative inflammatory parameters are 
warranted by these findings.  
 
4.6.3 General Discussion  
 
Perioperative studies to date have been hampered by differences in 
measurement modality; focus on the severe autonomic dysfunction noted in 
diabetic neuropathy and lack of adequate preoperative characterization and 
baseline measurements of function prior to the onset of an acute stressor 
(surgery).  Specific study has not been made of the effects of established 
preoperative parasympathetic autonomic dysfunction on the development of 
postoperative complications.  Neither have any attempts been made to 
develop mechanistic explanations for negative outcomes that have been 
described beyond haemodynamic imbalances (Lankhorst et al. 2014).   
 
Mechanisms by which vagal withdrawal could result in immune and cardiac 
dysfunction are yet to be tested in the perioperative context.  Experimental 
studies in other contexts where vagal activity has been modulated have 
shown improved outcomes in various disease processes, including 
myocardial ischaemia, sepsis and ileus. (Pavlov & Tracey 2005; Saeed et al. 
2005; Kakinuma et al. 2005; Thayer et al. 2011). 
 
Vagal modulation in the perioperative period could help determine the 
contribution of PAD to the development of postoperative morbidity.  
Preoperative interventions such as exercise-based prehabilitation could be 
expected to improve baseline vagal tone.  Perioperative use of 
pharmacological vagal modulation and/or direct nerve stimulation may prove 
problematic due to the potential for off target effects and would need to be 
assessed carefully prior to use in a randomised controlled trial. 
 
 
		  187 	
 
Parasympathetic Autonomic Dysfunction and Surgical Outcome  
	
	 	
4.6.4 Significance of the findings 
 
These data provide an alternative explanation for the development of 
postoperative morbidity in certain high-risk patients undergoing major surgery.  
The presence of parasympathetic autonomic dysfunction in other medical 
populations has provided several potential therapeutic targets to reduce the 
risk of morbidity and mortality, which could translate to the perioperative 
period. 
 
Second, these data highlight a population of high-risk patients who may not 
be identified by current conventional methods of testing, but who are at risk of 
perioperative morbidity.  Identification of these individuals in the preoperative 
period could help identify those who warrant increased vigilance in the 
perioperative period. 
 
4.6.5 Study Strengths and limitations 
 
4.6.5.1 Strengths: 
 
The study was designed, powered and executed based on an a priori 
hypothesis generated by reference to published clinical and translational 
literature.  The use of two cohorts from different centres adds strength to the 
results.   
 
Primary and Secondary outcomes were defined before analysis.  Individuals 
blinded to the eventual outcomes carried out data collection.  Similarly, 
analysis of physiological data was also undertaken prior to analysis of 
outcomes data.   
 
The demographics of patients included in this study, as well as the 
postoperative course of the study population suggest generalizability of the 
results may be reasonable. 
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4.6.5.2 Limitations: 
 
This was an observational study where much of the data was retrospectively 
collated. 
 
The inclusion of patients enrolled in a clinical trial (COMPETE-C) may limit the 
strength of conclusions drawn.  However, steps were taken to minimise the 
impact of this on outcome data analysis where known confounders were 
excluded from analysis.  Furthermore, both patients who did and did not 
receive GDT were equally represented in both cohorts and the final outcome 
of COMPETE-C showed no benefit for GDT. 
 
Different management (e.g. use of critical care services) in patients who 
presented with a low Anaerobic Threshold at UCLH cannot be excluded. 
 
Full Morbidity data was not available from the UCLH site (Clavien-Dindo).  
Further useful information could be gleaned from prospective data collection 
of other risk and morbidity scores and analysis of morbidity data as time to 
become morbidity free.  This would avoid the ‘snap-shot’ nature of recording 
single worst morbidity scores. 
 
Length of stay, bowel function and mortality data do however seem to support 
the Clavien-Dindo findings.  
 
Full laboratory and medication history data was not available from the DHP 
site.  This was mitigated by subsequent collection and analysis of the UCLH 
data, after it had been established that length of stay was increased at DHP. 
 
No specific immune function assays were carried out to support the 
hypothesis that PAD is associated with immune dysregulation in surgical 
patients. 
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4.7 Conclusion and further work 
 
Established Parasympathetic Autonomic Dysfunction (PAD) is common in 
high-risk surgical patients and is associated with increased postoperative 
morbidity and mortality.  
 
Further work will focus on description of the physiological phenotype 
associated with high-risk surgical patients with PAD.  Interventional studies 
where parasympathetic withdrawal is targeted will determine both whether 
PAD is a mechanism and/or a modifiable risk factor for the development of a 
suite of postoperative complications. 
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5 Intraoperative	cardiac	function	in	Parasympathetic	
Autonomic	dysfunction		
5.1 Introduction 
 
Preoperative parasympathetic autonomic dysfunction (PAD), as defined by 
reduced heart rate recovery after exercise, is associated with reduced cardiac 
function at preoperative CPET and impaired postoperative outcomes.   
 
5.1.1 Global Oxygen Delivery and postoperative outcome 
 
Reduced cardiac output and therefore DO2 with resultant end organ 
hypoperfusion in the perioperative period are strongly implicated in the 
subsequent development of multi organ dysfunction (MODS) and consequent 
morbidity and mortality.  This has resulted in widespread adoption of goal 
directed therapy (GDT) protocols that specifically target increased cardiac 
output and DO2 with some success in reducing postoperative complications 
(Aya et al. 2013; Grocott et al. 2013; Lees et al. 2009b; Shoemaker 1988). 
 
However, in the COMPETE-C trial where intraoperative GDT (stroke volume 
optimisation) was targeted at aerobically fit  (AT >10.9 ml.kg.min-1) and unfit 
(AT <11 ml.kg.min-1) individuals, no additional benefit was conferred by GDT 
and indeed, patients in the ‘fit’ cohort suffered detrimental outcomes (Challand 
et al. 2012).   
 
These findings are relevant since cardiac output measures in COMPETE-C 
improved from the start to the end of the case in both GDT and standard fluid 
therapy (control) groups (more so in aerobically fit individuals).  Given that a 
large proportion of patients with a low AT in COMPETE-C also manifest PAD 
(47% vs.25% in the aerobically ‘fit’ group), it is possible that PAD could 
underlie the additionally impaired response to fluid resuscitation seen in the 
aerobically ‘unfit’ cohort.  When combined with other potential mechanisms for 
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impaired postoperative outcomes in PAD discussed in previous chapters, it 
could be hypothesised that PAD confounded any potential outcome benefit for 
GDT in aerobically unfit patients.  Similarly, given that 1 in 4 aerobically ‘fit’ 
patients in COMPETE-C demonstrated PAD, a potential influence on 
response to fluid resuscitation and outcome could be postulated in these 
individuals. 
 
The preoperative exercise phenotype in PAD results in reduced global oxygen 
delivery at peak exercise.  What cannot be determined from these findings, 
however, is whether this translates into impaired intraoperative cardiac 
performance. 
 
In order to explore the relationship between preoperative PAD and 
intraoperative cardiac performance, the intraoperative cardiac output data of 
the Derriford Hospital Plymouth (COMPETE-C) cohort was reanalysed 
stratified for heart rate recovery. 
 
 
5.1.2 Hypothesis 
 
Parasympathetic autonomic dysfunction identified at preoperative exercise 
testing is associated with impaired intraoperative cardiac performance. 
 
 
5.1.3 Aims 
 
This hypothesis was addressed by exploring the effect of preoperative 
parasympathetic autonomic dysfunction on the following primary and 
secondary outcomes: 
 
Primary: 
 
• Intraoperative cardiac output as measured by non-invasive cardiac 
output monitoring (the oesophageal Doppler). 
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Secondary: 
 
• Use of intraoperative vasopressor medication. 
• Intraoperative fluid administration. 
 
 
 
5.2 Methods 
 
5.2.1 Patient Population 
 
Patients scheduled to undergo major colorectal surgery were enrolled in the 
COMPETE-C study at Derriford Hospital Plymouth (DHP) as previously 
described (Chapter 3). 
 
Data available from this study was reanalysed based on preoperative heart 
rate recovery parameters.  Abnormal heart rate recovery was defined as 
previously as a heart rate recovery of <12 bpm at 1 minute after cessation of 
loaded exercise. 
 
Data derived from the COMPETE-C trial provided information on 
intraoperative haemodynamic changes in patients randomised to 
intraoperative oesophageal Doppler guided stroke volume optimisation or 
current standard of care fluid therapy.  Due to the confounding nature of a 
pneumoperitoneum on intraoperative haemodynamics and autonomic function 
(Odeberg et al. 1994; Gannedahl et al. 1996), laparoscopic procedures were 
excluded from analysis and only open colorectal surgery examined.   
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5.3 Results 
 
5.3.1 Group demographics 
 
Global demographic data for the DHP cohort are presented in Chapter 3.  
 
There were no differences in intraoperative fluid administration between 
groups.  Neither was there any difference in epidural allocation.  Allocation to 
GDT or standard of care fluid therapy was even between groups (Table 5-1). 
 
Intraoperative Physiology: Normal HRR 
(HRR >12) 
n=153 
PAD 
(HRR ≤12) 
n=82 
P-
value 
GDT allocation (%), 48 52 --- 
Total volume of Intraoperative 
fluid  administered (ml), 
(mean, SEM) 
2684 (2393-2974) 2706 (2276-3135) 0.9 
Urine output (ml kg-1 h-1) 1.97 (0.82-3.5) 1.93 (0.94-3.35) 0.8 
Epidural (%) 50% 49% - 
Table 5-1: Global characteristics of Normal Heart rate recovery (HRR) and 
Parasympathetic Autonomic Dysfunction groups (PAD).  Values shown are mean (95% 
Confidence Interval) unless otherwise stated.  P-values are for two-way ANOVA.  GDT = Goal 
Directed Therapy.   
 
5.3.2 Intraoperative Haemodynamic Parameters  
 
PAD was associated with reduced cardiac contractility as defined by peak 
velocity and reflected in stroke volume at both the start and the end of the 
operative case (Table 5-2).   
 
In both the PAD and the normal heart rate recovery groups, peak velocity had 
increased by the end of the case (Normal: p=<0.01, PAD: p=<0.01; two way 
ANOVA).  Peak velocity increased proportionately less in PAD than in 
individuals with normal parasympathetic autonomic function (20% increase in 
peak velocity in the normal heart rate recovery group at the end of the case 
vs. 13% increase in PAD, p=<0.05).   
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These changes in peak velocity were reflected in reduced stroke volume in 
PAD patients, both at the start and end of the case (25% increase in the 
control group vs. 9% in PAD, p=<0.05).   
 
No difference was seen in heart rate between the groups at any point.  At the 
end of the operation, both PAD and control groups had lower heart rates as 
compared with the start of the operation. 
 
Mean Arterial Pressure (MAP) was similar across groups at the start of 
surgery.  Though Flow Time Corrected (FTc: a measure of total peripheral 
resistance), whilst in the normal range for both at the start of surgery, was 
reduced in the PAD group suggesting increased afterload.  MAP dropped 
after induction of anaesthesia in both groups, but was more likely to drop a 
prognostically significant >20% in individuals with PAD (RR 1.4, (1.2-1.6) 
p=0.08) (Bijker et al. 2007). 
 
MAP at the end of surgery was reduced in both cohorts.  In PAD, MAP at the 
end of the operation was more likely to be a prognostically important <55 
mmHg than in normal patients (RR: 1.3 (1.09-1.4); p=0.03) (Walsh et al. 
2013).  
 
Cardiac index was globally preserved across both cohorts at both the start 
and the end of surgery, independent of the presence or absence of 
parasympathetic dysfunction (p=0.35).  However, patients with PAD were 
more likely to exhibit a drop in cardiac index at the end of surgery, despite 
fluid resuscitation than their comparators without PAD ((30% of patients with 
PAD exhibited a drop in CI vs. 15% of those with normal HRR) Fisher’s exact 
test: RR 1.26 (95% CI 1.05 to 1.5); p=0.006). 
 
PAD patients received an increased total intraoperative metaraminol dose 
(vasopressor) as compared to those with normal heart rate recovery (4.8 mg 
vs. 7.7 mg, p=0.001), though they were no more likely to receive metaraminol 
than those with normal HRR (76% vs. 78%, P=0.76 (Fisher’s exact test)).  
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18% of patients with PAD received a dose of metaraminol in excess of 10mg 
vs. 9% of those with normal HRR (OR 2.2 (95% CI 1.1 to 5.1); p=0.05). 
 
Intraoperative 
Physiology: 
Normal HRR 
(HRR >12) 
n=153 
PAD 
(HRR ≤12) 
n=82 
P-value 
Heart Rate at start 
of case (bpm), 
75 (72-77) 78 (74-82) 0.22 
Heart Rate at end 
of case (bpm), 
68 (66-70) 71 (67-74) 0.22 
MAP at start of 
case (mmHg) 
106 (102-109) 106 (102-110) 0.8 
MAP at end of 
case (mmHg), 
79 (76-80) 74 (71-76) 0.02 
Peak Velocity 
start of case cm/s 
66.1  (61.4-71) 55.6 (52-59) 0.003 
Peak Velocity end 
of case cm/s 
80.5 (75-85) 63.8 (59-68) <0.01 
Stroke Volume 
(ml) Start of case 
85.8 (81-91) 76.2 (71-81) 0.01 
Stroke Volume 
(ml) 
End of case 
113.6 (107-120) 86.4 (81-91) < 0.01 
FTc, (s)  
Start of Case 
356 (348-364) 342 (330-354) 0.05 
FTc (s) 
End of Case 
380 (373-386) 370 (360-381) 0.08 
Cardiac Index 
Start of Case 
3 (2.5-3.2) 
 
2.9 (2.5-3.1) 0.28 
Cardiac Index 
End of Case 
3.9 (3.7-4) 3.7 (3.4-4) 0.35 
Intraoperative 
Metaraminol (mg, 
(mean, SEM) 
4.8 (4-5.5) 7.7  (5.7-9.7) 0.01 
Table 5-2: Intraoperative Haemodynamic parameters in patients undergoing major 
colorectal surgery with and without Parasympathetic Autonomic Dysfunction (PAD).  
Values shown are mean (95% Confidence Interval) unless otherwise stated.  P-values are for 
two-way ANOVA. MAP = Mean Arterial Pressure FTc = Flow Time Corrected. 
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Normal Heart rate recovery        Heart rate recovery <12 bpm             
Figure 5-1: Impact of PAD on intraoperative cardiac performance. All comparisons 
made by two-way ANOVA. Data are presented as mean ± SD. Asterisk= P ≤0.05 
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5.3.3 The relationship between reduced anaerobic threshold (<11 
ml.kg.min-1) and intraoperative haemodynamic parameters  
 
Given that the results presented above indicate that PAD is associated with 
impaired intraoperative cardiac performance, and that PAD is associated with 
a reduced anaerobic threshold, I examined whether a prognositically 
significant anaerobic threshold of 11 ml.kg.min-1 alone would reproduce the 
same haemodynamic profile seen in PAD. 
 
No difference was seen in stroke volume, heart rate, blood pressure or total 
peripheral resistance between groups at any point intraoperatively (Table 5-
3).  At the end of surgery, cardiac contractility as represented by peak velocity 
appeared to be reduced in individuals with a low AT, though not to statistical 
significance. 
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Intraoperative 
Physiology: 
AT >11  
ml.kg.min-1  
AT <11 
ml.kg.min-1 
P-value 
Heart Rate at start of 
case (bpm), 
76 (75-80) 78 (74-80) 0.5 
Heart Rate at end of 
case (bpm), 
69 (67-72) 68 (66-70) 0.4 
MAP at start of case 
(mmHg) 
106 (103-109) 105 (103-108) 0.8 
MAP at end of case 
(mmHg), 
77 (75-79) 79 (77-81) 0.3 
Peak Velocity start of 
case cm/s 
64 (57-65) 61 (57-65) 0.3 
Peak Velocity end of 
case cm/s 
78 (72-83) 72 (66.5-76) 0.07 
Stroke Volume (ml) 
Start of case 
77 (72-81) 74 (71-76.6) 0.1 
Stroke Volume (ml) 
End of case 
93 (87-99) 91 (89-96)  0.9 
FTc, (s)  
Start of Case 
355 (347-364) 350 (343-358) 0.36 
FTc (s) 
End of Case 
379 (372-386) 375 (370-382) 0.44 
Cardiac Index 
Start of Case 
3.6 (3.4-3.8) 2.9(2.8-3.1) <0.001 
Cardiac Index 
End of Case 
3.9 (3.6-4) 3 (2.8-3.2) <0.001 
Table 5-3: Intraoperative Haemodynamic parameters in patients undergoing major 
colorectal surgery with and without an anaerobic threshold <11.  Values shown are 
mean (95% Confidence Interval) unless otherwise stated.  P-values are for two way ANOVA.  
GDT = Goal Directed Therapy.  MAP = Mean Arterial Pressure FTc = Flow Time Corrected. 
 
5.3.4 Intraoperative haemodynamic parameters in aerobically ‘fit’ and 
‘unfit’ patients with and without PAD 
 
Since a low anaerobic threshold alone did not reliably reproduce the 
haemodynamic profile noted globally in PAD, but was associated with 
reduced cardiac contractility at the end of surgery, I sought to confirm the 
association of impaired cardiac contractility with vagal withdrawal by 
examining the influence of PAD on intraoperative haemodynamics in 
individuals who were aerobically ‘fit’ (AT >11) and ‘unfit’ (AT 11). 
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In ‘unfit’ individuals, cardiac contractility, as represented by peak velocity and 
reflected in stroke volume, was again reduced in PAD as compared with 
normal HRR. (Table 5-4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intraoperative Normal HRR PAD P-value 
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Physiology: (HRR >12) 
(n=48) 
(HRR ≤12) 
(n=31) 
All data are from patients with a preoperative Anaerobic Threshold of < 11 
ml.kg.min-1 (Aerobically unfit) 
Heart Rate at start 
of case (bpm), 
75 (70-79) 78 (72-84) 0.4 
Heart Rate at end 
of case (bpm), 
65 (62-67) 70 (65-77) 0.06 
MAP at start of 
case (mmHg) 
106 (101-111) 104 (98-110) 0.6 
MAP at end of 
case (mmHg), 
80 (75-84) 83 (76-89) 0.5 
Peak Velocity 
start of case cm/s 
62.4 (53.6-71.2) 55 (49-59.7) 0.15 
Peak Velocity end 
of case cm/s 
73.5 (65.3-81.6) 60.5 (54.8-67.1) 0.03 
Stroke Volume 
(ml) Start of case 
73.8 (64-83.7) 63.3 (54.6-71.9) 0.04 
Stroke Volume 
(ml) 
End of case 
87.2 (78-96.2) 70 (60-80) 0.02 
FTc, (s)  
Start of Case 
349 (335.6-363) 338.3 (319-357) 0.4 
FTc (s) 
End of Case 
378 (366-389) 357.6 (339-376.5) 0.05 
Cardiac Index 
Start of Case 
2.9 (2.6-3.2) 2.8 (2.4-3.3) 0.8 
Cardiac Index 
End of Case 
3.7 (3.3-4) 3.4 (3-4) 0.4 
Table 5-4: Intraoperative Haemodynamic parameters in patients undergoing major 
colorectal surgery with and without Parasympathetic Autonomic Dysfunction (PAD). All 
patients in this analysis have an anaerobic threshold of <11 ml.kg.min-1.  Values shown are 
mean (95% Confidence Interval) unless otherwise stated.  P-values are for student’s unpaired 
t-test or ANOVA.  GDT = Goal Directed Therapy.  MAP = Mean Arterial Pressure FTc = Flow 
Time Corrected. 
 
 
Similarly, when only haemodynamic parameters in aerobically ‘fit’ individuals 
with an AT >11 were examined, a similar haemodynamic profile was 
produced in individuals with PAD of relatively reduced cardiac contractility at 
both the start and end of surgery (Table 5-5). 
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Intraoperative Physiology: Normal HRR 
(HRR >12) 
(n=80) 
PAD 
(HRR ≤12) 
(n=33) 
P-value 
All data are from patients with a preoperative Anaerobic Threshold of > 11 
ml.kg.min-1 (Aerobically fit) 
Heart Rate at start of case 
(bpm), 
75 (72-80) 79 (73-85) 0.33 
Heart Rate at end of case 
(bpm), 
70 (67-72) 70 (66-74) 0.9 
MAP at start of case (mmHg) 105 (101-109) 107 (102-113) 0.6 
MAP at end of case (mmHg), 78 (75-80) 76 (71-81) 0.5 
Peak Velocity start of case 
cm/s 
66.9 (61.3-72.2) 56.3 (51.7-61) 0.02 
Peak Velocity end of case 
cm/s 
82.3 (75.6-89.14) 65.9 (59.8-72) 0.005 
Stroke Volume (ml) Start of 
case 
80.3 (74-86.7) 67.6 (62-73) 0.02 
Stroke Volume (ml) 
End of case 
98.9 (90.8-107) 79.1 (71.8-86.4) 0.005 
FTc, (s) 
Start of Case 
360.3 (351.1-
369.5) 
343.1 (325.6-
360.6) 
0.06 
FTc (s) 
End of Case 
379.6 (372-387.1) 378.4 (362.7-
394.1) 
0.9 
Cardiac Index 
Start of Case 
3 (2.8-3.3) 2.8 (2.5-3.2) 0.2 
Cardiac Index 
End of Case 
3.9 (3.6-4) 3.9 (3.4-4.3) 0.97 
Table 5-5: Intraoperative Haemodynamic parameters in patients undergoing major 
colorectal surgery with and without Parasympathetic Autonomic Dysfunction (PAD). All 
patients in this analysis have an anaerobic threshold of >11 ml.kg.min-1.  Values shown are 
mean (95% Confidence Interval) unless otherwise stated.  P-values are for student’s unpaired 
t-test or ANOVA.  GDT = Goal Directed Therapy.  MAP = Mean Arterial Pressure FTc = Flow 
Time Corrected. 
 
Both PAD and a low AT were associated with reduced cardiac contractility, as 
represented by peak velocity, at the end of surgery.  However, the presence 
or absence of PAD had a greater influence on peak velocity than AT alone 
(Figure 5-2, Table 5-6).  PAD with a reduced AT was associated with the most 
severely impaired cardiac contractility (One way ANOVA p=<0.001). 
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Figure 5-2: Peak velocity (mean +/- sd) at the end of surgery classified according to 
presence or absence of PAD and/or aerobic fitness (Anaerobic threshold > or < 11 
ml.kg.min-1).  HRR: Heart rate recovery, AT: Anaerobic threshold (ml.kg.min-1), PAD: 
Parasympathetic Autonomic Dysfunction.  One way classical ANOVA, p=<0.001) 
 
 
 
Peak 
Velocity 
(cm/ond) 
Normal 
Heart rate 
recovery 
(>12 bpm) 
Aerobically 
‘Fit’:   
AT > 11 
ml.kg.min-1 
Aerobically 
‘Unfit’:  
AT ><11 
ml.kg.min-1 
PAD 
(HRR 
<12 bpm) 
PAD + 
Low 
AT  
Mean 80.5 77.7 71.1 63.8 61 
95% CI of 
mean 
75-86 72.4-82.9 66.5-75.8 59.5-68.1 55-67 
Table 5-6: Peak velocity (mean +/- sd) at the end of surgery classified according to 
presence or absence of PAD and/or aerobic fitness (Anaerobic threshold > or < 11 
ml.kg.min-1).  HRR: Heart rate recovery, AT: Anaerobic threshold (ml.kg.min-1), PAD: 
Parasympathetic Autonomic Dysfunction. 
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5.4 Discussion 
 
5.4.1 Key findings 
 
1. Cardiac Contractility and Stroke Volume were reduced in patients with 
PAD at start and finish of surgery. 
2. Mean Blood Pressure was reduced in PAD at the start and finish of 
surgery. 
3. Intraoperative heart rate was not affected by PAD at any time point 
intraoperatively.  
4. An Anaerobic Threshold of <11 alone was not sufficient to produce the 
same haemodynamic profile as PAD. 
5. An Anaerobic Threshold of <11 and PAD were associated with the 
greatest impairments in cardiac contractility.  
 
5.4.2 Discussion of Key findings 
 
Patients with PAD demonstrate a distinct intraoperative haemodynamic profile 
characterised by reduced cardiac contractility, increased total peripheral 
resistance as represented by a reduced FTc and intraoperative hypotension 
requiring increased vasopressor usage. 
 
This profile complements the findings of reduced oxygen pulse, reduced peak 
VO2 and hypertension noted in individuals with PAD at preoperative exercise 
testing. 
 
5.4.2.1 Cardiac Contractility 	
As discussed previously, an increasing body of evidence is accumulating to 
support a role for intact parasympathetic function in mediating increased 
cardiac contractility.  
 
PAD was associated with reduced Stroke Volume (SV) and peak velocity 
(representing cardiac contractility) at both the start and end of the operative 
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case.  Of note, whilst both groups demonstrated an increase in SV and 
contractility at the end of the case (perhaps reflecting both fluid resuscitation 
and increased sympathetic drive as a result of surgical trauma), individuals 
with PAD failed to significantly increase contractility when compared with 
individuals with intact parasympathetic function.  For most GDT protocols, a 
sustained increase in stroke volume of 10% is taken as marker of successful 
fluid resuscitation.  As a cohort, patients with PAD failed to increase stroke 
volume in response to fluid therapy by 10% from baseline implying that this 
group of patients might not benefit from standard stroke volume guided GDT 
protocols, but in fact might be at risk of fluid overload. 
 
5.4.2.2 Heart Rate 
 
Significantly, intraoperative heart rate at any time point intraoperatively was 
not different between groups.  Using conventional monitoring (Heart Rate 
alone), it would not be possible to distinguish between individuals with and 
without PAD, emphasizing the utility of flow based intraoperative monitoring.  
Similarly, heart rate alone would not distinguish reduced cardiac output in 
aerobically ‘fit’ and ‘unfit’ individuals. 
 
5.4.2.3 Blood Pressure 
 
Intraoperative hypotension is associated with PAD.  Patients with PAD 
received higher doses of intraoperative vasopressor to maintain MAP than 
their comparators, despite similar fluid doses. 
 
This finding of increased systemic vascular resistance is supported by 
observations in Sino Aortic Denervation (SAD), an animal model of 
neurogenic hypertension characterised by impaired afferent parasympathetic 
function, of increased total peripheral resistance (Rodrigues et al. 2011).   
 
Similarly, parasympathetic withdrawal and increased systemic vascular 
resistance are key features of human hypertension (Julius 1991; Berg & 
Jensen 2011; Shepherd 1990; Davis et al. 2012). 
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Sustained, or even increased afterload, represented by a reduced corrected 
flow time on oesophageal Doppler monitoring, suggest that reductions in 
intraoperative blood pressure in PAD are due to reductions in Stroke Volume 
rather than vasoplegia. 
 
Intraoperative hypotension has been described previously in global autonomic 
dysfunction (Mazzeo et al. 2011; Knuttgen et al. 1990; Latson et al. 1994; 
Huang et al. 2006) and is associated with impaired postoperative outcomes, 
including stroke, acute kidney injury, myocardial ischaemia and infarction, 
increased length of stay and 1-year mortality (Walsh et al. 2013; Bijker et al. 
2012; Tassoudis et al. 2011; Bijker et al. 2009).   
 
In routine clinical practice, where cardiac output monitoring is infrequently 
undertaken (Pearse et al. 2014), hypotensive episodes are treated with fluid 
or further vasopressors (both of which have been associated with adverse 
clinical outcomes).  In the PAD patients examined here, such interventions 
may not be rational and could even be detrimental by causing fluid overload 
and/or further impairments in cardiac output.  Preoperative evidence of PAD 
should trigger increased intraoperative vigilance for hypotension and 
potentially the use of invasive blood pressure monitoring as well as flow 
directed cardiac output monitoring. 
 
5.4.2.4 Reduced Anaerobic Threshold and intraoperative 
haemodynamic parameters 
 
Low anaerobic threshold may be associated with impaired perioperative 
outcomes through mechanisms other than impaired cardiac output.  It is 
possible that PAD, a common association with a low AT is one of these 
mechanisms. 
 
At preoperative exercise testing, PAD was associated with a reduced 
anaerobic threshold.  Indeed, a greater proportion of patients with PAD 
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demonstrated a prognostically important AT of <11 ml.kg.min-1 than those 
without (RR 1.26 (95% CI 1.1 to 1.6); p=0.02).  
 
In this cohort of surgical patients, an AT of <11 ml.kg.min-1 alone did not 
reproduce the same intraoperative haemodynamic findings as PAD.  
Furthermore, PAD produced the same distinctive haemodynamic profile in 
patients with an AT >11 ml.kg.min-1. 
 
PAD was associated with both a reduced oxygen pulse at preoperative CPET 
and reduced intraoperative contractility.  The greater reductions in 
preoperative oxygen pulse seen in PAD when compared with low aerobic 
threshold preoperatively appeared to translate into impaired contractility at the 
end of surgery, again suggesting that impaired heart rate recovery represents 
established vagal withdrawal rather simply global deconditioning.   
 
Unlike in PAD, individuals with a low AT exhibited a reduced cardiac index at 
both the start and end of the operative case as compared with controls.  This 
comparatively low cardiac index despite no difference in SV, MAP or heart 
rate may be explained by an increased BMI in the AT <11 cohort as cardiac 
output not indexed to body weight was similarly unchanged between groups.  
Importantly, the cohort with a low AT was able to significantly increase stroke 
volume from the start to the end of the case (by 20%), demonstrating fluid 
responsiveness not seen in PAD.   
 
Low cardiac output is thought to fuel the development of perioperative organ 
dysfunction through tissue hypoperfusion.  Augmentation of DO2 using GDT in 
patients with a low AT did not however reduce morbidity in this cohort of 
patients (Challand et al. 2012) or others (Lai et al. 2015).  Indeed, the POM-O 
trial (Ackland et al. 2015) reported that patients with a low AT were more likely 
to achieve a DO2 (100 ml.min-1) associated with reduced postoperative 
morbidity.  This finding is reflected in this patient cohort by an increase in SV 
from start to end case of 17% in patients with an AT <11 ml.kg.min-1, 3% less 
than those with an AT >11.   
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5.4.2.5 The implications of PAD on intraoperative cardiac output 
management 
 
Multiple studies have demonstrated the deleterious effects of impaired global 
oxygen delivery on post-operative outcome (Aya et al. 2013).  Reduced 
cardiac performance caused by PAD, manifested in a preoperative reduction 
in oxygen pulse, chronotropic incompetence, a reduced stroke volume and 
cardiac contractility associated with hypotension, intraoperatively could result 
in reduced tissue oxygen delivery, causing impaired tissue oxygenation and 
the triggering of the neuroimmune cascade that results in multiorgan 
dysfunction.   
 
Given that the individuals studied were enrolled in a negative goal directed 
therapy trial, PAD presents an alternative explanation for failure to improve 
outcomes.   
 
Vagal withdrawal in itself has been associated with deleterious effects on 
cellular REDOX status and microcirculatory function (Wei & Kaul 2004; Pavlov 
& Tracey 2012) which may further be compounded by impaired cardiac 
function. 
 
Neither microcirculatory parameters, nor markers of tissue hypoperfusion 
were available in this data set to test the assumption of tissue hypoxia 
secondary to reduced oxygen delivery.  These would be best examined in a 
prospective trial. 
 
Vagal innervation is cardioprotective during cardiac stress (Mastitskaya et al, 
2012), withdrawal of which may be one of several potential mechanisms 
explaining why cardiac contractility was impaired intraoperatively.  However, 
no evidence was recorded for overt cardiac ischaemic pathophysiology in the 
perioperative period.  It is possible, however, that subclinical ischaemic 
episodes, associated with intraoperative hypotension, could have contributed 
to the negative postoperative outcomes recorded (Devereaux et al. 2012).    
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Cardiac Troponin or other markers of cardiac ischaemia were not measured in 
the DHP cohort.  Patients with PAD in the UCLH cohort did undergo cardiac 
troponin testing as part of clinical care in the first postoperative day more 
frequently than those without, perhaps suggesting an increased clinical 
suspicion of perioperative myocardial ischaemia (though for both groups 
troponin testing was a rare occurrence.  RR 1.03 (1 to 1.05), p=0.02).  Future 
work may benefit from detailed recording of perioperative markers of cardiac 
ischaemia including pre and postoperative troponin and BNP. 
 
5.4.3 Significance of the findings 
 
Established parasympathetic autonomic dysfunction is associated with 
impaired intraoperative cardiac performance, characterised by a low stroke 
volume and cardiac contractility associated with a reduced blood pressure.  
 
The identification of PAD in the preoperative period, aside from providing 
pertinent information for assessment of preoperative risk, should prompt more 
rigorous monitoring or management of intraoperative haemodynamic 
parameters.  Consideration should also be given to increased vigilance in 
these individuals for markers of perioperative cardiac ischaemia. 
 
PAD may predict patients who will not respond in a conventional manner to 
goal directed stroke volume optimisation.  Flow based haemodynamic 
monitoring should be employed in these patients to minimise the impact of 
excessive fluid therapy and vasopressor usage. 
 
5.4.4 Study Strengths and limitations 
 
1) Strengths: 
- The study was designed and executed based on an a priori hypothesis 
generated by reference to published clinical and translational literature 
and evidence gained from prior experiments. 
- The study is the first to examine a relationship between preoperative 
established PAD and intraoperative cardiac performance 
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- The study is the first to examine a relationship between preoperative 
CPET derived measures of aerobic fitness and intraoperative cardiac 
performance. 
- The study is linked to robust clinical outcome measures. 
 
2) Limitations: 
- The retrospective nature of the study may limit the strength of the 
conclusions drawn. 
- The inclusion of patients from a trial studying intraoperative GDT may 
confound the results. 
- The relatively small numbers of patients enrolled in the study may limit 
the wider applicability of findings. 
 
5.4.5 Conclusion and further work 
 
Established Parasympathetic Autonomic Dysfunction (PAD) is associated with 
a distinct intraoperative haemodynamic phenotype consisting of reduced 
cardiac contractility and is associated with intraoperative hypotension. 
 
Future studies should be prospective and examine the effects of established 
PAD on intraoperative cardiac performance under controlled uniform 
conditions.  Attention should be paid to microcirculatory and cellular REDOX 
parameters, as well as perioperative markers of myocardial ischaemia.  
Specific attention should be paid to stroke volume optimisation based Goal 
Directed Therapy to identify whether PAD is detrimental to outcome.  In terms 
of the wider anaesthetic literature, attention should be paid to addressing the 
lack of direct correlation between preoperative CPET markers of aerobic 
performance and intraoperative cardiac performance. 
 
Therapeutic studies, where vagal activity is modulated in the perioperative 
period, could establish whether the cardiac phenotype noted in PAD is 
reversible and whether restoration of parasympathetic autonomic function in 
this context is protective.   
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6 Sympathetic	Autonomic	Hyperactivity	
 
6.1 Introduction 
6.1.1 Sympathetic autonomic hyperactivity is associated with 
impaired outcomes 
 
Sympathetic activation is central to an adaptive, coordinated 
cardiorespiratory, metabolic and immune response to infection and tissue 
injury.  Acute hyperadrenergic stimulation, such as that seen during acute 
mental stress (Priyadarshini & Aich 2012), exercise (Fattor et al. 2005) and 
surgery (Desborough 2000), is characterised by several fold increases in the 
levels of circulating catecholamines, an increase in heart rate and blood 
pressure, endothelial activation and rapid, parallel decreases in heart rate 
variability (Mazzeo et al. 2011; Reyes del Paso et al. 2013; Nunan, 
Jakovljevic, et al. 2010; Thayer et al. 2010). 
 
Excessive or inappropriate sympathetic activation can lead to pathological 
derangement and is a ubiquitous feature at the onset of critical illness.  During 
the development of critical illness, persistent sympathetic autonomic 
activation, characteristically associated with cardiac dysfunction and immune 
paralysis, is a potent driver for the development of multi-organ dysfunction 
(Ackland et al. 2015).  
 
Acute psychological stress, associated with increased sympathetic activity, 
alone can in susceptible individuals provoke excessive sympathetic outflow 
with resultant deleterious effects.  Excessive sympathetic activation due to 
mental stress directly causes impairment of cardiac regulatory mechanisms, 
contributing to the development of cardiac ischaemia and endothelial 
dysfunction (Yeung et al. 1991; Ghiadoni et al. 2000; Deanfield et al. 1984; 
Rozanski et al. 1988; Ramachandruni et al. 2006).  
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In a minority of apparently otherwise healthy individuals, the thought of 
vigorous exercise alone results in excess increases in heart rate (EHRi), 
representing sympathetic autonomic hyperactivity.  These individuals are at 
increased risk of sudden cardiac, and all-cause death (Jouven et al., 2010).   
 
This excessive heart rate increase prior to exercise is easy to measure, but 
has not been used to define perioperative sympathetic autonomic 
hyperactivity in surgical patients previously.   
 
In surgical patients, reduced heart rate variability, associated with sympathetic 
autonomic hyperactivity, has been associated with perioperative 
haemodynamic instability and prolonged postoperative myocardial ischaemia 
(Huang et al. 2006; Laitio et al. 2004).  It could therefore be hypothesised that 
individuals exhibiting preoperative sympathetic autonomic hyperactivity 
defined by excessive heart rate increase before exercise might be at greater 
cardiac risk in the perioperative period.  
 
Given the utility of heart rate dynamic measures recorded at the time of 
preoperative CPET in predicting PAD and its sequelae, I set out to investigate 
whether a similar approach could be used to identify established sympathetic 
autonomic hyperactivity in high-risk surgical patients.  I also attempted to 
identify whether individuals with sympathetic autonomic hyperactivity as 
defined by excessive heart rate increase prior to commencement of loaded 
exercise at preoperative CPET, demonstrated altered cardiac function and 
increased risk of myocardial ischaemia during exercise and in the 
perioperative period.  
 
 
6.1.2 Is sympathetic autonomic hyperactivity present in 
parasympathetic autonomic dysfunction? 
 
Parasympathetic autonomic dysfunction, acting through several mechanisms 
outlined previously, is associated with a distinct physiological phenotype and 
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impaired postoperative outcomes in higher risk patients presenting for major 
surgery.  
 
What is not clear, however, is the role, if any, of ‘unopposed’ sympathetic 
autonomic activity in PAD.  A raised resting heart rate and raised blood 
pressure, seen in PAD, are traditionally associated with increased 
sympathetic outflow.  Heart rate variability analysis in patients with abnormal 
heart rate recovery after exercise demonstrated reduced global heart rate 
variability, also associated with sympathetic autonomic hyperactivity.   
Similarly, evidence for raised GRK2 and Pan-Arrestin in circulating 
lymphocytes was suggestive of increased sympathetic autonomic activity and 
renal-angiotensin-aldosterone system activation.  Reduced heart rate 
recovery itself may not always represent reduced parasympathetic activity 
alone, especially where ‘severe’ exercise has been undertaken (Buchheit, 
Laursen, et al. 2007). 
 
Autonomic activity is often described as a balance between sympathetic and 
parasympathetic function; both limbs of the ANS having unique yet 
complementary roles in homeostasis.  Whilst the two systems clearly interact, 
it does not automatically follow that parasympathetic withdrawal results in 
sympathetic autonomic hyperactivity, or that excessive sympathetic activation 
is always associated with chronic parasympathetic withdrawal.   
 
In animal models of baroreceptor dysfunction, where PAD is produced by 
surgical baroreceptor deafferentation (sinoaortic denervation or SAD, 
analogous to the baroreceptor dysfunction described in PAD), after an initial 
increase in blood pressure and heart rate, accompanied by increased 
circulating levels of catecholamines, (Cornish & Gilmore 1985; Schreihofer & 
Sved 1994) blood pressure and heart rate tend to normalise in the long term, 
to be replaced by blood pressure debuffering at times of stress (Norman et al. 
1980), accompanied by spiked increases in catecholamine production and 
sympathetic autonomic outflow (Cornish & Gilmore 1985; Schreihofer & Sved 
1994).   
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Chronic SAD is associated with reduced heart rate variability, diastolic 
dysfunction and reductions in the high frequency and very low frequency 
components of frequency domain measures of HRV, with an increase in the 
low frequency component.  These changes represent sympathetic 
hyperactivity associated with vagal withdrawal (Moraes-Silva et al. 2010).  It is 
highly possible that this phenotype would be reflected in patients with PAD. 
 
6.2 Primary Hypothesis 
 
Exaggerated heart rate rise prior to the onset of vigorous exercise 
(Cardiopulmonary Exercise Testing) is associated with electrocardiographic 
evidence of myocardial ischaemia. 
 
 
6.3 Aims 
 
This hypothesis was addressed by exploring the effect of preoperative 
sympathetic autonomic dysfunction on the following primary and secondary 
outcomes: 
 
 
Primary: 
• Electrocardiographic evidence of myocardial ischaemia in lead II during 
Cardiopulmonary Exercise Testing. 
Secondary: 
• Preoperative Exercise Physiology. 
• Intraoperative Cardiac Physiology. 
• Post operative outcome as defined by length of hospital stay (LOS). 
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6.3.1 Secondary Hypothesis: 
 
Parasympathetic Autonomic Dysfunction as defined by abnormal heart rate 
recovery after exercise is associated with sympathetic autonomic 
hyperactivity. 
 
 
6.4 Methods 
 
6.4.1 Patient Population 
 
 
Two cohorts at separate centres were studied before planned elective 
surgery.  Patients scheduled to undergo major colorectal surgery were 
enrolled as previously described at Derriford Hospital Plymouth (DHP) and 
University College London Hospitals (UCLH) having obtained IRB approval 
(MREC: 11/H0805/58).  Informed written consent was obtained from patients 
undergoing preoperative CPET as routinely requested by their clinical teams 
prior to major elective surgery.  Inclusion criteria were any surgical patient 
referred for preoperative CPET.  Exclusion criteria were according to 
American Thoracic Society guidelines (Weisman et al. 2003).   
 
6.4.2 Cardiopulmonary Exercise Testing (CPET) 
 
All patients enrolled underwent routinely requested maximal, incremental, 
symptom limited CPET prior to surgery.  The full protocol for CPET is in 
General Methods.  Figure 6-1 illustrates the phases of the CPET protocol.  As 
before, patients were acclimatised by sitting on the cycle for 3 minutes prior to 
the start of exercise.  During this period, baseline readings were recorded.  
Patients then undertook 3 minutes of zero load pedalling, prior to the initiation 
of ramped exercise.  Non-invasive blood pressure was taken at the start and 
end of the exercise test.   
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Heart rate increase was assessed as the difference between the heart rate at 
rest and the heart rate measured just before starting ramped loaded pedalling 
after 3 minutes of 0 Watt exercise. 
 
6.4.3 Intraoperative Haemodynamics 
 
As previously described, patients enrolled in the COMPETE-C trial at DHP 
underwent intraoperative cardiac output monitoring using the oesophageal 
Doppler monitor (see Chapter 11). 
 
 
 
 
 
Figure 6-1: EHRi was calculated during unloaded pedalling prior to ramped exercise 
 
 
Anaerobic Threshold and other physiological markers of exercise 
performance were measured as previously described. 
 
6.4.4 Exercise evoked ischaemia 
 
ST-segment depression was captured in lead II, as this lead is most easily 
obtained with conventional monitors and reflects the majority of ischaemic 
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events in the general population.  The nadir value at any time during exercise 
testing was taken to represent the most significant cardiac ischaemia. 
 
ST changes in this lead were defined as abnormal when ST depression of 0.1 
mV (1mm) or more occurred (Lurati Buse et al. 2009).  In order to control for 
the effects of dynamic heart rate changes on the ST segment during exercise, 
the ST-heart rate (ST/HR) index was calculated: 
 
ST nadir (mV) 
Heart Rate Gradient 
 
Atrial and/or ventricular dysrhythmias, including ectopic beats, were also 
noted.  
 
6.4.5 Sample Size and Statistical Analysis 
 
Using the definition of myocardial injury reported in the VISION study (Botto et 
al. 2014), where around 8% of patients who had undergone non-cardiac 
surgery developed myocardial injury, it was estimated that significant ST 
depression would occur in around twice the number of patients with EHRi.  
Having established a prevalence of 43% in the Plymouth derivation cohort, at 
least 900 patients would be required to sufficiently power the study (alpha 
0.05; power 80%).  
 
6.5 Results 
 
6.5.1 Patient Clinical and demographic variables 
 
Clinical and demographic variables were as described for the entire study 
population and are described in Chapters 9 and 10.  1,052 patients were 
recruited across both centres. The Heart Rate data was not recorded in three 
patients where technical error resulted in lost data. 
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6.5.2 Frequency Distribution Statistics 
 
Heart rate increase was distributed into quartiles.  Excess Heart Rate Rise 
was defined as an exaggerated heart rate rise of ≥15 bpm based on the cut 
off for the upper quartile for combined UCLH and DHP data (Table 5-1, Figure 
5-2).  This value was slightly higher than previous data showing an 
association between stress-evoked heart rate changes before the onset of 
exercise (≥12)(Jouven et al. 2009), but may reflect the effects of even the 
minimal physical activity caused by zero load cycling on heart rate (a small 
minority of patients achieved anaerobic threshold even during this light 
exercise).  Changes in heart rate during acclimatisation to the cycle ergometer 
were similar between centres. 
 
 
Descriptor UCLH DHP Combined 
Total Number of values 817 232 1049 
Total Number of excluded values: 0 0 0 
75% Percentile HRi (bpm): 15 16 15 
Median HRi (bpm): 9 (8-9) 10 (9-11) 9 (8-10) 
25% Percentile HRi (bpm): 5 5 5 
Maximum HRi (bpm): 81 63 81 
Mean HRi (95% CI) (bpm): 11  
(10 – 11.5) 
12  
(10.5 – 13) 
11  
(10.4-11.7) 
D’Agostino & Pearson omnibus normality 
test (alpha 0.05) 
No  No No 
Table 6-1: Frequency Distribution Statistics for Excessive Heart Rate Increase (EHRi), 
cohorts 1 & 2 (University College London Hospital: UCLH, Derriford Hospital Plymouth: 
DHP).  HRi= Heart Rate increase prior to loaded exercise during unloaded pedalling.  BPM= 
Beats per minute.   
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Figure 6-2: Distribution of changes in heart rate prior to loaded exercise. The 75% 
Percentile is marked and taken as representing an excessive heart rate increase (EHRi).   
 
6.5.3 Baseline Patient Clinical and demographic variables Stratified 
by Heart Rate Increase prior to exercise 
 
 UCLH DHP 
 Normal 
(HRi <15) 
EHRi 
(HRi ≥15) 
 
P 
Normal 
(HRi <15) 
EHRi 
(HRi ≥15) 
 
P 
Number (%) 626 (77%) 192 (23%) - 133 
(57.3%) 
99 
(42.7%) 
- 
Age (years) 60 (59-61) 65 (63-67) <0.001 65 (63-68) 67 (65-70) 0.68 
Male (n,[%]) 452 (73%) 83 (43%) - 87 (65%) 44 (46%) - 
BMI (kg/m2) 27 (26-28) 28 (27-29) - 27 (26.7-
28.2) 
29 (28.2-
30) 
- 
RCRI >2 (%) 5% 6% - 2% 2% - 
ASA grade  n/a n/a  2 (1-3) 2 (1-3)  
Malignancy 
(%) 
46% 46% - 77.4% 75% - 
Beta 
Blockers (%) 
12.5% 12.6% -  
Calcium 
Channel 
Blocker (%) 
5% 6% - 
Hypertension 
(%) 
33% 54% - 
Diabetes (%) 10% 10%   
Table 6-2: demographics for both cohorts, stratified by heart rate change during 
unloaded cycling (zero workload) of patients acclimatised to the exercise bike 
conditions.  Values shown are median (95% CIs) unless otherwise indicated.  Data analysed 
by ANOVA or Fisher’s exact test.  ANOVA = analysis of variance; EHRi= Excess Heart Rate 
Increase; HRi= Heart Rate increase; N=number; bpm= beats per minute; BMI= Body Mass 
Index (kg/m2); RCRI= Revised Cardiac Risk Index; ASA= American Society of 
Anesthesiologists grade; bpm= beats per minute.   
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In the UCLH cohort, patients exhibiting EHRi were slightly older.  This was not 
the case in the DHP cohort.  In both cohorts, proportionately more females 
exhibited EHRi than males.  Body Mass Index, use of cardiovascular drug 
therapy, and ASA were similar between and within groups. 
 
There was no relationship found between EHRi and the Revised Cardiac Risk 
index (relative risk of RCRI >2 1.00 (95% CI 0.77 to 1.29); p=0.98) or in the 
DHP cohort an ASA grade >2 (RR 0.9 (95% CI 0.68 to 1.35; p=0.95). 
 
 
6.5.4 Primary Outcome: Exercise Evoked Ischaemia 	
 
Continuous ECG recordings revealed an increased relative risk of developing 
significant ST depression (<1 mm) at any time during exercise in individuals 
with EHRi (RR: 1.7 (95% CI 1.3 to 2.1); p=,0.001).  Similarly, EHRi was 
associated with a greater risk of demonstrating a prognostically significant 
ST/HR index of >1.6  (RR 1.3 (95 % CI 1.1 to 1.4); p= <0.01).   
 
EHRi was not associated with exercise-evoked atrial and/or ventricular 
dysrhythmias (0 episodes of new atrial fibrillation in either group; 4 (1.4%) 
episodes of non-sustained VT in the EHRi group; 10 (1.5%) in the ‘normal’ 
group). 
 
EHRi was further associated with an increased risk of undergoing troponin 
testing at any point in the first 7 postoperative days (RR 1.03 (95% CI 1 to 
1.06); p=<0.03). 
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 Normal HRi EHRi p-value 
ST change (mm) -0.5 (-0.6 to -0.46) -0.7 (-0.8 to -0.55) 0.04 
ST/HR index  0.7 (0.6 to 0.8) 1.3 (1 to 1.5) <0.001 
Nadir ST segment > 
1mm 
 (RR: 1.7 (1.3 to 2.1) <0.001 
ST/HR index >1.6  RR 1.3 (1.1 to 1.4) <0.001 
Table 6-3: Exercise Evoked Ischaemia stratified by heart rate change during unloaded 
cycling.  Data are shown as mean (95% CI) for both cohorts.  Data are analysed by one-way 
ANOVA (Analysis of Variance). Fisher’s exact test used to calculate Relative Risk (RR).  HRi 
= Heart Rate increase; EHRi = Excess Heart Rate Increase.  	
6.5.5 CPET physiological and autonomic characteristics 
 
Neither resting, nor peak heart rates during exercise were associated with 
EHRi.  Consistent with hyper-adrenergic stimulation, blood pressure at rest 
was higher in patients with EHRi. Blood pressure recordings at peak exercise 
appeared unrelated to EHRi, though consequently the blood pressure rise 
recorded during exercise was lower in EHRi. 
 
Given the finding of an association between EHRi and ST-segment 
depression and an increased ST/HR index, compatible with myocardial 
ischaemia, an impaired cardiopulmonary reserve was expected. 
 
 Normal  EHRi p Value 
Pre-exercise 
Resting heart rate (bpm) 84 (82-85) 82 (80-84) 0.09 
Zero workload heart rate 
(bpm) 
90 (89-91) 107 (104-110) <0.001 
Heart rate change (bpm) 7 (7-9) 27 (24-26) <0.001 
Exercise 
Peak heart rate during 
exercise (bpm) 
138 (135-139) 139 (134-142) 0.45 
Heart rate gradient during 
exercise (bpm) 
54 (51-57) 56 (53-57) 0.6 
Table 6-4: CPET Heart Rate Data, stratified by heart rate change during unloaded 
cycling (zero workload) of patients acclimatised to the exercise bike conditions. 
N=number; bpm= beats per minute; Values shown are mean (95% Confidence Interval) 
unless otherwise stated.  P-values are for student’s unpaired t-test for means with Welch’s 
correction where standard deviations cannot be assumed.  Relative Risk and odds ratios 
calculated by Fisher’s exact test, Two-tailed, alpha <0.05 taken as statistically significant. 
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Figure 6-3: CPET Heart Rate Data, stratified by heart rate change during unloaded 
cycling (zero workload) of patients acclimatised to the exercise bike conditions. CPET 
= Cardiopulmonary Exercise Test; EHRi = Excess Heart Rate increase. BPM= beats per 
minute. Data analysed by one-way ANOVA.  Asterisk indicates statistical significance 
(p<0.05). 
 
 
Values for AT were not different between groups.  Peak VO2 and Oxygen 
pulse were both reduced in individuals with EHRi (oxygen pulse was reduced 
by around 6%).  Indeed, oxygen pulse, a robust surrogate for left ventricular 
performance, was less likely to meet age, gender and weight predicted norms 
in patients with EHRi (relative risk 1.26 (95% CI 1.14 to 1.39); p,0.001). 
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CPET Physiology: Normal HRi EHRi p-value 
AT (mean, 95% CI) 11.6 (11.38-11.85) 11.5(11-11.8) 0.5 
% of Predicted Peak VO2 (mean, 
95% CI) 
76% (74-77) 73% (70-75) 0.06 
Oxygen Pulse At AT ml.beat-1 
(mean, 95% CI) 
10.9 (10.16-11.1) 8.7 (8.3-9) <0.0001 
% of predicted Oxygen Pulse 
(mean, 95% CI) 
91%  (89-94) 85% (82-88) 0.002 
VE /CO2 at AT (mean, 95% CI) 30 (29-31) 31 (30-31_ 0.16 
Baseline SBP (mmHg): 144 (142 – 147) 157 (153- 161) 0.02 
Baseline DBP (mmHg): 83 (81 – 84) 86 (84 – 88) 0.02 
Peak SBP (Exercise, mmHg) 190 (186 -193) 192 (187 - 195)  0.22 
Peak DBP (Exercise, mmHg) 89 (86-92) 95 (88 – 102) 0.11 
Increase from baseline  
(SBP, mmHg) 
46 (43 – 49) 35 (31 – 38) <0.001 
Table 6-5: Cardiopulmonary exercise test (CPET) Physiological Data, stratified by heart 
rate change during unloaded cycling (zero workload) of patients acclimatised to the 
exercise bike conditions.) HRi = Heart Rate increase; EHRi = Excess Heart Rate Increase; 
bpm= beats per minute.  AT = Anaerobic threshold (ml O2 kg-1 min-1).  VO2 = Oxygen uptake 
(ml O2 kg-1 min-1).  Oxygen Pulse (, ml O2 beat-1). VE/VCO2 = ventilatory equivalents for 
Carbon Dioxide (Normal range 25-35).  SBP = Systolic Blood Pressure (mmHg); DBP = 
Diastolic Bood Pressure (mmHg).  Values shown are mean (95% Confidence Interval) unless 
otherwise stated.  P-values are for student’s unpaired t-test. 
 
6.5.6 Intraoperative Haemodynamic Parameters 
 
Patients with normal heart rate profiles and EHRi were distributed evenly 
across the two trial arms. Both groups received equivalent volumes of fluid 
and neither demonstrated an increased vasopressor requirement. 
 
 Normal 
(HRi <15) 
EHRi 
(HRi ≥15) 
 
P -value 
GDT allocation (%),  49 51  --- 
Intraoperative Fluid 
(ml), (mean,95% CI) 
2675 (2385-2966) 2732 (2303-3160) 0.8 
Intraoperative 
Metaraminol (mgs), 
(mean, 95% CI) 
5.5 (4.7 – 6.3) 5.5 (4.3-6.7) 0.9 
Table 6-6: Fluid and vasopressor therapy in patients undergoing major colorectal 
surgery stratified by heart rate change during unloaded cycling.  Values shown are 
mean (95% Confidence Interval) unless otherwise stated.  P-values are for one-way ANOVA.  
GDT = Goal Directed Therapy.  	
Heart rate after induction of anaesthesia was similar between groups.  There 
were no differences recorded in cardiac contractility (as measured by peak 
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velocity), stroke volume, baseline MAP or FTc after induction of anaesthesia 
between groups. 
 
By the end of surgery, mean MAP had reduced 5% more in patients exhibiting 
EHRi.  This was accompanied by both a relative increase in FTc, representing 
peripheral vasodilation, and a smaller increase in stroke volume, perhaps 
reflecting the reduced afterload (given that cardiac contractility was not 
measured as different between the cohorts).  Heart rate was relatively 
increased in the EHRi (Table 6-7). 
 
Cardiac Index was preserved throughout the operative period in both groups. 
 Normal 
(HRi <15) 
EHRi 
(HRi ≥15) 
 
P -value 
Heart Rate at start of case (bpm),  
(mean, 95%CI) 
75 (72-77) 78 (74-82) 0.22 
Heart Rate at end of case (bpm),  
(mean, 95% CI) 
68 (66-70) 80 (77-84) < 0.001 
MAP at start of case (mmHg), 
(mean, 95% CI) 
106 (102-109) 106 (102-110) 0.8 
MAP at end of case (mmHg),  
(mean, 95% CI) 
79 (75-83) 74 (69-79) 0.07 
FTc at start of case 349 (342-357) 358 (344-372) 0.24 
FTc at end of case 373 (366-379) 385 (373-400) 0.05 
Peak Velocity start of case cm/s 
(mean, 95% CI) 
62.3  (58.5-67) 62.2 (56.7-68) 0.2 
Peak Velocity end of case cm/s 
(mean, 95% CI) 
76.5 (71.6-81.3) 70.5 (63.5-78.2) 0.09 
Stroke Volume (ml) Start of case 
(mean, 95% CI) 
85.8 (81-91) 80 (74.5-85.5) 0.1 
Stroke Volume (ml) 
End of case 
(mean, 95% CI) 
110.6     
(105.4-117.6) 
88.1 (82.6-94) < 0.001 
 
Cardiac Index 
Start of Case 
3 (2.7-3.05) 2.9 (2.8-3.3) 0.3 
Cardiac Index  
End of Case 
4.0 (3.6-4.3) 3.7 (3.6 – 3.9) 0.3 
Table 6-7: Intraoperative Haemodynamic parameters in patients undergoing major 
colorectal surgery stratified by heart rate change during unloaded cycling.  Values 
shown are mean (95% Confidence Interval) unless otherwise stated.  P-values are for 
student’s unpaired t-test or ANOVA.  GDT = Goal Directed Therapy.  MAP = Mean Arterial 
Pressure, FTc – Flow Time corrected (seconds). 	
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Figure 6-4: Intraoperative Physiological Parameters stratified by heart rate change 
during unloaded cycling at time of preoperative exercise testing. All comparisons made 
by ANOVA. Asterisk denotes P ≤0.05. 
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6.5.7 Secondary Outcomes 
 
6.5.7.1 Hospital Length of stay 
 
EHRi was associated with an increased risk of a prolonged hospital stay 
(Table 6-8).  
  
 Normal 
(HRi <15) 
EHRi 
(HRi ≥15) 
 
P -value 
Hospital LOS (days) 8 (7-8) 9 (8.1-10) 0.0023 
Hazard Ratio: 
Hospital LOS 
N= 818 
HR 0.8 (0.6 to 0.9) HR 1.3 (1.1 to 1.5) 0.0003 
Table 6-8: Hospital Length of stay (mean, SD) stratified by heart rate change during 
unloaded cycling (zero workload) at time of preoperative exercise testing Values shown 
are median (95% Confidence Interval) unless otherwise stated.  P-values are for student’s 
unpaired t-test. The Mantel-Cox (Log-rank) test was used for calculation of Hazard Ratios. 
 
Figure 6-5: Hospital Length of stay stratified by heart rate change during unloaded 
cycling (zero workload) at time of preoperative exercise testing. Gehan-Breslow-
Wilcoxon log-rank test: n=818, p=0.0012 
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6.5.7.2 Relationship between PAD and Sympathetic autonomic 
hyperactivity (EHRi) 
 
There was no relationship between the presence of PAD and the likelihood of 
demonstrating EHRi (RR 1 (95% CI 0.92 to 1.1), p>0.9). 
 
The exercise and intraoperative phenotypes described in EHRi alone are not 
equivalent to those seen in PAD (Table 6-9). 	
Individuals who had both PAD and EHRi at preoperative exercise testing 
demonstrated significantly impaired oxygen pulse and aerobic performance 
when compared to PAD or EHRi alone and the entire study population. 
 
CPET 
Physiology  
Whole Study 
Cohort 
N=1052  
 
EHRi 
N= 315 
(HRi >15) 
PAD  
N=317 
(HRR ≤12) 
PAD + 
EHRi 
N=62 
P-value 
(ANOVA) 
AT (mean, 95% 
CI) 
11.5  
(9.5-13.5) 
11.5 
(11-11.8) 
11.1 
(10.6-11.6) 
10.39  
(9.8-10.9) 
<0.0001 
Peak VO2  
(mean, 95% CI) 
17.5 
 (14-21) 
16.6  
(14.3-17.9) 
15.2  
(14.8-15.8) 
10.5 
(8.8-12.1) 
<0.0001 
Oxygen Pulse 
(mean, 95% CI) 
10.9  
(9-13.5) 
8.7  
(8.3-9) 
10.6 
 (10-11) 
6.3 
 (5.2-7.4) 
<0.0001 
Table 6-9: Cardiopulmonary exercise testing (CPET) physiological and autonomic 
characteristics for individuals with and without Parasympathetic Autonomic 
Dysfunction (PAD) and/or Excessive Heart Rate increase (EHRi) before exercise.  
University College London and Derriford Hospital Plymouth data combined. AT = Anaerobic 
threshold (ml O2 kg-1 min-1).  VO2 = Oxygen uptake (ml O2 kg-1 min-1).  Oxygen Pulse (ml O2 
beat-1). Values shown are mean (95% Confidence Interval) unless otherwise stated.  P-values 
are for one-way classic ANOVA. 
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Figure 6-7: Oxygen Pulse (ml.O2.beat -1) classified according to presence or absence of 
PAD and/or EHRi.  Mean + SD.  UCLH data + DHP data combined. One-way classic ANOVA 
p <0.05  
 
 	
 All patients EHRi PAD 
 
PAD + 
EHRi 
P value 
Length of stay 
(days) (mean, 
SD) 
8 (6-16) 9 (7-10) 12 (9-16) 15 (12-19) 0.001 
Table 6-10: Hospital Length of stay stratified according the presence/absence of 
Sympathetic Autonomic Hyperactivity (EHRi), Parasympathetic Autonomic Dysfunction 
(PAD) or both. P-value is for one-way classic ANOVA. 
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6.6 Discussion 
 
6.6.1 Key findings 
 
1. Excessive Heart Rate increase (EHRi) prior to the commencement of 
loaded exercise was associated with electrocardiographic evidence of 
myocardial ischaemia.  
2. EHRi was associated with hypertension before exercise testing. 
3. EHRi was associated with impaired cardiac performance during 
exercise. 
4. EHRi was associated with reduced stroke volume and relative 
tachycardia at the end of surgery. 
5. EHRi was associated with an increased hospital length of stay. 
6. EHRi was not associated with parasympathetic autonomic 
dysfunction. 
 
6.6.2 Significance of the findings and discussion of results 
 
These data indicate that in surgical patients, the sympathetic autonomic 
response to unloaded pedalling during CPET is associated with an increased 
risk of myocardial ischaemia as well as impaired cardiac performance during 
exercise. 
 
6.6.2.1 Does EHRi represent mental stress? 
 
The excessive increases in heart rate noted in individuals with EHRi are likely 
predominantly due to mental stress and not due to physical exertion.  Despite 
the global lack of aerobic conditioning in the patient cohorts described, only a 
very small minority of patients achieved anaerobic threshold during the ‘warm 
up’ period of the test.  Similarly, anaerobic threshold itself was not different 
across cohorts, suggesting that aerobic conditioning did not play a major part 
in observed differences in CPET physiology.  Most pertinent, perhaps is the 
observation that peak heart rate did not differ between individuals with and 
without EHRi. 
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Data from other clinical circumstances have quite clearly demonstrated similar 
excessive heart rate increases with the thought of exercise alone and linked 
these to impaired cardiac outcome (Jouven et al. 2009).  A certain degree of 
anticipatory heart rate rise is expected prior to starting exercise, and is 
associated with physiological ‘preparation’ for the impending physical 
challenge (Hall & Guyton 2006).   
 
Mental stress related increases in heart rate and blood pressure have been 
associated with increased sympathetic activity.  Similarly, mental stress has 
been associated, in a variety of contexts, with reduced heart rate variability, 
increased low frequency power and reduced high frequency power (Dishman 
et al. 2000; Taelman et al. 2009; Boonnithi & Phongsuphap 2011). 
 
It is reasonably common for individuals to express anxiety about exercise 
testing, this anxiety being manifest in both trained and untrained individuals 
(O’Connor et al. 1995).  Further evidence for an excessive sympathetic 
response, likely due to mental stress, underlying the excess heart rate 
increase seen prior to loaded exercise comes from the observation of 
increased blood pressure in patients exhibiting EHRi prior to exercise.  This is 
despite no difference in the prevalence of hypertension in this group.  This 
anticipatory blood pressure rise has been linked to increased risk for the 
subsequent development of hypertension in middle aged men (Everson et al. 
1996).   
 
The population of surgical patients examined here consists overwhelmingly of 
older adults.  Late-life anxiety disorders and situational anxiety are common 
and rank amongst the ‘geriatric-giant’ disorders, being two times as prevalent 
as dementia among older adults and up to eight times more prevalent than 
major depressive disorders, resulting in significant impact on quality of life, 
morbidity, and mortality in this population (Hybels & Blazer 2003). 
 
It appears likely then, that mental stress plays a key part in the excessive pre 
exercise heart rate rise investigated here. 
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6.6.2.2 Is the high prevalence of females among the cohort with 
EHRi relevant?  
 
In this cohort of surgical patients, it is striking that the greater proportion of 
patients exhibiting EHRi were female.  There are two interacting reasons why 
this might be the case.   
 
Firstly, females demonstrate increased and different physiological responses 
to stress when compared with males from puberty onwards, possibly due to 
underlying differences in hypothalamic-pituitary-adrenal axis and autonomic 
nervous system function, influenced by gonadal hormones (Ordaz & Luna 
2012).  This translates to greater ‘cardiac’ or heart rate reactivity than males 
(who tend towards greater ‘vascular’ or blood pressure responses) when 
presented with a stressful situation (Allen et al. 1993). 
 
Second, excessive anticipatory heart rate rises are likely to reflect both 
increased anxiety and lack of experience of physical exercise in this cohort.  
Anxiety and anxiety disorders are, additionally, more common in females than 
males (Kessler et al. 2010). 
 
The greatest prevalence of physical inactivity reported is in adults over the 
age of 65 (66%), representing the same age group as these high-risk surgical 
patients.  In older adults, only 30% of older men and 15% of older women 
participate in any form of sustained regular physical activity (Schutzer & 
Graves 2004), potentially further increasing the likelihood of anxiety about 
exercising in females prior to formal exercise testing. 
 
In patients with chest pain referred for exercise testing, females are more 
likely to demonstrate higher anxiety scores at pre-test questionnaire (Rohani 
et al. 2011).  In the context of exercise testing in the diagnosis of chest pain, 
despite the lower likelihood of a test positive for myocardial ischaemia when 
compared with men, it is more likely for females referred for testing to 
demonstrate anxiety traits (Channer et al. 1985). 
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Despite the lower global likelihood of a positive diagnosis of ischaemic heart 
disease, amongst women referred with signs and symptoms of cardiac 
ischaemia, anxiety is predictive of increased cardiac symptom severity and 
greater healthcare utilisation costs (Rutledge et al. 2013).  Importantly, anxiety 
in women appears strongly predictive of the development of subsequent 
cardiac events (Rutledge et al. 2009). 
 
6.6.2.3 Mental stress and myocardial ischaemia 
 
Mental stress at rest has been strongly associated with evidence for 
myocardial ischaemia at the time of exercise testing.  Mental stress alone 
frequently elicits ECG changes associated with myocardial ischaemia (Wong 
& Freedman 1997; Deanfield et al. 1984), but not in all patients with known 
stable angina.   
 
Cardiac PET imaging studies in patients referred for exercise testing with 
known stable angina, however, demonstrate altered myocardial perfusion, in 
the absence of ECG changes (silent myocardial ischaemia), at times of 
mental stress in the majority of patients (Soufer et al. 2009; Deanfield et al. 
1984).  Patients known stable angina who develop silent myocardial 
ischaemia in response to mental stress exhibit abnormal myocardial perfusion 
and accompanying ST depression and angina after exercise testing 
(Deanfield et al. 1984). 
 
In the REMIT trial, reduced ventricular ejection fraction was recorded in at risk 
individuals susceptible to mentally evoked stress (W Jiang et al. 2013; Wei 
Jiang et al. 2013).  These changes have been paired with the observation of 
an increased peripheral vascular response where left ventricular afterload is 
increased during mental stress, mirrored by an increase in diastolic blood 
pressure in particular.  (W Jiang et al. 2013 a; W Jiang et al. 2013 b).  This 
peripheral vascular response is particularly predictive of the development of 
myocardial ischaemia and appears to be present in the individuals examined 
in this study. 
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Mental stress induced cardiac ischaemia is not limited to patients with 
demonstrable coronary artery occlusion.  Myocardial ischaemia provoked by 
mental stress appears to occur predominantly in coronary distributions in the 
absence of a flow limiting plaque; leading to the suggestion that mental stress 
may cause dynamic coronary obstruction (Legault et al. 1995).  This may be 
particularly relevant to the results from the Coronary CTA VISION study, 
where coronary occlusive load on CT angiography was poorly correlated with 
postoperative troponin leak.  This observation led the authors to conclude that 
several pathophysiological mechanisms for myocardial infarction could exist in 
the perioperative period (Sheth et al. 2015). 
 
Furthermore, aspects of the ischaemic cascade noted in individuals with 
mental stress induced cardiac ischaemia appear to occur at lower myocardial 
oxygen demand, relevant of course to the perioperative period (Burg & Soufer 
2014; Soufer et al. 2009; Krantz et al. 1996). 
 
Sympathetic hyperactivity secondary to mental stress can result in endothelial 
activation up to 90 minutes after the initiation of the stressor.  Excessive 
sympathetic stimulation can also cause extra-cardiac cellular injury (Barnes & 
Ackland 2010).  This would appear to be particularly relevant to the 
perioperative context, where pre-operative stress has previously been 
associated with impaired postoperative outcomes including pain (Heller et al. 
1984; Vaughn et al. 2007), intraoperative anaesthetic requirements (Kil et al. 
2012), postoperative nausea and vomiting (Van Den Bosch et al. 2005), 
cardiac complications including ischaemia and arrhythmias (Tully et al. 2011) 
and even mortality after cardiac surgery (Székely et al. 2001).   
 
In these high-risk surgical patients, a greater risk for exercise induced ST 
depression of >1 mm was noted.  In other, asymptomatic populations, ST 
depression to this degree has been identified as predictive of future cardiac 
events (Rywik et al. 2002). 
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6.6.2.4 Preoperative exercise testing and cardiac risk  
 
Although ST segment depression during exercise is well established as a 
marker of cardiac ischaemia, ST segment depression alone at preoperative 
exercise testing does not always correlate well with perioperative cardiac 
complications (Fleisher et al. 2014).   
 
The majority of studies examining preoperative exercise testing for prediction 
of cardiac risk have occurred in vascular patients as these patients are 
generally viewed as being at highest risk of postoperative ischaemic 
complications.  Study quality and study protocols have varied greatly, and 
patient outcomes in these studies are not thought to reflect current event rates 
(Fleisher et al. 2014).   
 
Data from some of these studies have suggested that the achievement of less 
than 75% to 85% of predicted maximal heart rate combined with ST segment 
depression of >1mm appears to be most predictive of post operative cardiac 
complications (Cutler et al. 1981).  However, in theses studies, ST/HR index 
was not used, the implications being that those individuals who did develop 
significant ST depression may have done so at lower heart rates. 
 
Exercise capacity remains the current greatest predictor of perioperative 
cardiac events, patients who can achieve 7 to 10 METs appearing at lowest 
risk, those performing <4-5 METs being at highest (Kertai et al. 2003).  As a 
discriminator in this study, this is unhelpful as the equivalent METs achieved 
by both groups (1 MET = 3.5 ml.O2.kg-1) are low (‘Normal’=4 METs, EHRi =3 
METs). 
 
Current ACC/AHA guidelines (Fleisher et al. 2014) suggest that it would be 
reasonable and useful for patients with poor exercise capacity (<4 METs) to 
undergo preoperative pharmacological stress testing.  In these patients, the 
presence of myocardial ischaemia is predictive of postoperative cardiac 
complications.  Stress echocardiography may be superior to both thallium 
imaging and electrocardiography at both identifying myocardial ischaemia and 
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predicting outcome.  Mental stress can be conceived as autologous stress 
testing.  Future work may focus on these more sensitive discriminators for 
myocardial ischaemia. 
 
6.6.2.5 Perioperative cardiac parameters and myocardial ischaemia  
 
In addition to electrocardiographic evidence of myocardial ischaemia, patients 
exhibiting EHRi demonstrated impaired cardiac performance at times of 
physiological stress.  A blunted oxygen pulse is a well-established marker of 
cardiac ischaemia (Belardinelli et al., 2003). 
 
Patients with EHRi demonstrated a significantly impaired oxygen pulse, not 
only when compared those without EHRi, but also when compared with the 
oxygen pulse recorded in the same population in PAD (10.9 vs. 10.6 (PAD) vs 
8.7 (EHRi).   
 
Similarly, despite comparable stroke volume and peak velocity after induction 
of anaesthesia, patients with EHRi had reduced values for these indices at the 
end of surgery.  It is possible that some of this deficit could be explained by 
undetected myocardial ischaemia.   
 
6.6.2.6 Potential implications for EHRi 
 
There are many clinical implications arising from this study.  Published 
literature, particularly the POISE trials (Devereaux 2008, 2012), supports the 
notion that a cohort of patients exists who may benefit from perioperative 
sympatholysis.  Currently, identification of precisely who will benefit the most 
is imperfect, and since the risks of post operative hypotension and CVA 
appear to outweigh the benefits of universal beta-blockade, it is possible that 
a population of patients who may benefit most from targeted, titrated beta-
blockade are being missed.   
 
Patients exhibiting EHRi who demonstrate apparently excessive sympathetic 
activity in response to stress could be postulated to be at greatest risk from 
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surgical stressors in the perioperative period.  Certainly in this cohort, an 
increased length of hospital stay was described, alongside a greater risk of 
being tested for myocardial ischaemia.  
 
6.6.2.7 Parasympathetic Autonomic Dysfunction and Sympathetic 
Autonomic Hyperactivity. 
 
The presence or absence or PAD appears to make no difference to the 
likelihood of exhibiting EHRi. 
 
Work presented in Chapter 9 of this thesis suggests that individuals with PAD 
are subject to sympathetic stress (raised GRK2 and Pan-Arrestin was 
described in these individuals).  These observations are combined with 
translational evidence for angiotensin II activation and impaired cardiac 
contractility in both animal and human models of PAD (Ackland et al. 2016). 
 
The exercise phenotype of EHRi alone was markedly different from that 
described in PAD.  Markers of cardiac ischaemia during exercise were more 
prominent in EHRi, as was impairment in oxygen pulse at peak exercise.  
Classical markers of aerobic fitness were not however significantly impaired 
when compared with control in EHRi, unlike in PAD.   
 
It is therefore likely that EHRi and PAD are describing different phenomena. 
EHRi appears to describe a group of individuals who respond to endogenous 
and exogenous stressors with an exaggerated sympathetic response.  
Sympathetic activity in PAD may be unopposed, elevated to compensate for 
cardiometabolic consequences of vagal withdrawal, or even possibly reduced.  
More subtle interrogation of autonomic parameters in patients with PAD 
defined by heart rate recovery is needed to differentiate between these states. 
 
These suppositions are supported by the description of a sub-group of 
patients with PAD who also demonstrate EHRi.  These individuals 
demonstrate markedly impaired performance at preoperative CPET, most 
strongly represented by a severely reduced oxygen pulse at peak VO2.  
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These patients appear also to be at an even greater risk of postoperative 
morbidity, represented by increased length of stay.  
 
It is conceivable that this at-risk group comprise individuals with PAD who 
also have a tendency towards sympathetic autonomic hyperactivity at times of 
stress.  Strong evidence supports the concept of a genetic influence on 
sympathetic activity, both in terms of heritable predisposition to anxiety 
disorders (Gordon & Hen 2004; Zavos et al. 2012) and on baseline 
sympathetic function (Zhu et al. 2005; Snieder et al. 2002).  The concept of 
genetic variation in adrenergic activity has been raised previously, and cited 
as a potential reason for variable effectiveness of perioperative beta blockade 
(Nagele & Liggett 2011).  These individuals comprise a population of patients 
who warrant further investigation.   
 
6.6.3 Study strengths and limitations 
 
Strengths of these data are that all analyses were performed blinded to both 
primary and secondary outcomes.  The description of EHRi in the context of 
perioperative CPET allowed thorough investigation and correlation with 
comprehensive physiological data that was not previously available in these 
individuals.   
 
Established biological plausibility for the phenomenon of EHRi and supporting 
observations in other medical contexts lends support to findings described in 
this chapter. 
 
The observational nature of the study, lack of intervention and lack of through 
autonomic and genetic phenotyping may limit more robust conclusions being 
drawn from this work.  Lack of granular information on the precise nature of 
postoperative complications in these patients is also missing. 
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6.6.4 Further Work 
 
Further work should focus on more thorough autonomic phenotyping.  This 
should include a thorough description of potential subtypes of autonomic 
dysfunction through a variety of alternate methodologies, including genetic.  
Translational work should focus on interventions to modify autonomic 
phenotype, looking for impact on cardiac, metabolic and immune outcomes in 
response to cardiac ischaemia, surgical stress and in models of sepsis.  
These interventions may include pharmacological therapy, including beta 
blockade and where appropriate anxiolysis, as well as prehabilitation.   
 
Important outcomes in further studies of EHRi should include perioperative 
biomarkers of cardiac injury including BNP and troponin, as well as dynamic 
perfusion imaging +/- angiography in affected patients to further elucidate the 
link between EHRi and coronary artery disease.  Further exercise testing 
should focus on types and timing of ST depression.  
 
Anxiety scoring, incidence of depressive and affective illness and investigation 
of the cardiac responses to ‘pure’ mental stress (such as mental arithmetic) 
linked to perioperative outcome in targeted patients may help to non-
invasively identify patients at greater risk of adverse perioperative cardiac 
outcomes, even in the absence of known cardiac disease. 
 
6.6.5 Conclusion  
 
This study has identified a significant cohort of patients who exhibit 
cardiovascular changes associated with excess sympatho-adrenal activity in 
the perioperative setting.  These patients develop exercise induced ST 
depression (ECG defined ischaemia) and suffer a prolonged hospital length of 
stay.  
 
These patients may represent a cohort who could benefit from targeted 
intervention, such as perioperative sympatholysis, in order to avoid the 
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deleterious effects of sympathetic autonomic hyperactivity on physiological 
and cellular function. 
 
Prior to the initiation of further perioperative beta blockade trials, a 
mechanistic re-evaluation of the appropriate clinical indications and timing for 
perioperative sympatholysis is warranted. 
 
Data presented in this chapter has also been published in an 
accompanying paper (see appendices) (Whittle et al. 2015) 
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7 Discussion		
 
7.1 Introduction 
 
Convincing clinical and translational data predict a mechanistic role for 
autonomic dysfunction in the pathogenesis of perioperative morbidity.  Data 
presented in this thesis indicate that preoperative parasympathetic autonomic 
dysfunction (PAD) as defined by impaired heart rate recovery in the first 
minute after maximal symptom limited exercise is common (>35% of patients 
studied) and is associated with increased postoperative morbidity and 
mortality in high risk patients undergoing major surgery.  Similarly, 
sympathetic autonomic hyperactivity as defined by excessive heart rate rise 
prior to exercise (EHRi) is common (>40% of patients studied), distinct from 
PAD and associated with increased perioperative morbidity in the same group 
of surgical patients. 
 
Physiological data derived from preoperative cardiopulmonary exercise 
testing (CPET) revealed that impaired post exercise heart rate recovery is 
associated with a distinct exercise phenotype consisting of impaired cardiac 
contractile and chronotropic performance associated with a reduced aerobic 
exercise capacity.  Impairments in cardiac contractile performance were 
further reported intraoperatively.  
 
Lymphocytes isolated preoperatively from individuals with PAD exhibited 
raised levels of a key mediator of G-protein receptor function, G-protein 
receptor kinase 2 (GRK2).  Raised GRK2 levels have not only important 
implications for both beta adrenoreceptor and angiotensin receptor 
expression, with downstream consequences on the cardiac function, but also 
on innate immunity; likely reflected in the increased septic complications 
reported in patients with PAD. 
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These data imply that PAD represents a common, yet previously under-
recognised pathological mechanism, with potentially important implications for 
preoperative risk prediction, perioperative management and postoperative 
outcomes.  
 
Data presented in this thesis derived from the same cohorts of patients, but 
examining sympathetic autonomic hyperactivity as defined by excessive heart 
rate rise (EHRi) prior to the commencement of loaded exercise at the time of 
cardiopulmonary exercise testing, described a group of patients with an 
exercise phenotype distinct from those with PAD, characterised by cardiac 
functional impairment and an increased propensity to myocardial ischaemia 
during exercise. 
 
Intraoperatively, patients with preoperative EHRi were more likely to develop 
significant hypotension; which has elsewhere been associated with impaired 
perioperative outcome (Bijker et al. 2009). 
 
These data again describe a distinct cohort of patients who warrant further 
study, particularly in terms of whether targeted sympatholysis may or may not 
be beneficial in these individuals, in the light of on going efforts to personalise 
medical therapies.   
 
7.2 Summary of key findings 
 
7.2.1 Parasympathetic Autonomic Dysfunction  
 
7.2.1.1 Heart rate recovery is a measure of preoperative   
parasympathetic autonomic dysfunction 
 
Delayed heart rate recovery after cessation of exercise represents delayed 
recovery of vagal tone or parasympathetic autonomic dysfunction (Pierpont et 
al. 2000; Imai et al. 1994a; Savin et al. 1982; Cole et al. 2000).  In an 
analogous population to the one examined in this thesis, delayed heart rate 
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recovery has further been associated with baroreceptor dysfunction, another 
correlate of PAD (Ackland et al., 2016).  Heart rate recovery values in the high 
risk surgical population presented in this thesis, correlate well with those seen 
in at-risk cardiac patient populations, where slower recovery has previously 
been associated with vagal withdrawal. 
 
Heart rate variability, a modality commonly used to assess all aspects of 
autonomic function, also appears related to heart rate recovery in the surgical 
population examined in this thesis.  Reduced heart rate recovery was 
associated with reduced RMSSD heart rate variability (representing vagal 
withdrawal) values both pre- and immediately postoperatively.  RMSSD is 
widely accepted, amongst time domain measures of heart rate variability, as 
being the most representative of parasympathetic withdrawal. 
 
7.2.1.2 Reduced heart rate recovery after exercise is associated 
with a distinct exercise phenotype characterised by 
impaired cardiac contractility at times of physiological 
demand 
 
Reduced heart rate recovery after exercise is associated with physical 
deconditioning, illustrated by reductions in commonly accepted markers of 
aerobic fitness, including VO2 peak and anaerobic threshold.   
 
Reduced heart rate recovery after exercise is further associated with 
chronotropic incompetence, reflected in a raised resting heart rate and 
reduced peak heart rate at time of CPET, which may influence the observed 
reductions in peak VO2 in patients with PAD. 
 
Impaired cardiac contractility in PAD, particularly at times of increased 
physiological demand, was demonstrated by a reduced oxygen pulse at peak 
exercise, which is a surrogate for reduced stroke volume. 
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7.2.1.3 Parasympathetic Autonomic Dysfunction is associated with 
an increased risk of myocardial ischaemia as defined by 
heart rate associated ECG changes during exercise 
 
Patients exhibiting impaired heart rate recovery after exercise are more likely 
to demonstrate a ST/HR index score suggestive of cardiac ischaemia during 
exercise testing.  Furthermore, a reduced oxygen pulse, also common in 
these individuals is strongly associated with myocardial ischaemia.  
 
7.2.1.4 G-protein receptor kinase 2 (GRK2), a key regulator of beta 
adrenoreceptor activity, is elevated in circulating 
lymphocytes isolated from individuals with PAD 
 
GRK2 was elevated in circulating lymphocytes derived from patients with 
impaired heart rate recovery.  These increases appear to reflect the degree of 
PAD in each individual.  Alterations in GRK2 levels in circulating white cells 
are likely to mirror myocardial expression of the beta adrenoreceptor and be 
associated with alterations in innate immune function. 
 
7.2.1.5 Abnormal heart rate recovery is common in high risk 
surgical patients presenting for major surgery 
 
More than 30% of the patients in the study population exhibited reduced heart 
rate recovery after exercise.  Parasympathetic autonomic dysfunction has not 
previously been described in the surgical context.  Patients with PAD 
presenting for surgery may benefit from targeted interventions to reduce 
perioperative risk. 
 
7.2.1.6 PAD is associated with hypertension 
 
Hypertension is strongly associated with baroreceptor dysfunction, itself 
associated with afferent vagal dysfunction (Thrasher 2005).  PAD is also 
associated with diabetes and cardiac failure, conditions where autonomic 
dysfunction is strongly related to prognosis. 
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7.2.1.7 Preoperative parasympathetic autonomic dysfunction 
predicts postoperative morbidity and mortality 
independently of other common risk factors 
 
Whilst an anaerobic threshold of less than 11 ml/kg/min, commonly used to 
predict increased perioperative risk, did predict an increased hospital length of 
stay in the study population, reduced heart rate recovery (PAD) was the 
strongest predictor of a prolonged hospital admission when included in a 
Cox’s proportional hazards model.  
 
In terms of postoperative morbidity, PAD was strongly associated with 
delayed return of normal bowel function, a process dependent on vagal 
activity.   
 
7.2.1.8 Parasympathetic Autonomic Dysfunction is associated with 
an increased risk of postoperative infectious complications 
 
White cell count and neutrophil to lymphocyte ratio were both increased in 
PAD on postoperative day 2 as compared with controls.  Postoperative sepsis 
was also more common in patients with PAD.   
 
7.2.1.9 Parasympathetic Autonomic Dysfunction is associated with 
reduced intraoperative cardiac contractility 
 
Relatively reduced cardiac contractility, as defined by peak velocity, was 
present in PAD at the start of the operative case prior to skin incision.  PAD 
was further associated with a failure to increase cardiac contractility 
significantly in response to fluid resuscitation, resulting in relatively reduced 
cardiac performance at the end of the operative case.  The probability of 
success of fluid optimisation algorithms may be unsure in individuals with 
PAD, warranting further study. 
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7.2.1.10 Parasympathetic Autonomic Dysfunction is associated with 
intraoperative hypotension 
 
The observation of significantly reduced mean arterial pressure 
intraoperatively in patients with PAD was accompanied by an exaggerated 
decrease in cardiac afterload, measured as an increase in corrected flow time 
on the oesophageal Doppler.  Patients with PAD received greater doses of 
vasopressor drugs to maintain blood pressure during surgery.  Cardiac 
autonomic dysfunction has previously been associated with intraoperative 
haemodynamic instability, which in itself is associated with adverse 
perioperative outcomes.   
 
 
7.2.2 Sympathetic Autonomic Hyperactivity 
 
7.2.2.1 Sympathetic autonomic hyperactivity is associated with 
exercise induced cardiac ischaemia 
 
Excess sympathetic drive has previously been shown to be strongly 
associated with increased myocardial oxygen demand, coronary arterial 
spasm, and the promotion of myocardial ischaemia through mechanical 
processes.  Patients with sympathetic autonomic hyperactivity in this study 
were more likely to demonstrate significant ST depression during exercise 
testing.  A reduced oxygen pulse at peak exercise was also demonstrated 
which may also be related to ischaemia related impairments in cardiac 
function.  The degree of electrocardiographically defined cardiac ischaemia 
described was greater in the EHRi cohort than the PAD cohort. 
 
7.2.2.2 EHRi represents a physiological phenotype distinct from 
the one described in PAD 
 
Aside from EHRi, heart rate dynamics were not different before, during and 
after exercise testing in patients with sympathetic autonomic hyperactivity.  
Neither was anaerobic threshold.  
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Abnormal heart rate recovery after exercise (PAD) was not associated with 
EHRi.  Cardiac contractile impairment and ischaemia during exercise were 
indicated through reductions in oxygen pulse at peak exercise, as well as 
Peak VO2.  These findings were mirrored by relative reductions in cardiac 
performance at the end of surgery (represented by stroke volume and peak 
velocity measured with the oesophageal Doppler), despite values for these 
measurements being equivalent after induction of anaesthesia, unlike in PAD 
where relative cardiac contractile impairment was present after induction of 
anaesthesia. 
 
7.2.2.3 EHRi is associated with a prolonged hospital length of stay 
 
Specific morbidity domains were not explored in this thesis, however, the 
increased likelihood of inducible ischaemia during CPET may translate to an 
increased risk of perioperative myocardial injury (Botto et al. 2014; Devereaux 
et al. 2012), itself associated with impaired postoperative outcome. 
 
Global impairments in cardiac function are associated with postoperative 
morbidity in many domains, as well as prolonged hospital length of stay and 
increased mortality.  
 
 
7.3 Interpretation of results 
 
7.3.1 Parasympathetic Autonomic Dysfunction 
7.3.1.1 Parasympathetic Autonomic Dysfunction is common in 
surgical patients and is related to a range of environmental, 
physiological and pathophysiological influences 
 
Parasympathetic autonomic dysfunction has previously been associated with 
impaired outcome in both the short and long-term in both cardiac and general 
medical populations (Cole et al. 2000; Shishehbor et al. 2006; Jouven et al. 
2005).  Moreover, PAD may not immediately be apparent from history or 
clinical examination alone, requiring specialist testing to reveal any deficits.   
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Abnormal heart rate recovery after exercise is common in both the general 
and the wider cardiac population, with the incidence ranging from 20 to 40% 
(Cole et al. 2000; Nishime et al. 2000; Dhoble et al. 2014; Jouven et al. 2005). 
The incidence of >35% in the high-risk surgical population in this study 
corresponds well with that described in cohorts with known cardiac failure. 
 
Heart rate recovery thresholds vary across several large prospective studies.  
The threshold of 12 beats per minute in the first minute after exercise 
identified in this study population corresponded well with that identified in high 
risk cardiac patients (Cole et al. 1999; Nishime et al. 2000).  In other study 
populations however, a range of measurement techniques, time points and 
values for abnormality have been identified (Imai et al. 1994; Jouven et al. 
2005; Pierpont et al. 2000).  What is consistent across these studies is that 
abnormal heart rate recovery values identify patients at highest risk of 
mortality regardless of which specific definition is used.  Similarly, it is well 
established that early heart rate recovery after exercise is representative of 
return of vagal activity (Imai et al. 1994; Sugawara et al. 2001).  The influence 
of vagal withdrawal on both physiological performance and postoperative 
outcome appears to be graded, and patients with the lowest parasympathetic 
activity are at the greatest risk. 
 
The causes of PAD in the surgical population are likely to be varied and not 
linked to a single pathology, but rather a combination of genetic, age related, 
environmental, therapeutic and disease related processes (Trevizani et al. 
2012; Ghaffari et al. 2011; Nishime et al. 2000; Yilmaz et al. 2013; Bilsel et al. 
2006; Sacre et al. 2012). 
 
Impaired heart rate recovery, in this study, did not appear to be influenced by 
whether the patient was taking beta-blocking medication.  This finding is 
supported by those of other studies that also failed to demonstrate any 
influence of continued beta-blockade on heart rate recovery (Pal et al. 2013; 
Crouse et al. 1989).  The lack of influence of sympatholytic medication on the 
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recovery of heart rate after exercise further reinforces the role of return of 
vagal tone over withdrawal of sympathetic activity (Imai et al. 1994). 
 
The PAD phenotype was not solely ascribable to the most commonly 
understood cause of autonomic dysfunction, namely diabetes mellitus, since a 
diagnosis of diabetes was present in less than 20% of the population with 
PAD.  In this study population, hypertension was the diagnosis most 
commonly associated with PAD.  This finding is supported by previous reports 
describing hypertension as the most common pathology associated with 
autonomic impairment (Pal et al. 2013). 
 
7.3.1.2 Heart rate recovery after exercise as a measure of 
parasympathetic autonomic dysfunction. 
 
Heart rate recovery after exercise is well established as a measure of return 
of vagal activity (Pierpont et al. 2000; Lauer 2009; Imai et al. 1994).  Whilst 
CPET was used in this study, in practice, more simple apparatus could be 
used to determine heart rate recovery.  Use of exercise to determine vagal 
withdrawal has the advantage of being non-invasive and also of not requiring 
sophisticated software to determine heart rate dynamics. 
 
In this study, heart rate recovery was measured in the seated position 
following symptom limited maximal exercise.  This technique is both internally 
and externally reproducible and is also compatible with currently used 
exercise testing techniques in the surgical population (e.g. CPET and Bruce 
protocol). 
 
Delayed heart rate recovery, in the patient population studied, was associated 
with reductions both pre and postoperatively with another widely accepted 
marker of vagal withdrawal, namely reduced heart rate variability (rMSSD).  
 
 The interaction between heart rate variability and heart rate recovery is 
complex.  Indeed, heart rate variability alone has been questioned as a 
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reliable indicator of sympatho-vagal balance (Billman 2013; Milicević 2005).  
Certainly, measures of parasympathetic tone derived from analysis of heart 
rate variability are confounded by differences in basal heart rate (O Monfredi 
et al. 2014). 
It is for this reason that heart rate variability measures were not used to 
primarily identify either parasympathetic or sympathetic autonomic 
dysfunction in this thesis.  It is unhelpful to conceive of autonomic function as 
a pendulum swinging from enhanced vagal to sympathetic activity dependent 
on the individual and environmental conditions.  Both sympathetic and 
parasympathetic activities interact, but either system may independently 
demonstrate impairments in function.  This concept is clearly illustrated by the 
lack of interaction between heart rate recovery and pre-exercise heart rate 
increase in the study population described in this thesis.   
 
Where rMSSD is decreased preoperatively in patients with impaired heart rate 
recovery, heart rate variability measures could conceivably be used to predict 
or track perioperative autonomic function, in particular responses to 
physiological challenges and therapeutic strategies.  This would particularly 
be the case where heart rate dynamics at preoperative CPET support a 
diagnosis of PAD or otherwise.  The observation in the POM-O study that 
reduced parasympathetic activity, measured using heart rate variability, after 
goal directed therapy (GDT) was associated with a failure of GDT to improve 
postoperative outcomes is supportive of this concept (Ackland et al. 2015). 
 
Further support for the notion that delayed heart rate recovery is 
representative of parasympathetic dysfunction is provided by observations of 
low spontaneous baroreceptor sensitivity (BRS) in a comparable cohort of 
patients with impaired heart rate recovery to the one described in this thesis 
(Ackland et al., 2016).  BRS, measurable contemporaneously, also proffers a 
potential monitoring modality for perioperative parasympathetic autonomic 
function. 
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7.3.1.3 Clinical and experimental translational research supports a 
mechanistic role for vagal withdrawal in the promotion of 
perioperative morbidity 
 
Both clinical and experimental translational studies have demonstrated in 
other contexts that loss of parasympathetic efferent activity promotes the 
development of cardiovascular and immune impairment, in part through the 
promotion of systemic inflammation (Ackland et al., 2016; Czura & Tracey, 
2005; Tang, Dewland, Wencker, & Katz, 2009). 
 
Conversely, parasympathetic neuromodulation has been used to limit tissue 
injury and morbidity in a range of pathological and experimental conditions 
(Kox et al. 2011; Cheyuo et al. 2011; Dos Santos et al. 2011). 
 
Both established PAD and further reductions in vagal activity in the 
perioperative period might therefore directly contribute to the development of 
postoperative morbidity and mortality. 
 
Data presented in this thesis supports this hypothesis, since both all cause 
and discrete morbidities, linked in other populations with PAD, are associated 
in the surgical population with delayed heart rate recovery.  In particular, 
morbidities mechanistically linked with parasympathetic modulation of tissue 
injury, such as infection, impaired gastrointestinal function and myocardial 
dysfunction, were more common in patients with PAD. 
 
More general markers of perioperative morbidity were also increased in PAD, 
with hospital length of stay, intraoperative hypotension and elevated or severe 
overall morbidity (Clavien-Dindo) scores being more common in this 
population.  Importantly, mortality was also increased in the PAD population.   
These findings are supported by the established pathological role of 
parasympathetic autonomic dysfunction in cardiac failure, where failure to 
improve autonomic function despite maximal medical therapy is also 
associated with increased mortality (Nolan et al. 1998).  A further small study 
in thoracic surgical patients supports morbidity findings presented in this 
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thesis, where a threshold HRR of <12 beats/minute following a six-minute 
walk test was associated with postoperative cardiopulmonary complications 
(Ha et al. 2015). 
 
Excess morbidity in specific domains associated with PAD 
(infectious/inflammatory and gastrointestinal complications) lends further 
support to the hypothesis that vagal withdrawal is the motor driving the 
development of perioperative organ dysfunction. 
 
7.3.1.4 Immune dysfunction secondary to vagal withdrawal may 
underlie the development of perioperative inflammatory and 
infectious complications 
 
The vagal anti-inflammatory reflex (Tracey 2002) is well established as a key 
modulator of innate immunity.  Specific influences on the inflammatory 
response have been well described in both clinical and translational models of 
vagal withdrawal (Czura & Tracey 2005; Desborough 2000b; Rosas-Ballina & 
Tracey 2009; Rosas-Ballina et al. 2011; Thayer et al. 2011; Jankowska et al. 
2006). 
 
Neutrophil to lymphocyte ratio (NLR), a marker of inflammation associated 
with impaired immune function, was not significantly different at baseline in 
patients with PAD, in the postoperative period.  However, NLR values in PAD 
were raised relative to those in patients without PAD.   
 
NLR has been shown in several studies to be a useful biomarker for both 
postoperative morbidity and cancer recurrence (Sultan et al. 2014).  The 
observation that NLR values at baseline were elevated in both patients with 
and without PAD as compared with population norms, may reflect the high 
prevalence of carcinoma (50%) as well as aerobic deconditioning (Sultan et 
al. 2014) in the study population.  Certainly, a low anaerobic threshold, very 
common in the studied cohorts, has been associated with a raised baseline 
NLR as well as down regulation of monocyte CD14+ expression, representing 
chronic inflammation.  Values for preoperative NLR seen here are equivalent 
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to those seen in high risk patients as defined by low AT in a similar surgical 
context (Sultan et al. 2014). 
 
A 641 patient multi-centre prospective observational study (Ackland et al 
2016, manuscript under review), carried out after collection of the data 
presented in this study and with the same inclusion criteria showed graded 
increases in total leucocyte count as well as progressive decreases in 
lymphocyte fraction associated with progressively lower heart rate recovery 
values at baseline.  A heart rate recovery of <12 bpm was associated with an 
NLR of >2.8 and a reduced lymphocyte: monocyte ratio.  Evidence from both 
studies would therefore warrant closer and more detailed examination of the 
role of chronic inflammation in patients with PAD in the development of 
postoperative inflammatory and infectious complications. 
 
CRP, a commonly used marker of inflammation in the clinical setting, was not 
different in individuals with PAD in this study.  However, single CRP values 
alone, which are expected to rise in the postoperative period in all patients, do 
not tell the full story of the perioperative inflammatory response.  Full profiling 
of CRP ebb and flow was not carried out, neither was high sensitivity CRP, a 
potentially more suitable test, assessed at baseline (Edwards et al. 2011).  
 
Further evidence for a potential role for PAD in altered immunity is proffered 
by the observation of raised GRK2 in circulating lymphocytes derived from 
individuals with impaired heart rate recovery at preoperative CPET.  
 
Translational work, where sinoaortic denervation in rodents (SAD) was used 
as a model of parasympathetic autonomic dysfunction carried out in the same 
laboratory (Ackland et al., 2016) supports this hypothesis. 
 
Chronic SAD is associated with elevated angiotensin II levels, which are 
thought to lie at the centre of the physiological and cellular consequences of 
sinoaortic denervation.  Chronic elevations in Angiotensin II, common in 
cardiac failure and baroreceptor dysfunction, mediate end organ damage, 
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hypertension, endothelial, cellular and immune dysfunction (Shan et al. 2004).  
In our SAD model, elevations in angiotensin II were implied through observed 
increases in angiotensin-II receptor 1a expression in conditions of 
baroreceptor dysfunction (Ackland et al., 2016). 
 
One mechanism through which angiotensin II generates cellular dysfunction is 
through mediation of mitochondrial Reactive Oxygen Species (ROS) 
production.  Angiotensin II stimulation induces mitochondrial KATP channel 
opening resulting in mitochondrial membrane depolarisation and consequent 
reversal of electron transfer (Dikalov & Nazarewicz 2013).  
 
The GRK2 up-regulation described in circulating immune cells in this study 
might be attributable in part to increased sympatho-adrenal activity and 
angiotensin II levels, mediated by the beta adrenergic receptor and the 
angiotensin II type 1a receptor (Rockman et al. 1996) (Ackland et al., 2016; 
Lymperopoulos, 2011), however alternative pathways for the modulation of 
this highly conserved mediator, including the generation of mitochondrial 
ROS, have been described and appear increasingly important (Ciccarelli et al. 
2013). 
 
Inflammation, associated with vagal withdrawal, produces mitochondrial 
damage in host cells, compromising cell survival and organ function (Singer 
2007).   The observation that GRK2 localizes at the mitochondrion where it 
plays a protective role during hypoxic/ischaemic conditions by promoting 
mitochondrial biogenesis and increasing ATP production, has led to an 
interest in the role of mitochondrial reactive oxygen species (ROS) in the 
modulation of GRK2 expression (Ciccarelli et al. 2013).  GRK2 levels in 
mitochondria are noted to be elevated in inflammatory states, this elevation is 
felt to be adaptive and protective; in models where GRK2 is deleted, 
exaggerated inflammatory cytokine/chemokine production and end-organ 
damage has been described (Sorriento et al. 2013).  Raised GRK2 in 
leucocytes in PAD might therefore be expected in response to an 
inflammatory phenotype generated by increased mitochondrial reactive 
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oxygen species production in response to increased circulating levels of 
angiotensin II. 
 
Mitochondrial destabilisation with subsequent ROS production is the final 
common pathway of NLRP3 inflammasome activation (Zhou et al. 2010).  The 
mitochondrial destabilisation caused by elevated angiotensin II levels in SAD, 
would therefore be predicted to result in activation of the NLRP3 
inflammasome, further promoting a pro-inflammatory state.  
 
In the SAD model described previously, macrophage mitochondrial ROS 
production at baseline was elevated (Figure 7-1).  GRK2 levels were raised in 
both cardiomyocytes and peritoneal lymphocytes derived from animals with 
experimental baroreceptor dysfunction.  Inflammasome activation with 
consequent increases in caspase-1 was also evident at immunoblot.  These 
observations support the hypothesis that elevated angiotensin II levels in 
response to baroreceptor dysfunction promote mitochondrial ROS release, 
which in turn promotes NLRP3 inflammasome activation and compensatory 
increases in GRK2. 
 
 
Figure 7-1: Constitutive ROS generation in peritoneal macrophages is increased in 
SAD animals as compared with sham operated litter mates (a.u. = arbitrary units, 
p=<0.05). (Unpublished work – Ackland, Del-Arroyo, Whittle) 
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Critical to the function of monocytes as effector cells is their ability to protect 
the host by migrating to inflammatory sites.  This chemotactic role is mediated 
by MCP-1, which binds the G protein-coupled receptor CCR2.  Increases in 
GRK2 expression desensitize the CCR2 receptor, regulating the intensity and 
duration of chemokine stimulation resulting in reduced migration of cells in 
response to chemotactic stimuli (Liu et al. 2013; Aragay et al. 1998).  Raised 
GRK2 levels secondary to increased levels of both adrenocortical and RAAS 
stimulation, resulting in increased mitochondrial ROS production, would be 
expected to result in impaired monocyte chemotaxis, further contributing to 
immune dysregulation.  
 
Elevated GRK2 levels in circulating lymphocytes derived from patients with 
parasympathetic autonomic dysfunction may therefore signal a distinct 
inflammatory immunophenotype.  Full characterization of ROS production, 
mitochondrial function and inflammasome activation is therefore warranted in 
patients with PAD.   
 
 
7.3.1.5 Parasympathetic autonomic dysfunction results in 
postoperative gastrointestinal dysfunction (PGID) 
 
Not only is PGID linked with increased hospital length of stay (Doorly & 
Senagore 2012), it is also strongly linked with postoperative vagal withdrawal 
(Lubbers et al. 2010; Karmali et al. 2015) and inflammation (itself associated 
with PAD) (Havel et al. 1992). 
 
In this study population, PAD was strongly associated with delay in 
resumption of normal bowel function as well as increased hospital length of 
stay.   
 
Strategies to treat PGID through augmentation of vagal activity have included 
direct vagal stimulation and early administration of lipid rich feed (Lubbers et 
al. 2010) as well as sham feeding (which appears to beneficially modulate 
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autonomic activity as measured by heart rate variability) (Karmali et al. 2015) 
and avoidance of morphine (Tu et al. 2014).  These approaches have met 
with mixed success. 
 
To date no study has been made of the influence of established PAD on 
postoperative gastrointestinal function, though a plausible role in the 
pathogenesis of PGID could be hypothesised.  Confirmation of this role is 
proffered by the recorded delay in resumption of bowel function in this study.  
The PAD population may proffer a well-defined cohort in whom strategies to 
augment vagal activity in an attempt to limit PGID could be of benefit. 
 
 
7.3.1.6 The distinct cardiac phenotype described in surgical 
patients with PAD is supported by both translational 
laboratory work and findings in other medical populations 
 
PAD was associated with both reduced anaerobic threshold and peak VO2.  
Chronotropic incompetence, well described in autonomic dysfunction 
(Brubaker & Kitzman 2011), is likely to influence reduced peak VO2, although 
does not fully explain the observed reductions in physical performance. 
 
Reduced cardiac contractility at peak exercise and at the end of surgery was 
evident in patients with PAD.  These reductions appeared ‘dose-dependent’, 
supporting a role for vagal activity in the promotion of positive inotropy.  In this 
study, patients with PAD were unable to increase cardiac output in response 
to inotropic influences in the same way as those with normal parasympathetic 
function, despite baseline cardiac contractility not being different between 
groups.  
 
Reduced vagal activity and autonomic dysfunction are common in, and 
contribute to, the pathogenesis of critical illness (Thayer et al. 2011).  At the 
same time, in critically ill patients, an inability to increase cardiac output in 
response to beta adrenoreceptor stimulation is a negative prognostic factor 
(Collin et al. 2008).  It would appear that patients presenting for major surgery 
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with established parasympathetic autonomic dysfunction, who are at risk of 
developing postoperative morbidity, including critical illness, share this aspect 
of the critical illness phenotype even before the onset of critical illness.   
 
Data from a wide canon of published work, particularly in the cardiac patient 
population, demonstrate that PAD is mechanistically responsible for impaired 
cardiac and therefore reduced exercise performance (Imai et al. 1994b; Ritt et 
al. 2012; Watanabe et al. 2001).  Increasing degrees of autonomic 
dysfunction have previously been linked to increasing impairments in left 
ventricular function (Compostella et al. 2014; Nolan et al. 1998).  Strong 
supportive evidence is accumulating in the wider literature for a mechanistic 
role for sustained vagal activity in the promotion of cardiac contractility. 
 
The M3 subtype of the muscarinic acetylcholine receptor may underlie some 
of the deficits in cardiac function noted in PAD.  Intact M3 activity appears 
central to the modulation of inotropy, especially in pathological conditions.  
Additionally, M3 activity appears to support cytoprotection and adaptive 
ventricular remodelling in cardiac ischaemia.  In models of both cardiac failure 
and cardiac ischaemia, ventricular cardiomyocyte expression of the M3 
receptor appears to increase (Wang et al. 2007; Kakinuma et al. 2009; 
Kakinuma et al. 2005; Kakinuma et al. 2013).  This may reflect an adaptive 
response to the progressive vagal withdrawal that is both prognostic and 
pathognomonic in these conditions.  Further exploration of this relationship in 
human PAD may provide a therapeutic target for the maintenance of cardiac 
function in critical illness and the perioperative period. 
 
A series of experiments carried out with a partner laboratory at UCL 
(Machada et al 2016) support the notion that the strength of vagal tone 
determines exercise capacity.  In this series of experiments, vagal 
preganglionic neurons in the dorsal vagal motor nucleus (DVMN) were 
genetically targeted.  Silencing of these neurons dramatically impaired 
exercise capacity, whereas optogenetic recruitment of the same neurons 
enhanced cardiac contractility and prolonged exercise endurance.   
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These results are supported by the human data presented in this thesis (and 
in the larger surgical population reported in the accompanying manuscript).  
Stroke volume, as represented by oxygen pulse at CPET appears to be 
related in a graded manner to heart rate recovery (or vagal activity). 
 
Parasympathetic autonomic dysfunction represents a disease state where 
appropriate biological variability is impaired, with consequent neurohormonal 
dysregulation.  RAAS and adrenal activation are common, with resultant 
alterations in G-protein coupled receptor (GPCR) trafficking through 
phosphorylation dependent and independent mechanisms (Ackland et al., 
2016).  These changes result in impaired signalling due to homologous 
receptor desensitisation and down regulation (particularly beta adrenergic) 
and are in large part responsible for the loss of inotropy noted in cardiac 
failure. 
 
Cardiac oxidative stress as a result of angiotensin induced mitochondrial ROS 
release, generated though NADPH-oxidase-2 (NOX2) and subsequent 
mitochondrial dysfunction may also underlie decrements in cardiac contractile 
function (Ackland et al., 2016).  NOX2 activation also contributes to cardiac 
hypertrophy and may further impair contractility through impairment of optimal 
calcium release in response to stretch (Murdoch et al. 2011; Bendall et al. 
2007; Choi et al. 2008). 
 
The elevated GRK2 levels noted in circulating lymphocytes derived from 
patients with PAD are likely to reflect expression in ventricular cardiomyocytes 
from the same individuals (Ackland et al., 2016; Iaccarino et al., 2005).  This 
observation has been confirmed in a series of translational experiments 
carried out with other investigators in the same laboratory at UCL (Ackland et 
al., 2016)(see appendix for manuscript).  SAD was again used as an 
experimental model of PAD.  Molecular and physiological changes invoked by 
sinoaortic denervation were compared with those noted in the same patient 
population described in this thesis. 
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As in critical illness, and likely through shared mechanisms, PAD was 
associated with an inability to mount an appropriate contractile response to 
beta adrenergic stimulation (both during exercise and surgery).  SAD, 
similarly, was associated with a failure to respond to inotropy (a dobutamine 
challenge test) with increases in cardiac contractility.   
 
In a parallel manner, as in established cardiac failure, GRK2 elevation was 
noted in both circulating lymphocytes in PAD and in both peritoneal 
leucocytes and ventricular cardiomyocytes in SAD.  Beta-arrestin expression, 
a downstream mediator from GRK2 of beta adrenoreceptor recycling and of 
cell survival signalling, was also increased in the rat model of SAD.   
 
As previously described, NOX2 induced ROS release, acting in part to 
increase GRK2 expression, may underlie some of the observed changes in 
cardiac contractility as with alterations in immune function.  In a murine NOX2 
knockout model, GRK2 levels did not rise after SAD in ventricular 
cardiomyocytes derived from knockout animals.  Ejection fraction was, 
moreover preserved in the same NOX2 -/- animals after SAD.  These findings 
strongly support a role for oxidative stress underlying the cardiac dysfunction 
noted in both SAD and PAD (Ackland et al. 2016).   
 
Taken together, a series of mechanisms have been described in the 
laboratory whereby intact vagal function is necessary to support demand 
related increases in cardiac contractile function.  These laboratory studies are 
supported both by the observation of impaired cardiac contractility in surgical 
patients with PAD and by evidence of altered G-protein coupled receptor 
regulation in the same patients.  A series of potential therapeutic targets for 
the support and preservation of cardiac inotropic function are implied by the 
influence of PAD on cardiac contractility.   
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7.3.1.7 Parasympathetic Autonomic Dysfunction is associated with 
an increased risk of inducible myocardial ischaemia 
 
PAD was associated with an increased likelihood of exhibiting an ST/HR 
index score suggestive of myocardial ischaemia and ischaemic heart disease. 
Individuals with an elevated ST/HR score are at increased risk of positive 
coronary angiography, cardiac morbidity and mortality (Kligfield 2008; Okin et 
al. 1996).  Furthermore, an abnormal heart rate recovery has, in cardiac 
patients, been associated with inducible impairments in left ventricular systolic 
function during exercise, presumed in part due to myocardial ischaemia, but 
remaining independently predictive of death (Watanabe et al. 2001). 
 
Further support for inducible cardiac ischaemia in PAD is provided by the 
observation of a reduced peak oxygen pulse in this study, which perhaps 
reflects inducible impairments in left ventricular systolic function described by 
Watanabe.  A reduced oxygen pulse is strongly associated with the presence 
of myocardial ischaemia during exercise, possibly due to a flattening of the 
VO2/Heart rate curve at the onset of ischaemia due to a reduced stroke 
volume (Belardinelli et al. 2003).   
 
Surgical patients with heart rate recovery defined PAD manifest certain key 
features suggestive of myocardial ischaemia during exercise testing.  
Coronary artery disease is increasingly recognized as a disease of chronic 
inflammation.  This lends support to the observations that PAD is associated 
with ischaemic heart disease and cardiac failure in surgical patients, manifest 
by impaired cardiac performance during CPET. 
 
These observations have important clinical implications for the high-risk 
surgical patient with PAD.  Not only is increased vigilance for perioperative 
myocardial ischaemia mandated by these findings, but also support of vagal 
function is suggested as a potential therapeutic target in the prevention of 
perioperative myocardial injury. 
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7.3.1.8 Prospective data supports a role for parasympathetic 
autonomic dysfunction in the generation of postoperative 
morbidity 
 
In a multi-centre prospective study (POM-HR) of 641 patients with the same 
inclusion criteria as described in this thesis (Ackland 2016 – under review 
brain immunity and behaviour), post operative morbidity was measured using 
the Postoperative morbidity score (POMS) on days 3 and 5.  Abnormal heart 
rate recovery, present in 44% of the studied population, was defined, as here, 
as being ≤12 bpm.  
 
Delayed heart rate recovery was more common in patients with a reduced 
anaerobic threshold (<11.1 ml.kg.min-1), as reflected in the data presented in 
this thesis.  Again, beta blockade was not associated with reduced heart rate 
recovery. However, as in this study, the likelihood of receiving cardiac or 
diabetic medications was associated with PAD.  Hypertension was again 
affirmed as the most commonly linked pathology with autonomic impairment. 
 
PAD was associated with increased postoperative cardiovascular dysfunction, 
specifically hypotension, and renal morbidity by postoperative day 5.  
Similarly, time to become morbidity free was delayed across all patients and 
operation types included in the study.  This was reflected in prolonged 
hospitalisation; PAD being independently associated with delayed hospital 
discharge in Cox regression analysis. 
 
As described previously, patients with impaired heart rate recovery enrolled in 
POM-HR were more likely to demonstrate leucocyte subset measures 
associated with chronic inflammation and postoperative morbidity/cancer 
occurrence at baseline.  Postoperative changes in NLR were not described. 
 
These data, suggesting not only a chronic inflammatory phenotype in PAD, 
but organ system specific morbidity that can plausibly be linked to 
parasympathetic autonomic dysfunction, further support a role for established 
vagal withdrawal in impaired perioperative outcomes.   
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7.3.2 Sympathetic Autonomic Dysfunction 
 
7.3.2.1 Sympathetic Autonomic Dysfunction is associated with a 
distinct cardiac phenotype and impaired perioperative 
outcomes 
 
Both sympathetic and parasympathetic autonomic dysfunction are, through 
complementary, sometimes overlapping, but ultimately different, mechanisms, 
predicted to result in impaired perioperative outcomes.  Data presented in this 
thesis demonstrate that an abnormal sympathetic autonomic response 
provoked by unloaded pedalling prior to loaded exercise at CPET is 
associated with a specific physiological phenotype, comprising ECG defined 
cardiac ischaemia, impaired cardiac performance and resulting in a prolonged 
hospital stay postoperatively. 
 
Importantly, the cohort exhibiting an excessive heart rate increase (EHRi) 
prior to exercise, whilst overlapping with, was not the same as that exhibiting 
PAD. The presence of both forms of autonomic dysfunction was associated 
with an especially poor perioperative prognosis. 
 
Excessive heart rate increase prior to exercise is more common in females 
than males and is related to mental stress (Jouven et al. 2009).  Despite 
similar levels of deconditioning across groups (anaerobic threshold was not 
different in between cohorts with and without EHRi), peak VO2 was impaired 
in patients with sympathetic hyperactivity.  
 
Regardless of a similar prevalence of hypertension across groups, blood 
pressure was also raised at the start of exercise in the EHRi cohort, further 
suggesting that sympathetic activation due to anxiety underlies the excessive 
heart rate increase noted.  Population data supporting an increased 
prevalence of anxiety and an increased likelihood of heart rate reactivity in 
females further support mental stress underlying heart rate dynamic changes 
described in this thesis.  
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In the wider literature, several studies using different experimental models 
have also demonstrated that mental stress alone can trigger myocardial 
ischaemia (Deanfield et al. 1984; Yeung et al. 1991).  It is therefore 
conceivable that mental stressors such as task-orientated tests (e.g. mental 
arithmetic) could similarly identify individuals at preoperative assessment who 
are at risk of sympathetic autonomic hyperactivity.  Both this possibility and a 
potential role of preoperative anxiolysis in these higher risk individuals should 
form the basis of future studies. 
 
Systemically, sympathetic autonomic hyperactivity has been implicated in 
immune and cellular dysfunction, bacterial overgrowth, infection, 
intraoperative haemodynamic embarrassment, hepatic dysfunction and the 
pathogenesis of acute lung injury (Toner et al. 2013).  Sympathetically 
mediated intraoperative hypertension and tachycardia have been associated 
elsewhere with postoperative morbidity and prolonged hospital stay after 
major non-cardiac surgery.  Again, inter-individual genetic differences 
(previously described in the perioperative population in the context of beta-
blocker responsiveness and perioperative myocardial infarction) in adrenergic 
response, may underlie the heart rate response to mental stress and should 
form the basis of future studies.   
 
The preoperative identification of individuals at highest risk of excessive 
sympathetic activation could form the basis for targeted sympatholysis.  This 
is important, since to date, strategies where all higher risk patients are 
submitted to beta-blockade have demonstrated an excessive incidence of off-
target effects (POISE Group, 2008).    
 
These data suggest a need to re-evaluate perioperative modulation of 
sympathetic outflow in the light of this description of a potential ‘at-risk’ cohort.  
Mechanistic re-evaluation of indications and timing of perioperative beta and 
alpha blockade may prove fruitful in maximising benefit and minimising harm 
resultant from these potentially powerful interventions.   
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7.4 Importance of results 
 
Data presented in this thesis represent the first time that preoperative heart 
rate dynamics measured at time of CPET have been used to evaluate the 
impact of autonomic dysfunction on relevant perioperative outcomes.   
 
Both parasympathetic and sympathetic autonomic dysfunction are revealed 
as common in the high risk surgical population and are associated with 
cardiopulmonary dysfunction and increased risk of impaired perioperative 
outcomes.  The demographics of the populations presented in this thesis 
would suggest that results presented here are generalizable to the wider high-
risk non-cardiac surgical population.  
 
Autonomic dysfunction, through a variety of mechanisms, is highly likely to 
mechanistically drive multi-organ dysfunction.  In particular, important 
perioperative morbidities including hypotension, infection and cardiac 
dysfunction were more common in patients with PAD, results that are 
consistent with laboratory data exploring the pathophysiological role of 
parasympathetic autonomic dysfunction. 
 
Aside from reinforcing the need to continue relevant translational mechanistic 
research into pathways by which autonomic dysfunction drives cardiac, 
metabolic and immune dysfunction, several potentially powerful therapeutic 
interventions are indicated for further investigation. 
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7.5 Further work 
 
The exploratory work presented in this thesis suggests several promising 
potential avenues for further investigation. 
 
7.5.1 Clinical studies 
 
7.5.1.1 Confirmation of autonomic dysfunction as an independent 
risk factor for perioperative morbidity and improvement of 
surgical risk prediction tools 	
The results of the first multi centre prospective study in high-risk surgical 
patients using the same criteria as described in this study for defining PAD 
have now been collated (see Appendices).  These data confirm an 
independent association between PAD and increased perioperative morbidity. 
 
Further study should now confirm the association in different specific surgical 
populations (e.g. cancer patients, especially those who have received 
chemotherapy which is strongly associated with oxidative stress and 
decrements in autonomic function (Adams et al. 2015; Morrow et al. 1992; 
Tjeerdsma et al. 1999; Nuver et al. 2005)).  Similarly, a role for chronic 
inflammation associated with autonomic dysfunction in the development of 
postoperative morbidity should be explored.  Particular areas of focus should 
include pre-defined morbidity (specifically gastrointestinal and cardiac 
dysfunction), as well as examining in more detail other complementary 
readouts of autonomic function including heart rate variability and 
baroreceptor sensitivity.  
 
These data should then be used both to refine existing risk prediction models 
and in the development of new risk prediction tools.   
 
 
		  267 	
 
Discussion 
	
	 	
7.5.1.2 Detailed profiling of perioperative autonomic activity in 
relation to outcome, cardiac and immune function 
 
Profiling of a ‘normal’ autonomic response to a pre-defined 
surgical/anaesthetic insult would help define abnormality and allow 
identification of an abnormal perioperative autonomic trajectory.  A potential 
role for autonomic monitoring in the perioperative period (baroreceptor 
sensitivity or heart rate variability) to guide therapeutic interventions could 
then be investigated.  Similarly, description of baseline levels and 
perioperative profiles of serum angiotensin II and catecholamine levels in 
patients with and without autonomic dysfunction may aid in the development 
of specific therapeutic strategies.  In particular, relation of catecholamine and 
angiotensin levels to markers of cardiac and immune dysfunction as well as 
continuous measures of autonomic dysfunction could tailor therapeutic 
interventions to time points of greatest efficacy.   
 
Biomarkers of cardiac dysfunction and/or damage should be examined 
throughout the operative period in patients with and without autonomic 
dysfunction and associated with outcome.  These should include troponin, 
HsCRP and BNP.  Association with markers of severity of autonomic 
dysfunction should be sought.  These observations could inform therapeutic 
trials of ‘tailored’ interventions, such as beta blockade or anxiolysis, through 
identification of those at highest risk of complications. 
 
 
7.5.1.3 Risk profiling and proactive management of specific 
morbidities associated with autonomic dysfunction 
 
Proactive management of other specific postoperative morbidities associated 
with autonomic dysfunction should be explored; this could include sham 
feeding for PGID. 
 
The use of heart rate dynamics during exercise alone, without formal Bruce 
protocol testing or CPET could be examined.  Other modes of assessment of 
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autonomic function should also be explored, including heart rate responses to 
mental stressors (e.g. mental arithmetic).   
7.5.1.4 Interventions to enhance vagal activity 
 
Strategies to optimise vagal tone throughout the perioperative period may be 
explored.  Aerobic training may improve autonomic function in addition to 
aerobic fitness (Collier et al. 2009; Jin et al. 2013), though sedentary 
individuals with low vagal activity at the start of an exercise programme 
appear to benefit least (Hautala et al. 2003).  
 
Similarly, relaxation techniques such as guided meditation may be explored in 
the preoperative period for any impact on parasympathetic activity and 
postoperative outcome. 
 
Therapeutic interventions common in the perioperative period such as 
neuraxial anaesthesia, analgesic choice (e.g. use of remifentanil), avoidance 
of anticholinergic agents, early feeding etc. could be bundled to produce a 
‘vagus friendly’ strategy which would be hypothesised to reduce perioperative 
morbidity in patients with PAD.  This would be best tested in a randomised 
controlled trial. 
 
Finally, non-invasive vagal stimulation throughout the perioperative period 
should be evaluated as a potential therapeutic modality for individuals with 
PAD.  Non invasive vagal stimulation has been used with success in several 
conditions such as rheumatoid arthritis, depression, epilepsy and in cardiac 
failure (Kraus et al. 2007; Clancy et al. 2014; Bonaz, Bruno; Sinniger, Valerie; 
Pellissier 2011; Krahl & Clark 2012; De Ferrari 2014).  It has not, however, 
been used in the acute setting, its efficacy in this context is therefore not 
known. 
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7.6 Conclusion 
 
Maintenance of biological variability is central to health and is coordinated by 
the autonomic nervous system.  Loss of biological variability, manifest in both 
parasympathetic and sympathetic autonomic dysfunction, promotes a 
multitude of pathophysiological processes resulting in morbidity and mortality. 
 
In high-risk patients undergoing major surgery, autonomic dysfunction is 
associated with several pathophysiological mechanisms that have been 
previously demonstrated to negatively influence postoperative outcome.  Data 
presented in this thesis demonstrate that both parasympathetic and 
sympathetic autonomic dysfunction is associated with increased perioperative 
morbidity and hospital length of stay. 
 
Parasympathetic Autonomic Dysfunction is common in the high-risk surgical 
population and is associated with markers of systemic inflammation and 
immune dysfunction as well as impairments in cardiac contractile function at 
times of increased physiological demand.   
 
Sympathetic Autonomic Dysfunction, also common in the study population, 
was present in a population distinct from that presenting with PAD and was 
associated in particular with an increased risk of inducible myocardial 
ischaemia accompanied by decrements in myocardial contractile 
performance. 
 
Several implications arise as a consequence of these data.  First, further work 
to establish population norms for this particular group of patients may provide 
a useful preoperative screening test.  Second, these data provide an 
alternative, novel explanation for the continuing debate over conflicting data in 
the perioperative haemodynamic literature (Doherty & Buggy 2012).  Third, 
controversies over various perioperative pharmacological interventions 
including beta-blockade (Devereaux 2008) and clonidine (Devereaux, Sessler, 
et al. 2014) may be re-addressed by targeted, personalized drug 
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administration guided by autonomic phenotype.  The precedent of 
sympathetic (beta adrenoreceptor) blockade improving autonomic function in 
heart failure (Floras 2009) is an important example of how uncovering 
otherwise clinically concealed information can refine management 
significantly.   
 
These data offer further support to the concept that autonomic dysfunction, far 
from being merely associated with pathology, underlies and mechanistically 
drives the development of multi-organ dysfunction.   
 
Further investigation is warranted, particularly in the context of the high risk 
surgical patient, of both mechanisms through which autonomic dysfunction 
might drive the development of morbidity and therapeutic interventions and 
strategies to minimise the unwanted impact of this previously under 
recognised disease process. 
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2) COMPETE-C	Study	protocol		
ISRCTN14680495 DOI 10.1186/ISRCTN14680495 
Cardiac Output Monitoring and Pre-operative Exercise Testing for Colorectal 
surgery 
 
Primary contact 
Dr Gary Minto 
Contact details 
Department of Anaesthesia 
9th Floor Plateau 
Derriford Hospital 
Plymouth 
PL68DH 
United Kingdom 
+44 (0)1752 439205 
gary.minto@phnt.swest.nhs.uk 
 
Study information 
Scientific title 
Amongst patients having major elective colorectal surgery does intraoperative 
goal directed fluid therapy particularly decrease postoperative hospital length 
of stay in patients who are categorised "high risk" on the basis of a 
preoperative cardiopulmonary exercise test result? - a double-blind parallel-
arm randomised controlled single-centre trial 
Acronym 
COMPETE-C 
Study hypothesis 
Major colorectal surgery has traditionally been associated with a prolonged 
hospital stay and a moderate risk (1-5%) of mortality or serious 
cardiopulmonary morbidity.  
 
Improved outcomes have been reported by international units and in NHS 
hospitals using a specific care bundle for major colorectal surgery: "Enhanced 
Recovery after Surgery" (ERAS). Such patient care pathways employ a 
multimodal approach to promote a rapid return to normal function. The Danish 
group around Kehlet, the originator of ERAS, claim that a hospital stay of 3 
days or less for major colorectal surgery is now customary in their institutions 
whilst median stays using an ERAS approach of around 6 days have been 
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produced elsewhere  
 
Controversies exist regarding intraoperative fluid management for major 
colorectal surgery. In recent decades fluid restriction has been advocated, 
however such an approach uniformly applied risks bowel ischaemia and other 
complications.  
 
Goal Directed Fluid therapy (GDT) refers to fluid management targeted 
toward improving the cardiac output to set levels, hence improving end organ 
perfusion. Minimally invasive devices are now available to measure cardiac 
stroke volume. Intra-operative GDT has been shown to reduce median 
hospital length of stay after major colorectal surgery from 9 to 7 days.  
 
This study aims to determine whether goal directed fluid therapy gives 
additional benefit to patients undergoing surgery within an ERAS programme, 
and aims to address the controversies regarding fluid management.  
 
As of 2007, Plymouth Hospitals NHS Trust provides a service to risk stratify 
patients undergoing elective surgery by Cardiopulmonary Exercise Testing 
(CPET), which can identify patients with a low cardiorespiratory reserve. 
These patients are at increased risk of complications after surgery. We have 
the capacity to perform CPET pre-operatively for all patients booked for 
elective major colonic or colorectal resection surgery. It may be that a subset 
of less fit patients may benefit more from GDT than a fitter cohort. 
Ethics approval 
Cornwall and Plymouth Research Ethics Committee, approved on 09/09/2008 
(ref: 08/H0203/159) 
Study design 
Double-blind parallel-arm randomised controlled single-centre trial 
Primary study design 
Interventional 
Secondary study design 
Randomised controlled trial 
Trial setting 
Hospitals 
Trial type 
Treatment 
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Condition 
Elective major colorectal surgery 
Intervention 
1. Cardiopulmonary Exercise Test (CPET)  
The CPET test will be done in accordance with the consensus protocol from 
UK centre with reference to American Thoracic Society (ATS)/ American 
College of Chest Physicians (ACCP) recommendations. Anaerobic threshold 
will be determined by the V slope method with correlation with ventilatory 
equivalents.  
 
2.Oesophageal Doppler monitoring (and Goal Directed Fluid Therapy)  
All patients will receive oesophageal Doppler monitoring throughout the 
operation. This monitoring will be carried out by a trained investigator. 
Patients in the intervention group will be given warmed colloid (6% 
Hydroxyethyl starch) before surgical incision to reach GDT goals as per a 
predetermined protocol and have additional fluid boli administered as dictated 
by this algorithm until cessation of surgery.  
 
The disposable oesophageal probe will be removed at the conclusion of 
surgery. The anaesthetist responsible for care will be blinded to the Doppler 
readings. The researcher carrying out the optimisation will be aware of all 
anaesthetic activity. 
Intervention type 
Procedure/Surgery 
Primary outcome measures 
Amongst patients having major elective colorectal surgery under an Enhanced 
Recovery after Surgery (ERAS) pathway: 
1. Does intraoperative goal directed fluid therapy decrease postoperative 
hospital length of stay when compared with standard therapy alone in patients 
who are categorised “high risk” on the basis of a preoperative 
cardiopulmonary exercise test result? 
2. Does intraoperative goal directed fluid therapy decrease postoperative 
hospital length of stay when compared with standard therapy alone in patients 
who are categorised “standard risk” on the basis of a preoperative 
cardiopulmonary exercise test result? 
3. Does intraoperative goal directed fluid therapy decrease postoperative 
hospital length of stay when compared with standard therapy alone in all 
patients? 
Secondary outcome measures 
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Amongst patients having major elective colorectal surgery under an ERAS 
pathway, does intraoperative goal directed fluid therapy make a difference to 
the following when compared with standard therapy alone?:  
1. Peri-operative mortality (30 days)  
2. Postoperative hypotension 
3. Postoperative fluid requirement 
4. Return of gastrointestinal function  
5. Tolerance of diet 
 
Secondary outcomes 2-5 will be assessed every post-op day until the 
participants meet discharge criteria (median length of stay for this surgery is 
currently 9 days [as of 17/02/2009]). 
Eligibility 
Participant inclusion criteria 
1. Both males and females, age 18 and older  
2. Elective colorectal surgical patients scheduled for major surgery 
3. Patients with a measurable anaerobic threshold (AT) above 8 ml O2/kg/min 
Participant type 
Patient 
Age group 
Adult 
Gender 
Both 
Target number of participants 
168 
Participant exclusion criteria 
Absolute:  
1. Unwillingness to participate  
2. Inability to perform the tests and consent within the timetable for elective 
surgery  
3. Measured Anaerobic Threshold below 8 ml O2/kg/min. Such patients will 
be considered to be extremely unfit and as such will not be suitable for 
inclusion in the trial.  
4. Withdrawn by anaesthetist or surgeon  
5. Acute myocardial infarction (3–5 days)  
6. Unstable angina  
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7. Uncontrolled arrhythmias causing symptoms or haemodynamic 
compromise  
8. Syncope  
9. Active endocarditis  
10. Acute myocarditis or pericarditis  
11. Symptomatic severe aortic stenosis  
12. Uncontrolled heart failure  
13. Acute pulmonary embolus or pulmonary infarction  
14. Thrombosis of lower extremities  
15. Suspected dissecting aneurysm  
16. Uncontrolled asthma  
17. Pulmonary edema  
18. Room air desaturation at rest <85% 
19. Respiratory failure  
20. Acute noncardiopulmonary disorder that may affect exercise performance 
or be aggravated by exercise (i.e. infection, renal failure, thyrotoxicosis)  
21. Severe oesophageal disease  
22. Recent oesophageal or upper airway surgery  
23. Systemic steroid medication  
24. Bleeding diathesis  
 
Relative:  
25. Left main coronary stenosis or its equivalent  
26. Moderate stenotic valvular heart disease  
27. Severe untreated arterial hypertension at rest (200 mm Hg systolic, 120 
mm Hg diastolic)  
28. Tachyarrhythmias or bradyarrhythmias  
29. High-degree atrioventricular block  
30. Hypertrophic cardiomyopathy  
31. Significant pulmonary hypertension  
32. Advanced or complicated pregnancy  
33. Electrolyte abnormalities  
34. Orthopaedic impairment that compromises exercise performance 
Recruitment start date 
10/03/2009 
Recruitment end date 
31/12/2010 
 
 
Publication summary 
2011 results in http://www.ncbi.nlm.nih.gov/pubmed/21873370 
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Supplemental Materials: 
1) Summary Table of all types of surgery included in this thesis 
 
Surgical	Specialty	 Type	of	surgery:	 Total	number	per	
specialty	
Urology:	 Prostatectomy	 170	
	 Nephrectomy	
	 Cystectomy	
	 Cystourethoscopy	
	 Neobladder	formation	
	 Mitrofannoff	formation	
General	Surgery	 Laparotomy	 406	
	 Reversal	colostomy	
	 Colectomy	
	 Formation	ileostomy	
	 Reversal	ileostomy	
	 Anterior	Resection	
	 Incisional	Hernia	Repair	
	 Hiatus	Hernia	repair	
	 Proctectomy	
	 Division	of	Adhesions	
	 Exanteration	pelvis	
	 Inguinal	Hernia	repair	
	 Enterocutaneous	fistula	
repair	
	 Rectopexy	
	 Pouch	formation	
	 Panproctocolectomy	
	 Small	bowel	resection	
	 Reversal	of	Hartmann’s	
	 Rectopexy	
Upper	GI/HPB	surgery	 Oesophagectomy	 81	
	 Gastrectomy	
	 Liver	resection	
	 Whipple’s	procedure	
Plastics:	 Abdominal	Wall	
reconstruction	
2	
Vascular	Surgery	 Open	repair	AAA	 57	
	 Endovascular	repair	AAA	
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(EVAR	&	FEVAR)	
	 Repair	Thoracoabdominal	
aneurysm	
	 Popliteal	aneurysm	repair	
	 Aortic	arch	repair	
Gynaecological	surgery	 Hysterectomy,	Salpingo-
oophorectomy	
4	
	 Rectal-Vaginal	fistula	
repair	
	 Transvaginal	rectocele	
repair	
	 Myomectomy	
Maxillo-Facial	Surgery	 Free-Flap	 90	
	 Neck	Dissection	
	 Surgical	Resection	of	oral	
tumour	
	 Resection	parotid	tumour	
Orthopaedic	 Sacrum	fixation	 4	
	 Hip	Replacement	
	 Knee	Replacement	
	 Other	Orthopaedic	
Procedure	
 
2) Oxygen Pulse classified by quartile of preoperative anaerobic 
threshold 
 
Anaerobic threshold quartile is ml.O2.kg 
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Oxygen	Pulse		
(ml.O2.beat-1)	
Quartile	1:		
AT<9	
Quartile	2:	
AT	9	-10.9	
Quartile	3:	
AT	11-13	
Quartile	4:	
AT	>13	
Mean	 9	 10.2	 11.4	 12.9	
95%	 CI	 of	
mean	
8.5-9.4	 9.9-10.6	 11-11.7	 12.1-136	
 
3) Full Hazard Ratios for hospital length of stay 
Likelihood	of	remaining	in	hospital	
Condition:	 Hazard	Ratio	(Mantel-Cox)	
(95%	CI)	
P	value	
Normal	Heart	Rate	
Recovery	vs.	Abnormal	
Heart	Rate	Recovery	
1.45	(1.14-1.9)	 0.0027	
Anaerobic	Threshold	<11	
vs.	Anaerobic	Threshold	
>11	
1.3	(1.13-1.5)	 0.0004	
Normal	Heart	Rate	
Recovery	vs.	Anaerobic	
Threshold	<11	&	
Abnormal	Heart	Rate	
Recovery	
1.5	(1.3-1.8)	 <0.001	
 
 
